<html lang="en"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <link rel="shortcut icon" href="./favicon.png">
    <link rel="preload" href="./static/media/SourceSansPro-Regular.DZLUzqI4.woff2" as="font" type="font/woff2" crossorigin="">
    <link rel="preload" href="./static/media/SourceSansPro-SemiBold.sKQIyTMz.woff2" as="font" type="font/woff2" crossorigin="">
    <link rel="preload" href="./static/media/SourceSansPro-Bold.-6c9oR8J.woff2" as="font" type="font/woff2" crossorigin="">

    <title>app</title>

    <!-- initialize window.prerenderReady to false and then set to true in React app when app is ready for indexing -->
    <script>
      window.prerenderReady = false
    </script>
    <script type="module" crossorigin="" src="./static/js/index.BlylrL8P.js"></script>
    <link rel="stylesheet" crossorigin="" href="./static/css/index.DpJG_94W.css">
  <style media=""></style><style data-emotion="st-emotion-cache-global" data-s=""></style><style data-emotion="st-emotion-cache" data-s=""></style><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/index.BqlD3NTA.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/index.DW_MHI2K.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/FormClearHelper.UtDFKbpT.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/FileHelper.DV2KuUj6.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/ProgressBar.BtMHwdZZ.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/Hooks.YZgOFmbn.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/UploadFileInfo.C-jY39rj.js"></head>
  <body>
    <noscript>You need to enable JavaScript to run this app.</noscript>
    <div id="root"><div class=""><div class="withScreencast" data-testid="stScreencast"><div class="stApp stAppEmbeddingId-t80xj8le8w0l st-emotion-cache-1r4qj8v ee4bbma0" data-testid="stApp" data-test-script-state="notRunning" data-test-connection-state="CONNECTED"><header tabindex="-1" class="stAppHeader st-emotion-cache-12fmjuu e4hpqof0" data-testid="stHeader"><div class="stDecoration st-emotion-cache-1dp5vir e4hpqof1" data-testid="stDecoration" id="stDecoration"></div><div class="stAppToolbar st-emotion-cache-15ecox0 e4hpqof2" data-testid="stToolbar"><div class="stToolbarActions st-emotion-cache-1p1m4ay e1i26tt72" data-testid="stToolbarActions"></div><span id="MainMenu" class="stMainMenu st-emotion-cache-czk5ss ev04twb8" data-testid="stMainMenu" aria-haspopup="true" aria-expanded="false"><button kind="headerNoPadding" data-testid="stBaseButton-headerNoPadding" aria-label="" class="st-emotion-cache-l1ktzw em9zgd018"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="e144pc0f1 st-emotion-cache-1pbsqtx ex0cdmw0"><path fill="none" d="M0 0h24v24H0V0z"></path><path d="M12 8c1.1 0 2-.9 2-2s-.9-2-2-2-2 .9-2 2 .9 2 2 2zm0 2c-1.1 0-2 .9-2 2s.9 2 2 2 2-.9 2-2-.9-2-2-2zm0 6c-1.1 0-2 .9-2 2s.9 2 2 2 2-.9 2-2-.9-2-2-2z"></path></svg></button></span></div></header><div class="stAppViewContainer appview-container st-emotion-cache-1yiq2ps eht7o1d0" data-testid="stAppViewContainer" data-layout="narrow"><section tabindex="0" class="stMain st-emotion-cache-bm2z3a eht7o1d1" data-testid="stMain"><div class="stMainBlockContainer block-container st-emotion-cache-mtjnbi eht7o1d4" data-testid="stMainBlockContainer"><div data-testid="stVerticalBlockBorderWrapper" data-test-scroll-behavior="normal" class="st-emotion-cache-0 eu6p4el5"><div class="st-emotion-cache-b95f0i eu6p4el4"><div class="stVerticalBlock st-emotion-cache-1n76uvr eu6p4el3" data-testid="stVerticalBlock" width="704"><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="stHeading" data-testid="stHeading"><div data-testid="stMarkdownContainer" class="st-emotion-cache-1104ytp e1icttdg0"><div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 id="olmocr">OLMOCR<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#olmocr" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div></div></div></div><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="st-emotion-cache-8atqhb e1mlolmg0"><div class="stFileUploader st-emotion-cache-0 e17y52ym15" data-testid="stFileUploader" width="704"><label data-testid="stWidgetLabel" aria-hidden="true" class="st-emotion-cache-1s2v671 e1dx5vew0"><div data-testid="stMarkdownContainer" class="st-emotion-cache-wq5ihp e1icttdg0"><p>Upload a PDF or Image</p></div></label><section role="presentation" tabindex="0" data-testid="stFileUploaderDropzone" aria-label="Upload a PDF or Image" class="st-emotion-cache-1gulkj5 e17y52ym0"><input data-testid="stFileUploaderDropzoneInput" accept="application/streamlit,.pdf,.png,.jpg,.jpeg" type="file" style="border: 0px; clip: rect(0px, 0px, 0px, 0px); clip-path: inset(50%); height: 1px; margin: 0px -1px -1px 0px; overflow: hidden; padding: 0px; position: absolute; width: 1px; white-space: nowrap;" tabindex="-1"><div data-testid="stFileUploaderDropzoneInstructions" class="st-emotion-cache-u8hs99 e17y52ym1"><span class="st-emotion-cache-nwtri e17y52ym2"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="e144pc0f1 st-emotion-cache-6rlrad ex0cdmw0"><path fill="none" d="M0 0h24v24H0V0z"></path><path d="M19.35 10.04A7.49 7.49 0 0012 4C9.11 4 6.6 5.64 5.35 8.04A5.994 5.994 0 000 14c0 3.31 2.69 6 6 6h13c2.76 0 5-2.24 5-5 0-2.64-2.05-4.78-4.65-4.96zM19 18H6c-2.21 0-4-1.79-4-4 0-2.05 1.53-3.76 3.56-3.97l1.07-.11.5-.95A5.469 5.469 0 0112 6c2.62 0 4.88 1.86 5.39 4.43l.3 1.5 1.53.11A2.98 2.98 0 0122 15c0 1.65-1.35 3-3 3zM8 13h2.55v3h2.9v-3H16l-4-4z"></path></svg></span><div class="st-emotion-cache-j7qwjs e17y52ym4"><span class="st-emotion-cache-9ycgxx e17y52ym3">Drag and drop file here</span><small class="st-emotion-cache-1rpn56r ejh2rmr0">Limit 200MB per file • PDF, PNG, JPG, JPEG</small></div></div><button kind="secondary" data-testid="stBaseButton-secondary" aria-label="" class="st-emotion-cache-ocsh0s em9zgd02">Browse files</button></section><div class="st-emotion-cache-fis6aj e17y52ym5"><ul class="st-emotion-cache-14m29r0 e17y52ym6"><li class="st-emotion-cache-1l95nvm e17y52ym7"><div class="stFileUploaderFile st-emotion-cache-12xsiil e17y52ym10" data-testid="stFileUploaderFile"><div class="st-emotion-cache-10ix4kq e17y52ym12"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="e144pc0f1 st-emotion-cache-4mjat2 ex0cdmw0"><path fill="none" d="M0 0h24v24H0V0z"></path><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zM6 20V4h7v5h5v11H6z"></path></svg></div><div class="stFileUploaderFileData st-emotion-cache-1l4firl e17y52ym8"><div class="stFileUploaderFileName st-emotion-cache-1uixxvy e17y52ym9" data-testid="stFileUploaderFileName" title="KRCHN Palliative Care Nursing_ Comprehensive Overview and Guidelines.pdf">KRCHN Palliative Care Nursing_ Comprehensive Overview and Guidelines.pdf</div><small class="st-emotion-cache-1rpn56r ejh2rmr0">0.6MB</small></div><div data-testid="stFileUploaderDeleteBtn"><button kind="minimal" data-testid="stBaseButton-minimal" aria-label="" class="st-emotion-cache-8ccstr em9zgd06"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="e144pc0f1 st-emotion-cache-1pbsqtx ex0cdmw0"><path fill="none" d="M0 0h24v24H0V0z"></path><path d="M19 6.41L17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41z"></path></svg></button></div></div></li></ul></div></div></div></div><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="stButton st-emotion-cache-8atqhb e1mlolmg0" data-testid="stButton"><button kind="secondary" data-testid="stBaseButton-secondary" aria-label="" class="st-emotion-cache-ocsh0s em9zgd02"><div data-testid="stMarkdownContainer" class="st-emotion-cache-1hyd1ho e1icttdg0"><p>Submit</p></div></button></div></div><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="stMarkdown" data-testid="stMarkdown"><div data-testid="stMarkdownContainer" class="st-emotion-cache-1104ytp e1icttdg0"><p><strong>Processing file:</strong> KRCHN Palliative Care Nursing_ Comprehensive Overview and Guidelines.pdf</p></div></div></div><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="stMarkdown" data-testid="stMarkdown"><div data-testid="stMarkdownContainer" class="st-emotion-cache-1104ytp e1icttdg0"><p>5</p>
<p>studocu</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="krchn-palliative-care-1">Krchn Palliative Care 1<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#krchn-palliative-care-1" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Community Health Nursing (Kenya Medical Training College)</p>
<p><img src="assets/images/image-20251229-a97f6875.jpeg" alt="img-0.jpeg"></p>
<p>Scan to open on Studocu</p>
<p>Studocu is not sponsored or endorsed by any college or university</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>UNIT: Palliative care Nursing and Oncology nursing</p>
<p>CLASS: KRCHN, March, 2019, YR. 2, SEM. 1</p>
<p>LECTURER: Njeri Karienye</p>
<p>Objectives</p>
<p>By the end of this unit the learner should be able to:</p>
<ul>
<li>Define terms</li>
<li>Describe the concept of palliative care</li>
<li>Explain the interdisciplinary team approach in palliative care</li>
<li>Describe holistic management of palliative care patients</li>
<li>Describe the common emergencies in palliative care patients</li>
<li>Describe bereavement process, grief process</li>
<li>Describe the self-care of the care-givers</li>
<li>Discuss the ethical-legal issues in palliative care</li>
</ul>
<p>Introduction</p>
<ul>
<li>Kenya Hospices and Palliative Care Association (KEHPCA) in 2006 carried out a needs assessment survey in the centers providing palliative care and found that there is definite limited skill resource in terms of numbers of service providers and even the level of skill.</li>
<li>There was also a lack of awareness on E.g HIV&amp;AIDS Palliative care and inadequate training of both health care providers and non-health care providers in HIV&amp;AIDS palliative care.</li>
<li>This has resulted in the unmet need for palliative care for those who are already affected and infected by HIV&amp;AIDS, cancer and other life threatening diseases.</li>
<li>The number of service providers was also found to be low with limited resources to support Palliative Care Services.</li>
<li>The report recommended training on Palliative care</li>
</ul>
<p>Definition</p>
<ul>
<li>Palliative care is an approach that improves the quality of life of patients and their families facing the problems associated with life-threatening illness, through the prevention and relief of suffering by means of early identification and impeccable assessment and treatment of pain and other problems, E.g physical, psychosocial and spiritual (WHO, 2002)</li>
</ul>
<p>Palliative care is part of the essential package of care for all people living with life limiting illnesses. In sub-Saharan Africa it has been developed with a specific remit for people living with HIV/AIDS and cancer, but is also needed for those with other chronic life-limiting illnesses such as end-stage organ failure.</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="aim-of-palliative-care">Aim of palliative care<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#aim-of-palliative-care" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Achieving the best possible quality of life for all patients and their families by meeting their physical, psychological and spiritual needs</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="about-palliative-care-importance-of-palliative-care">About palliative care / importance of palliative care:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#about-palliative-care-importance-of-palliative-care" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Provides relief from pain and other distressing symptoms</li>
<li>Affirms life and regards dying as a normal process</li>
<li>Intends neither to hasten nor postpone death</li>
<li>Integrates the psychological and spiritual aspects of patient care</li>
<li>Offers a support system to help patients live as actively as possible until death</li>
<li>Offers a support system to help the family cope during the patients illness and in their own bereavement</li>
<li>Uses a team approach to address the needs of patients and their families, including bereavement counselling, if indicated</li>
<li>Will enhance quality of life and may also positively influence the course of illness</li>
<li>Is applicable early in the course of illness, in conjunction with other therapies that are intended to prolong life, such as chemotherapy or radiation therapy, and includes those investigations needed to better understand and manage distressing clinical complications.</li>
<li>Palliative care employs a holistic approach, which enables people to die with dignity while supporting those close to them.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="main-barriers-to-palliative-care-development">Main barriers to palliative care development<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#main-barriers-to-palliative-care-development" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Psychological barriers</li>
<li>Social barriers</li>
<li>Cultural barriers</li>
<li>Financial barriers</li>
</ul>
<p>The development of palliative care has been limited by additional human factors. Both hospice and palliative care have come to be associated with the end of life. Psychologically most people fear and avoid anything relating to death. There is often a belief that even acknowledging the possibility that one may die soon is harmful. There is no evidence to support this belief and recent evidence points to the possibility that palliative care may actually improve survival.</p>
<p>However, efforts to engage the public and policy makers on the need for palliative care have met with limited success. In many countries, informing patients of their diagnosis and prognosis when he/she has life threatening illness, is prohibited or strongly discouraged. Previously this had been the case in most cultures, but views have been changing in the past several decades to the point where there is now some acceptance of the idea that</p>
<p>patients themselves should be given the choice as to whether to receive this information. Life-threatening illness can have a major impact financially. In many countries effective medical treatment may only be available to those with the financial resources to pay for care.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="principles-of-palliative-care">Principles of palliative care<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#principles-of-palliative-care" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Palliative care is based on the philosophy of total care and it employs the following principles:</p>
<p>a) Teamwork</p>
<ul>
<li>Involving team of medical workers, i.e. physicians, nurses, social workers, pastoral care professionals, physical and occupational therapist, pharmacist whose skills are required.</li>
</ul>
<p>b) Pain relief</p>
<ul>
<li>Ensuring that the client experience death free of avoidable pain and suffering and in accordance with the client's and family's issue</li>
</ul>
<p>c) Support</p>
<ul>
<li>Ensuring availability of support for the client to enable them carry out activities they enjoy doing that improve the quality of their life.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="world-health-organization-who-public-health-model-of-palliative-care">World Health Organization (WHO) Public Health Model of palliative care<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#world-health-organization-who-public-health-model-of-palliative-care" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>This model has 4 key pillars namely:</li>
<li>Physical: e.g Nursing, treating, prescribing treatment</li>
<li>Psychological: e.g Listening, counseling, being there for them</li>
<li>Social: e.g Help with finances, housing, family support</li>
<li>Spiritual: e.g Prayer, counseling, carrying out rituals or rites.</li>
</ul>
<p>To effectively integrate palliative care into a society and change the experience of patients and families, all the four pillars of the WHO Public Health Model must be addressed. Therefore to address the pillars, the following components of palliative care must be there/present according to the same model:</p>
<ol>
<li>Appropriate policies</li>
</ol>
<p>Start by identifying key policy stakeholders. These frequently include both national and regional/county government policy makers and regulators. Review national health policies and related regulations to establish whether they incorporate the relief of pain and palliative care as priorities. If they do not, advocate for incorporation of both of these concepts as priorities into the National Health Plan, legislation, and regulations as they evolve. Review existing funding and service delivery models for providing care within the country. Determine how they might support the delivery of palliative care both at the community level and within existing acute and long-term care organizations through home care and consult services, and palliative care units. Review how doctors and other health care professionals providing palliative care are reimbursed.</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Establish if the country has an essential medicines policy. If they do, include opioids and other palliative care medicines in the policy.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-adequate-drug-availability">2) Adequate drug availability<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-adequate-drug-availability" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Identify leaders and start by identifying national opinion leaders responsible for drug availability, e.g., drug regulators, pharmacologists, pharmacists and law enforcement officials. Ensure that they are all engaged in the process and willing to review and improve drug availability policies and practices. Estimate Opioid Need. Use a simple strategy to estimate the annual opioid need for E.g the cancer patients. Assume that 60% of patients with advanced cancer will be the principal consumers and that they will each use an average of 100 mg morphine per day for the last 100 days (three months) of their lives, i.e., a total of 10 g of morphine per patient. This technique will estimate only a portion of the total opioid need for the country. As an example, for a country with five million people and 3,500 new diagnoses of cancer per year, two thirds of which present with stage III or IV cancer, if 60% of these patients (2,100) have pain and need 10 g of morphine each before they die, that country will need 21 kg of morphine per year just to manage these cancer patients' pain. Ensure an Affordable Supply.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3-education-of-health-care-workers-and-the-public">3) Education of health care workers and the public<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-education-of-health-care-workers-and-the-public" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>i) Identify leaders: Start by identifying national opinion leaders responsible for education e.g., clinical and education experts, deans of medical schools, nursing, pharmacy and social work schools. Ensure that they are all engaged in the process and willing to change existing educational curricula and courses and develop new ones.</p>
<p>ii) Identify target audiences: To implement palliative care effectively across the country, there will be many different target audiences who will require education to increase their awareness and change their attitudes, knowledge and skills related to palliative care. These include: the media and public, medical, nursing, social work/ psychology and pharmacy health care professionals and trainees, experts training in palliative care, spiritual leaders and patients and families.</p>
<p>iii) Media and public advocacy: Develop an educational intervention and advocacy tools to engage the media and heighten public awareness of the need for and benefits of palliative care for patients at any time during an illness experience.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="4-implementation-of-palliative-care-services-at-all-levels-throughout-the-society">4) Implementation of palliative care services at all levels throughout the society.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-implementation-of-palliative-care-services-at-all-levels-throughout-the-society" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Palliative care programme development has been very uneven internationally and is correlated with Human Development Index levels. Without policy support for palliative care and funding mechanisms, growth is restricted to whatever is achieved by pioneers making sacrifices to create hospice and palliative care services in their communities</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="approaches-of-palliative-care">Approaches of palliative care<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#approaches-of-palliative-care" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-patient-centred">i) Patient centred<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-patient-centred" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>In order to improve the quality of life, a patient centred care is vital.</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>It helps in defining wishes and goals</li>
<li>Also assist the patient to obtain the type of care they want</li>
</ul>
<p>ii) Support for the caregiver</p>
<ul>
<li>The role of a caregiver is a vital one and there are many resources to assist</li>
<li>Enhance the caregiver’s skills with the right information</li>
</ul>
<p>Essential elements of quality palliative homecare:</p>
<ul>
<li>Integrated teamwork</li>
<li>Management of pain and physical symptoms</li>
<li>Holistic care</li>
<li>Caring, compassionate and skilled providers</li>
<li>Timely and responsive care</li>
<li>Patient and family preparedness</li>
</ul>
<p>Essential components of palliative care</p>
<ul>
<li>Pain and symptom control</li>
<li>Effective communication</li>
<li>Rehabilitation</li>
<li>Continuity of care</li>
<li>Breaking of bad news</li>
<li>Psychosocial care</li>
<li>Spiritual care</li>
<li>Social care</li>
<li>Terminal/ end of life</li>
<li>Education</li>
<li>Research</li>
</ul>
<p>NB: Ability to support and to meet the needs of dying clients and their support systems is affected by a multitude of factors.</p>
<p>These factors include:</p>
<ul>
<li>The initial stage of the time of diagnosis</li>
<li>Post and present treatments</li>
<li>Whether the client is experiencing a recurrence or progression of the disease</li>
<li>The client’s relationship with the health care provider</li>
<li>The health care provider experience and comfort level with death and dying issues</li>
<li>The client’s family/support system or lack thereof</li>
<li>The symptoms he/she is experiencing</li>
<li>His/her own fears and concerns about death</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="physiological-changes-towards-the-end-of-life">Physiological changes towards The End of Life<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#physiological-changes-towards-the-end-of-life" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Decreased urine output, resulting in the need for the urinal, bedpan, commode, and /or characterization.</li>
<li>Decreased GI fluid, resulting in decreased episodes of vomiting, need for NGT.</li>
<li>Decreased pulmonary secretions, resulting in decreased cough, coughing, chocking and suctioning</li>
<li>Decreased pharyngeal secretions for those too weak to swallow, less likely to feel like drowning.</li>
<li>Decrease fluid overload resulting in decreased peripheral and pulmonary edema</li>
<li>Reabsorption of fluid, resulting in decreased ascites decreased peri-tumor edema with decreased pain.</li>
<li>Decreased wound and fistula drainage</li>
<li>Decreased intracranial pressure in some patients resulting in increased lucidity</li>
<li>Decreased care, cost and burden of maintain hydration</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="management-of-signs-and-symptoms-for-common-problems-in-the-terminally-ill-patients">Management of signs and symptoms (for common problems in the terminally ill patients)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#management-of-signs-and-symptoms-for-common-problems-in-the-terminally-ill-patients" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>The common problems in the terminally ill patients are:</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="a-pain">A) Pain<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-pain" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>These patients are usually in very severe pain. They are therefore put on medications that help alleviate pain/ reduce it to a bearable level.</li>
<li>This is aimed at ensuring that the client experience death free of avoidable pain and suffering and in accordance with the client's and family's issue.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pain-management">Pain management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pain-management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Relieve pain as fast as possible and prevent its return.</li>
<li>Use pharmacologic and/or non-pharmacologic methods</li>
<li>Control pain while treating the underlying cause (e.g. infection)</li>
<li>Reassess pain regularly using assessment tools</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="non-pharmacological-pain-management">Non-pharmacological pain management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#non-pharmacological-pain-management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>This can be:</p>
<p><strong>Physical</strong>: E.g. massage, exercise, physiotherapy, surgery</p>
<p><strong>Psychological</strong>: Strengthen the patient's coping mechanisms through counselling, relaxation therapies etc.</p>
<p><strong>Social</strong>: Help the patient resolve social or cultural problems through community resources, financial and legal support, etc.</p>
<p><strong>Spiritual</strong>: E.g. religious counselling and prayer.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pharmacological-pain-management">Pharmacological pain management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pharmacological-pain-management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Use WHO guidelines i.e</p>
<p>Pain management should be by the:</p>
<ul>
<li>Mouth: Use the oral route where possible.</li>
<li>Clock: Analgesia should be given at fixed time intervals.
Give the next dose before pain recurs.</li>
<li>Individual: Involve adults and children fully in their care.
Link doses to their daily routine</li>
<li>Ladder: Choose analgesics according to the World Health Organization (WHO) analgesic ladder covering mild, moderate and severe pain.</li>
<li>The choice of analgesic depends on the severity, site and type of pain.</li>
<li>Start patients on Step 1 analgesics for mild pain, if ineffective then, Change to a Step 2 analgesic</li>
<li>Then to Step 3 as required, If Step 1 or 2 analgesics don't work</li>
<li>Don't switch to another analgesic at the same level, move up a step</li>
<li>A combination of a non-opioid and an opioid drug is effective (they have different modes of action).</li>
<li>Don't combine weak with strong opioids.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="other-medications-for-managing-pain-adjuvants">Other medications for managing pain - (adjuvants)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#other-medications-for-managing-pain-adjuvants" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Adjuvants can be combined with Step 1, 2 or 3 drugs</li>
<li>If the oral route isn't possible, use alternative methods.</li>
<li>These can include rectal, intravenous, nasogastric tube, transdermal and subcutaneous routes.</li>
<li>The majority of patients can have their pain controlled in the home care/outpatient settings using the WHO analgesic ladder as a guide.</li>
<li>Only in very severe cases may they need to be an inpatient.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="6d853583">Mild pain – Step 1<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#6d853583" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="paracetamol">Paracetamol<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#paracetamol" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Adult dose: 500mg–1g p.o 6hrly; maximum daily dose 4g.</li>
<li>NB: Hepatotoxicity can occur if more than maximum dose is given per day.</li>
<li>Can be combined with a non-steroidal anti-inflammatory drug (NSAID)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="children">Children<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#children" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>under 1 year 10–15mg/kg p.o 6–8hrly;</li>
<li>1–5 years 10–15mg/kg p.o 6–8hrly</li>
<li>5–12 years 250–500mg p.o 6–8hrly.</li>
<li>Maximum dose 75mg/kg/day.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="ibuprofen-nsaid">Ibuprofen (NSAID)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ibuprofen-nsaid" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Adult dose: 400mg p.o 6–8hrly. Maximum dose 1.2g per day.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Caution: can cause serious side effects, e.g. gastro-intestinal (GI) bleeding or renal toxicity.</li>
<li>If GI symptoms occur, stop and give H2 reception antagonist (e.g. Ranitidine).</li>
</ul>
<p>In children:</p>
<p><strong>5mg/kg po 6–8hrly.</strong></p>
<p><strong>Maximum 30mg/kg/day in three or four divided doses</strong></p>
<p><strong>Diclofenac (NSAID)</strong></p>
<ul>
<li>Adult dose: 50mg po 8hrly. Maximum dose 150mg per day</li>
</ul>
<p>In children</p>
<ul>
<li>6 months to 12 years: 2–3mg/kg per 24hrs po in two or three doses</li>
</ul>
<p><strong>Moderate pain – Step 2 (weak opioids)</strong></p>
<p><strong>Codeine</strong></p>
<p>Codeine is the commonest weak opioid:</p>
<ul>
<li>Adult dose: 30–60mg po 4 hrly (maximum dose 180–240mg per day),</li>
<li>Codeine is often combined with Step 1 analgesics.</li>
<li>Give laxatives to avoid constipation unless patient has diarrhoea.</li>
<li>If pain relief is not achieved on the ceiling dose (max dose 240mg per day), move to a strong opioid</li>
</ul>
<p>Children</p>
<p>Over 6 months: 0.5–1mg/kg p.o 6hrly</p>
<p><strong>Tramadol</strong></p>
<ul>
<li>Adult dose: 50–100mg p.o 4–6hrly.</li>
<li>NB: Start with a regular small dose and increase if no response is observed.</li>
<li>Dose limit is 400mg/day.</li>
</ul>
<p>Children</p>
<p>Over 12 years: 50–100mg p.o 4–6hrly</p>
<p><strong>Severe pain – Step 3 (strong opioids)</strong></p>
<p><strong>Morphine</strong></p>
<ul>
<li>Opioid-naive infants &lt;6 months, starting dose 0.02mg/kg p.o 4hrly;</li>
<li>Opioid-naive infants &gt;6 months, starting dose 0.04 mg/kg p.o 4hrly.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="children">Children<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#children" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Younger than six months are more sensitive to possible opioid-induced respiratory depression, so they need a lower starting dose</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="morphine">Morphine<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#morphine" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Morphine is the 'gold standard' against which other analgesics are measured.</li>
<li>The correct morphine dose is the one that gives pain relief, there is no 'ceiling' or maximum dose, but any increase should be gradual.</li>
<li>Starting dose is 2.5–20mg p.o 4hrly, the level depending on age, previous use of opiates, etc.</li>
<li>Patients changing from regular administration of a Step 2 opioid should start on morphine 10 mg p.o 4hrly.</li>
<li>If patient is cachexic, or not on Step 2 analgesics, start morphine at 5mg p.o 4hrly.</li>
<li>Start frail/elderly patients on morphine at 2.5mg .po 6–8hrly, due to the likelihood of impaired renal function. Breakthrough' or 'rescue' doses of morphine can be given as often as required (ideally the same as the 4hrly dose).</li>
<li>Keep a record of each rescue dose.</li>
<li>Titrate the regular dose of morphine over several days until the patient is pain free.</li>
<li>Either add the total daily dose and the total breakthrough dose given in 24 hours and divide by six to get a new 4hrly dose, or give 30–50% increments (e.g. 5–10–15mg etc.) as 4hrly doses.</li>
<li>Increments of less than 30% are ineffective. If needed, give a double dose of morphine at night to allow pain-free sleep.</li>
<li>If the patient can't swallow, use other routes, e.g. rectal, subcutaneous, buccal, intravenous or gastrostomy tube.</li>
<li>Ratio of morphine P.O: SC is 2:1, e.g. 10mg of oral morphine equates to 5mg of SC morphine.</li>
<li>Ratio of morphine: P.O: IV is 2–3:1, e.g. 30mg of oral morphine equates to 10mg of IV morphine.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="morphine-side-effects-and-management">Morphine side effects and management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#morphine-side-effects-and-management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>The health care provider ought to explain common morphine side-effects to patients and prevent where possible:</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="constipation">Constipation<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#constipation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Always give with a laxative, e.g. bisacodyl 5mg at night increasing to 15 mg if needed.</li>
<li>Do not give laxative if the patient has diarrhoea.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="nausea-and-vomiting">Nausea and vomiting<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nausea-and-vomiting" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Give metoclopramide 10mg 8hrly, or haloperidol 1.5 mg once a day.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="drowsiness">Drowsiness<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drowsiness" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>May occur in the first few days, if it does not improve after about three days, cut down on morphine dose.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="itching">Itching<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#itching" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Less common but if it occurs, give chlorpheniramine.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="nb">NB:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nb" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Patients on a stable morphine dose should not be sedated.</li>
<li>If sedated, reduce the dose and consider adjuvants.</li>
<li>Morphine is available in immediate-release and slow-release oral formulations.</li>
<li>Use slow-release morphine once pain is controlled.</li>
<li>Divide the total 24-hour dose into two to get the twice-daily dosage.</li>
<li>Fentanyl patches can be started once pain is under control on morphine and you know the amount of analgesia the patient needs in 24 hours.</li>
<li>Don't use Fentanyl for acute pain.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="adjuvant-analgesics">Adjuvant analgesics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#adjuvant-analgesics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Although their primary purpose is not analgesic, these medications relieve pain through other mechanisms</li>
<li>Adjuvants are particularly useful in pain that is only partially sensitive to opioids, e.g. neuropathic and bone pain, smooth or skeletal muscle spasms, or pain related to anxiety.</li>
<li>Use adjuvants alone or in conjunction with Step 1, 2 and 3 analgesics.</li>
</ul>
<p>Examples of the types of adjuvants that are relevant to palliative care are :</p>
<p>Antidepressants, Anticonvulsants, Antispasmodics, Muscle relaxants / Anxiolytics, Corticosteroids</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="antidepressants">Antidepressants<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#antidepressants" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Use for neuropathic pain, presenting primarily as burning or dysaesthesia. Eg: Amitriptyline.</li>
<li>Adult dose 10–75 mg at night, where you should start with a low dose and slowly increase it as needed.</li>
<li>Can also be given in a dose of 0.5–2 mg/kg at night.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="side-effects-include">Side effects include:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#side-effects-include" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Dry mouth</li>
<li>Drowsiness.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="nb-use-with-caution-in-the-elderly-and-those-with-cardiac-disease">NB: Use with caution in the elderly and those with cardiac disease.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nb-use-with-caution-in-the-elderly-and-those-with-cardiac-disease" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="anticonvulsants">Anticonvulsants<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#anticonvulsants" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Use for neuropathic pain. Eg: Carbamazepine.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Adult dose should start at 100mg twice a day, and can be increased to 800mg twice a day.</li>
<li>Sodium valporate 200mg – 1.2g per day.</li>
<li>Gabapentin 100mg three times a day, increase up to 3.6g daily.</li>
</ul>
<p><strong>NB:</strong></p>
<ul>
<li>Use Phenytoin in the absence of these drugs, at the rate of 100mg 2–3 times/day</li>
<li>Use Phenytoin and Carbamazepine with caution because of the rapid metabolism of other drugs metabolised in the liver.</li>
</ul>
<p><strong>Antispasmodics</strong></p>
<ul>
<li>Use for muscle spasm, such as colicky abdominal pain or renal colic. Eg Hyoscine Butylbromide (Buscopan)</li>
<li>Dose: Adult: start at 10mg three times /day, Can be increased to 40mg three times/day</li>
</ul>
<p><strong>NB.</strong>
Can cause nausea, dry mouth and constipation.</p>
<p><strong>Muscle relaxants / Anxiolytics</strong></p>
<ul>
<li>Use for skeletal muscle spasm and anxiety-related pain. Eg Diazepam.</li>
<li>Adult dose 5mg orally 2–3 times/day</li>
</ul>
<p><strong>Corticosteriods</strong></p>
<ul>
<li>Use for bone pain, neuropathic pain, headache due to raised intracranial pressure, or pain associated with oedema and inflammation. Eg: Dexamethasone.</li>
<li>Adult dose 2–4mg per day for most situations, apart from raised intracranial pressure, nerve compression and spinal cord compression.</li>
<li>For raised Intracranial pressure start at 24mg per day and reduce by 2mg daily to the lowest effective maintenance dose.</li>
<li>For nerve-compression types of pain 8mg is often used and for spinal cord compression 16mg is usually the starting dose.</li>
</ul>
<p>If dexamethasone is not available, then adults can also be given prednisolone where a conversion rate of 4mg dexamethasone to 30mg prednisolone can be used.</p>
<p><strong>NB:</strong> In advanced disease, corticosteroids may improve appetite, decrease nausea and malaise and improve quality of life.</p>
<p><strong>Adverse effects include</strong>
Neuropsychiatric syndromes, gastrointestinal disturbances and immunosuppression</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="recommendations-on-pain-management-using-drugs-by-world-health-organization-who">Recommendations on Pain management using drugs by World Health Organization (WHO)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#recommendations-on-pain-management-using-drugs-by-world-health-organization-who" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>The drugs should be given:</p>
<p>i) By Mouth</p>
<p>This should be the route of choice because it is convenient and easy. If no longer tolerable, subcutaneous route should be used.</p>
<p>ii) By Clock</p>
<p>This means that drugs should be given regularly at the same time.</p>
<p>iii) By ladder</p>
<p>This means that you start with one drug that is the weakest, increase the dosage as necessary and only move to the next stronger drug after exhausting the potential of the weaker drug e.g. you cannot move straight to opioid drugs such as morphine before you finish exploiting paracetamol.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="the-who-analgesic-ladder">The WHO Analgesic Ladder:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#the-who-analgesic-ladder" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Step 1: Non Opioids: -</p>
<p>These are drugs such as Paracetamol and other non-steroidal anti-inflammatory drugs.</p>
<p>Step 2: Mild Opioids: -</p>
<p>These are drugs such as Codeine often combined with Paracetamol.</p>
<p>Step 3: Strong Opioids: -</p>
<p>In this category, there is morphine which can be of immediate release e.g. Oramorph and of sustained release e.g. subcutaneous Diamorphine</p>
<p>B) Anorexia</p>
<p>These patients are unable to eat because of being weak, anxious, depressed and nauseated</p>
<p>The patient should therefore:</p>
<ul>
<li>Be encouraged to feed</li>
<li>Given drugs that reduce nausea</li>
<li>Given the opportunity to choose diet</li>
<li>Given cool and more appealing drinks</li>
<li>In case patient can't feed orally, alternative methods should be used</li>
</ul>
<p>C) Nausea and Vomiting</p>
<ul>
<li>
<p>This can be reduced by giving treatment for the same</p>
</li>
<li>
<p>Patient should be positioned properly to prevent aspiration.</p>
</li>
<li>
<p>Anti - emetics should be administered, dry foods and carbonated beverages should be encouraged as they are less nauseating</p>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="d-depression">D) Depression<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-depression" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>It requires treatment and referral to psychiatrists for management</li>
<li>Social support from family and friends is also essential so that the patient does not feel neglected</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="e-diarrhea">E) Diarrhea<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-diarrhea" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>It may results from side effects of medication, infection and change in diet</li>
<li>Patients should be given low residue diet</li>
<li>Gas causing foods should be eliminated from the diet</li>
<li>Patient should be encouraged to take fluids other than plain water to replace lost electrolytes</li>
<li>Perineal care essential</li>
<li>In case of constipation, high residue diet should be given and nurse should continuously monitor</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="f-dehydration">F) Dehydration<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#f-dehydration" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Results from reduced intake of fluids</li>
<li>NB: Some dehydration is beneficial as it dries secretions and reduces the risk of fluid accumulation in cavities but severe dehydration should not be allowed</li>
<li>Oral fluids should be administered and if need be IV fluids should be used.</li>
<li>Monitor input- output accurately</li>
<li>Mouth care should be maintained</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="g-skin-breakdown">G) Skin breakdown<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#g-skin-breakdown" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Most patients are bed ridden because they are weak or depressed</li>
<li>Adequate nutrition and hydration should be maintained to promote skin integrity</li>
<li>Pressure area care should be done</li>
<li>Position changing should be done frequently (at least 2 hourly) to prevent bed sore</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="h-respiratory-problems">H) Respiratory problems<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#h-respiratory-problems" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>They are common due to retained secretions which result from inability to expectorate and immobility</li>
<li>Respiration rate and depth should be monitored</li>
<li>Chest physiotherapy should also be done</li>
<li>Oxygen should be administered when necessary</li>
<li>Suctioning should be done in case of increased secretions</li>
<li>Appropriate positioning necessary</li>
<li>Drugs that reduce secretions may be used e.g. atropine</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="domains-of-palliative-care">Domains of palliative care<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#domains-of-palliative-care" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-disease-management">a) Disease management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-disease-management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Primary diagnosis</li>
<li>Secondary diagnoses or co-morbidities</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Prognosis</li>
<li>Adverse events</li>
<li>Allergies</li>
</ul>
<p>b) Physical</p>
<ul>
<li>Pain and other symptoms</li>
<li>Level of consciousness, cognition</li>
<li>Function level of safety, aides, falls risk</li>
<li>Needs and implications for care</li>
<li>Motor (e.g. mobility, swallowing, excretion)</li>
<li>Senses (e.g. hearing, sight, smell, taste, touch)</li>
<li>Physiologic (e.g. breathing, circulation, sexual)</li>
<li>Nutrition and hydration</li>
<li>Wounds</li>
<li>Habits (e.g. alcohol, smoking)</li>
</ul>
<p>c) Psychological</p>
<ul>
<li>Personality, strengths, behaviour, motivation.</li>
<li>Impact of illness on patient and family</li>
<li>Depression, anxiety</li>
<li>Emotions (e.g. anger, distress, hopelessness, loneliness)</li>
<li>Fears (e.g. abandonment, burden, death)</li>
<li>Control, dignity, independence, self image</li>
<li>Conflict. Guilt, stress, coping</li>
</ul>
<p>d) Loss &amp; bereavement</p>
<ul>
<li>Loss</li>
<li>Grief (e.g. acute, chronic, anticipatory)</li>
<li>Bereavement planning &amp; Referral pathway</li>
<li>Ongoing support for complicated grief.</li>
</ul>
<p>e) End of life care</p>
<ul>
<li>Use of Pathways Protocols to guide care</li>
<li>Preferred place of death</li>
<li>Anticipation and management of physiological changes in the last hours of life. Education of patient/family/staff.</li>
<li>Responsive care for patient and family</li>
<li>Advanced care planning</li>
<li>Organ donation</li>
<li>Preparation for expected death</li>
<li>Information giving and responsive care.</li>
<li>Rites, rituals</li>
<li>Pronouncement, certification of death</li>
<li>Care of family at time of and following death eg. privacy, involvement in care.</li>
<li>Arrangements for the body eg. mortuary viewing</li>
<li>Funerals, memorial services</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>f) Social</p>
<ul>
<li>
<p>Cultural values, beliefs, practices</p>
</li>
<li>
<p>Relationships, roles with family, friends, community</p>
</li>
<li>
<p>Isolation, abandonment, reconciliation, support systems</p>
</li>
<li>
<p>Privacy, intimacy, sexuality</p>
</li>
<li>
<p>Routines, rituals, recreation, vocation</p>
</li>
<li>
<p>Financial resources, expenses – welfare needs.</p>
</li>
<li>
<p>Legal (e.g. powers of attorney for business, for healthcare, advance directives, last will/testament, beneficiaries)</p>
</li>
<li>
<p>Family caregiver support</p>
</li>
<li>
<p>Guardianship, custody issues</p>
</li>
<li>
<p>Special needs – indigen</p>
</li>
</ul>
<p>g) Spiritual</p>
<ul>
<li>Meaning</li>
<li>Values, beliefs, practices</li>
<li>Pastoral and spiritual support</li>
<li>Rites, rituals, symbols.</li>
</ul>
<p>Model of care</p>
<p>A Palliative Care Model is proposed to:</p>
<ul>
<li>Provide services for patients with life limiting illness, regardless of diagnosis</li>
<li>Address the palliative care needs of patients and their families during their illness trajectory</li>
<li>Deliver care in any setting - hospital, palliative care unit, residential care or home</li>
<li>Identify partnerships between specialist palliative care services and primary care providers.</li>
</ul>
<p>Principles of the model</p>
<p>The principles that underpin this Palliative Care Model are:</p>
<ul>
<li>A life-limiting illness is an illness that can be reasonably expected to cause the death of a patient within a foreseeable future.</li>
<li>The patient and family is the unit that should understand that, the person’s illness affects not only the person who is unwell but also the family and any difficulties experienced by the family will in turn have impact on the person who is unwell.</li>
<li>Palliative care is multidisciplinary and is an integral part of the health care system. Every person with a life-limiting illness has a fundamental right to access care that is underpinned by a palliative approach.</li>
<li>There is a formal process of assessment, informed consent inclusive of boundaries of care and decision making around advance care plans. For example, orders for “not for resuscitation”.</li>
<li>Quality of life can be enhanced by access to physical, psychological, emotional, social and spiritual support provided in a culturally appropriate manner.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>People with a life-limiting illness and their families, will have access to information about options for future care so that they are able to actively participate in decision making about treatment, care and end-of-life issues.</li>
<li>People with life limiting illness will have access to quality care to meet their needs. This care is delivered by trained staffs who are supported by specialist palliative care services.</li>
<li>People with life limiting illness have the right to spend as much time as possible in their own home and community, therefore out patient follow-up will be provided where possible in local community settings, or by using Telehealth and other technologies, to avoid unnecessary travel and burden to patients and families.</li>
<li>Patients and families need to experience a seamless service system, with smooth and timely transitions from one service to another. This includes:</li>
<li>Timely referral to a palliative care service (preferably not in crisis)</li>
<li>Effective communication with the patient and family and between services</li>
<li>Speedy and straightforward admission to appropriate inpatient care when required</li>
<li>Speedy and straightforward transfer from acute care to an appropriate palliative care service setting if this is required</li>
<li>Continuity of health care provision across the various care settings</li>
<li>Coordination and integration of services across all settings with other medical, health or community care providers.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="coordination-of-palliative-care">Coordination of palliative care<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#coordination-of-palliative-care" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>This can be achieved in a variety of ways and will depend on local circumstances. Each team should identify the other teams/services with which they interact most frequently and should develop plans to promote coordinated care. These plans may include:</p>
<ul>
<li>Establishing joint out-patient or community-based clinics</li>
<li>Undertaking joint ward rounds/case review</li>
<li>Participating in multidisciplinary meetings that include people from different services.</li>
</ul>
<p>The need for palliative care often goes unrecognized as there are misconceptions about the skills and expertise that can be offered by the specialist palliative care team, even as early as the diagnosis of the patient's illness. The following framework details the steps involved in the palliative care therapeutic process that guides the interactions between health professionals, patient and families.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="steps-in-palliative-care-process-process-of-providing-palliative-care">Steps in palliative care process / Process of providing palliative care /<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#steps-in-palliative-care-process-process-of-providing-palliative-care" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="1-assessment">1. Assessment<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-assessment" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Patient and family history including presenting problems and current, past and potential issues.</li>
<li>Physical examination</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>What social structures and supports are in place? How do the family function? – family or carers, other support structures (health facility, community), health issues for family or carers, functional/practical issues, financial issues</li>
<li>Psychological and emotional responses to the illness and its effects, what was the pre-illness personality and how did they usually manage and cope, fears, anxiety, understanding, concerns for family, previous psychological/psychiatric issues, Intelligence, cognition, needs (intervention/counselling/ medication).</li>
<li>Spirituality/religious beliefs i.e existential concerns, spiritual/religious needs, rites or rituals, religious paraphernalia, staff awareness/knowledge of these needs and where to seek help.</li>
<li>Expectations regarding the care and the outcomes from the contact</li>
<li>Are there any priorities of care for the patient or family</li>
<li>What is the complexity of the care that is, or that may be required.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-communication">2. Communication<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-communication" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>The patient and family’s understanding of the illness and its actual or potential impact on both</li>
<li>What information they require?</li>
<li>How prepared they are for this information?</li>
<li>To manage how the information should be provided.</li>
<li>To determine when and where the information should be provided</li>
<li>Who information can be or should be shared with.</li>
<li>How they respond to the information provided?</li>
<li>The understanding of what has been provided.</li>
<li>Is there a need for additional information</li>
<li>Is a translator or translation of information required?</li>
<li>Has consent to share information been given?</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="the-importance-of-effective-communication-in-palliative-care">The importance of effective communication in palliative care<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#the-importance-of-effective-communication-in-palliative-care" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Family members often recall in detail the sensitivity or lack of it, of the doctor or staff as their relative was dying. These memories affect the grieving process, how the family was told about what was being done, how they were informed of the changes in the medical situation and especially how attentive the doctor and staff were in controlling the patient’s distress and physical symptoms.</p>
<p>Effective communication fosters a very strong relationship between the caregiver and the patient as well as family members. Truthful communication about the future is also vital if patients are to be permitted the dignity of deciding how to spend their remaining time. Good communication maintains effective professional relationships, which fosters a high standard of care. Communication is seen as a therapy, which is used to help the patient to either cope with or solve the problem.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="possible-consequences-of-ineffective-communication-in-palliative-care">Possible consequences of ineffective communication in palliative care<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#possible-consequences-of-ineffective-communication-in-palliative-care" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Not communicating accurate essential information to patients may provoke greater problems. Protecting patients from the reality of their situation often creates further problems and can lead to inconsistent messages being given by other members of the inter-disciplinary team. Hiding the truth often leads to conspiracies of silence that usually build up to a heightened state of fear, anxiety and confusion, rather than provide one of calmness. Poor communication is a threat to patient care and can lead both to mistrust and to a source of staff stress. Communicating effectively is essential for engaging the patient and their family in their care. Not communicating about the nature and seriousness of an illness can lead to a lack of planning for the future e.g. not writing a will, not planning who will take care, etc</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3-decision-making">3. Decision making<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-decision-making" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>What is the capacity of the patient and family to make any decisions?</li>
<li>Have the goals of care been determined?</li>
<li>Are there any priorities for the care that is required?</li>
<li>What are the treatment options available and what are the benefits, risks and burdens associated with these?</li>
<li>What are the treatment choices?</li>
<li>Has consent for treatment been obtained?</li>
<li>Have there been any requests to withhold or withdraw therapy?</li>
<li>Have there been any requests to be given therapy that offers no benefit?</li>
<li>Requests to hasten death?</li>
<li>Have “Advance directives” been recorded?</li>
<li>If there is conflict is it possible to resolve this?</li>
<li>Legal guardianship/Surrogate decision making/Power of attorney</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="4-care-planning">4. Care planning<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-care-planning" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>
<p>Negotiation of process of plan of care that includes:</p>
</li>
<li>
<p>Discussion about the issues</p>
</li>
<li>
<p>Ways to deal with these issues.</p>
</li>
<li>
<p>Treatment options to manage the issues.</p>
</li>
<li>
<p>What type of care is required?</p>
</li>
<li>
<p>Who should provide the care?</p>
</li>
<li>
<p>Where the care should be provided?</p>
</li>
<li>
<p>Have the needs of both the family and/or carers been factored into the plan?</p>
</li>
<li>
<p>Support(s)</p>
</li>
<li>
<p>Despite</p>
</li>
<li>
<p>Dealing with emergencies</p>
</li>
<li>
<p>Discharge planning</p>
</li>
<li>
<p>Terminal Care</p>
</li>
<li>
<p>Bereavement</p>
</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="5">
<li>Care delivery</li>
</ol>
<ul>
<li>Determine the composition of the team(s) required to provide the care.
&gt; Based on the level of need and complexity of the care.
&gt; Do family members have any role in the provision of care?</li>
<li>Coordination and leadership of the team(s) involved in the care.</li>
<li>Education and training requirements of the care team</li>
<li>Education and training needs of the family/carers.</li>
<li>Is any support required by the team providing the care?</li>
<li>What support is required by the family/carers?</li>
<li>Where is the care going to be provided and is this likely to change at any time due to the patients or family’s requirements?</li>
<li>What services are essential and what services may have a supportive role?</li>
<li>Practical issues related to the care e.g supply/storage of equipment, dealing with infectious wastes.</li>
</ul>
<ol start="6">
<li>Endorsement of the plan</li>
</ol>
<ul>
<li>How able are the patient and family to participate in the care planning?</li>
<li>What is everyone’s understanding – including health carers of what is discussed and decided upon?</li>
<li>Are there any additional questions or issues which need to be addressed</li>
<li>Is everyone satisfied with the plan of care?</li>
<li>Does the plan of care cause distress to anyone in the group?</li>
<li>How complex is the care required and what are the implications both for the patient and family and for the health care staff?</li>
</ul>
<p>Models of palliative care delivery</p>
<p>To meet the challenge of providing palliative care in Kenya, a variety of models for palliative care delivery have been developed, which include the following examples listed below. All of these models can be found at specialist, county level and primary care / community levels of the health system.</p>
<ul>
<li>
<p>Specialist palliative care organisations (Eg. Nairobi Hospice in Kenya, kisumu hospice.
Specialist services may be provided across the continuum of care at tertiary, secondary and primary levels of care. They also provide an element of leadership, training, mentorship and supervision.</p>
</li>
<li>
<p>Hospital-based palliative care teams (Eg. Kenyatta National Referral Hospital):
These teams provide specialist services within the hospital context and this is a model of palliative care delivery that is growing in the region. In Kenya, the Kenya Hospices and Palliative Care Association (KEHPCA) is working with the government to train teams in various regional hospitals and to increase access to palliative care services across the country.</p>
</li>
<li>
<p>Inpatient services</p>
</li>
</ul>
<p>19</p>
<p>While the majority of palliative care in the region is provided in the home, or through hospital-based teams, inpatient services can provide care in particular for patients with difficult symptoms that cannot be brought under control in the home.</p>
<ul>
<li>
<p><strong>Home-based care</strong>
Much of palliative care provision in Kenya occurs in the home. It may be provided through specialist palliative care teams that visit patients and support them in the home, or else through home-based care services provided by community volunteers and supported by palliative care staff. In Africa home-based care is a well established model of care provision within the context of HIV/AIDS.</p>
</li>
<li>
<p><strong>Outreach services</strong>
Some palliative care providers have outreach services that support other organisations to provide palliative care, or provide roadside and mobile clinics. These services help to increase accessibility to palliative care service provision for those in rural and difficult to reach communities.</p>
</li>
<li>
<p><strong>Importance of standards in palliative care</strong></p>
</li>
<li>
<p>To provide common understanding of the work to be done and indicate a level of quality for services provision</p>
</li>
<li>
<p>To help to ensure that the quality of services being provided is maintained as operational coverage is extended</p>
</li>
<li>
<p>To help the process of continuous improvement of services quality by determining those areas of service provision where problems that require remedial attention exist</p>
</li>
<li>
<p>To serve to inform patients and their families of what quality of care they expect and should demand as services users</p>
</li>
<li>
<p>To enable staff to know what they are expected to provide</p>
</li>
<li>
<p>To serve as a resource for palliative care training</p>
</li>
<li>
<p><strong>Palliative care service require skills in the following areas:</strong></p>
</li>
<li>
<p>Communication</p>
</li>
<li>
<p>Decision-making</p>
</li>
<li>
<p>Management of the complication of treatment and diseases</p>
</li>
<li>
<p>Management of pain and symptoms</p>
</li>
<li>
<p>Psycho-social care for patient and family</p>
</li>
<li>
<p>Spiritual understanding and approaches</p>
</li>
<li>
<p>Care of the dying</p>
</li>
<li>
<p>Bereavement care</p>
</li>
<li>
<p><strong>Network of palliative care teams across the levels of health care</strong></p>
</li>
</ul>
<p>a) <strong>Community level :</strong></p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Community leaders, traditional healers and family caregivers, who are trained to provide basic home-based care and who are supervised by primary care level nurses.</li>
</ul>
<p>b) Primary care level:</p>
<ul>
<li>Nurses trained in basic palliative care who are supervised by the district/county level and who train and supervise community volunteers and family caregivers.</li>
</ul>
<p>c) Secondary care level (district /County hospital)</p>
<ul>
<li>Specialist palliative care team: physician, nurse who supervises primary health-care clinics, part-time social worker and pharmacist.</li>
</ul>
<p>d) Tertiary care level (national or regional hospital)</p>
<ul>
<li>Specialist palliative care team: physician, nurse, part-time social worker and pharmacist. All physicians and nurses dealing with cancer patients provide basic palliative care, supervised by the specialist team.</li>
</ul>
<p>Across the levels of care, services can be provided through the following:</p>
<p>Inpatient care</p>
<p>In low-income countries, where a stand-alone unit for inpatients would be relatively cost-intensive, a specialized palliative care team is an effective way of providing palliative care services to inpatients in a variety of health-care settings. A specialized team may be more sustainable than a free-standing unit.</p>
<p>A palliative care team is typically composed of a physician trained in palliative medicine, clinical nurses and social worker, all supported by adequate administrative staff. Such a team has no dedicated beds of its own but advises on every aspect of palliative care. This approach makes it possible to provide palliative care consultations to a large number of patients, in a hospital or nursing home. It is an ideal way of providing specialist care while at the same time training the large numbers of physicians and nurses with whom the team interacts.</p>
<p>Outpatient care</p>
<p>In some developing countries, the day-care unit or outpatient unit performs the important role of offering low-cost care to people who are not too sick to attend. It also offers an opportunity to review a patient's need for periodic procedures such as draining pleural effusions or ascites and to train the patient's family in how to provide care. Often, day-care services may focus on providing respite for relatives by ensuring that patients get medications, food, their physical, psychological and spiritual needs met.</p>
<p>Home-based care</p>
<p>In high-income countries, home-based care services are usually more resource-intensive than in low- and middle-income countries. They often operate from a specialist palliative care unit or hospice and sometimes provide round-the-clock coverage.</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>In low- and middle-income countries, where patients usually prefer to die at home, home-based care is generally more acceptable and affordable than hospital care. E.g with the support of local non-governmental organizations, the Ministry of Health of Uganda has included pain relief and palliative care in a home-care package, based on a needs assessment of patients and their caregivers. Services include essential drugs for the relief of pain and other symptoms, as well as the provision of food for the patient and support for the patient's family (Logie and Harding, 2005).</p>
<p>A variety of models of home-based palliative care are currently being implemented in low-resource countries. A popular approach in low-resource settings, where the number of people needing care is high and the number of nurses and doctors available to provide that care is low, is to provide care through community caregivers or volunteers who are supervised by a nurse trained in palliative care. Ideally, any model of home care will have strong links to an inpatient facility for patients requiring more intensive palliative care for symptom control or for terminal care.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ethical-and-legal-issues-in-palliative-care">Ethical and legal issues in palliative care<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ethical-and-legal-issues-in-palliative-care" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>In recognizing the importance of human rights within the health field, the Kenyan Patients’ Rights Charter states that every patient has the right to:</p>
<ul>
<li>A healthy and safe environment</li>
<li>Participate in decision making</li>
<li>Access to health care</li>
<li>Knowledge of one’s health insurance/medical aid scheme</li>
<li>Choice of health services</li>
<li>Be treated by a normal health care provider</li>
<li>Confidentiality and privacy</li>
<li>Informed consent</li>
<li>Refuse treatment</li>
<li>Be referred for a second opinion</li>
<li>Continuity of care</li>
<li>Complain about health services</li>
</ul>
<p>Ethical and legal issues that should be addressed in a palliative care plan and programme include the following:</p>
<ul>
<li>Allocation of adequate human and financial resources to palliative care</li>
<li>Integration of palliative care with curative care to ensure high-quality care</li>
<li>Societal, individual and professional obligations and responsibilities regarding the provision of care</li>
<li>Differing perceptions and attitudes in different cultural contexts concerning, E.g, quality-of-life versus length-of-life goals, enduring or relieving pain and the end of life</li>
<li>Autonomy of decision-making, and valid informed consent of the patient and family</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>
<p>Legal and cultural barriers to accessing palliative care, in particular opioids.</p>
</li>
<li>
<p>Autonomy (Respecting patient’s wishes)</p>
</li>
<li>
<p>Help the patient to have choice and control over their life and what happens to them</p>
</li>
<li>
<p>Help them to set achievable goals</p>
</li>
<li>
<p>Give accurate and truthful information to the patient</p>
</li>
<li>
<p>Respect confidentiality</p>
</li>
<li>
<p>Get informed consent for changes in treatment</p>
</li>
<li>
<p>Minimize harm</p>
</li>
<li>
<p>Avoid treatments/drugs that may harm or have no overall benefit for the patient</p>
</li>
<li>
<p>Stop treatments/drugs that are no longer helpful</p>
</li>
<li>
<p>Be aware of the social and financial cost of treatments</p>
</li>
<li>
<p>Avoid interventions that stop patients achieving their goals</p>
</li>
</ul>
<p>Do Good (Beneficence)</p>
<ul>
<li>Communicate well</li>
<li>Give care and treatment that will give overall benefit to the patient</li>
<li>Support the patient</li>
<li>Control pain and other symptoms</li>
</ul>
<p>Justice</p>
<ul>
<li>Respect patients’ human rights</li>
<li>Balance the needs of the individual with those of the family and society</li>
<li>Use available resources fairly</li>
</ul>
<p>The Ethical framework for palliative care</p>
<p>Autonomy</p>
<ul>
<li>Autonomy is about the respect for a person’s right to make decisions concerning their care. Autonomy promotes the development of a trusting relationship between a health care worker and a patient.</li>
<li>It also means the patient becomes an active member of the management team, which restores a sense of control in the face of an illness that has deprived that person of control.</li>
<li>In order to give due attention to this principle, several matters are involved, and these are set out next.</li>
</ul>
<p>Communication
The patient has a right to know about the diagnosis, the treatment that is proposed, its effects and any side effects.</p>
<ul>
<li>It is the responsibility of the health care worker to ensure that the patient is fully informed.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>This will involve an assessment by the health care worker both of the patient’s understanding and of how much the patient wants to know.</li>
<li>Failure to communicate honestly with the patient can isolate the patient, preventing a therapeutic sharing of the patient’s fears, anxieties and other concerns.</li>
<li>In the case of a child patient, especially an older child, opinions and concerns are often not sought. This increases the child’s pain.</li>
<li>The child can be left to feel responsible for their illness and even for their parents’ suffering.</li>
<li>It is most important for the health professional to include the child in communications with the family about the illness and in decision-making.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="consent">Consent<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#consent" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Once the patient is given sufficient information, they have the prerogative to accept or not accept the care or treatment offered.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="confidentiality">Confidentiality<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#confidentiality" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Confidentiality protects the autonomy of the patient by allowing them to control information about themselves.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="privacy">Privacy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#privacy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Central to a respect for personal autonomy is the concept that the privacy of the individual must be respected.</li>
<li>The principle of non-maleficence is not absolute, and must be balanced against</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="beneficence">Beneficence<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#beneficence" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>To ‘do good’, health professionals should reflect on patient care decisions with this question in mind: ‘Will this treatment benefit the patient?’ This requires considering risks versus benefits and deciding whether the benefits outweigh the risks.</li>
<li>Often, families will not want a patient to know their diagnosis, or perhaps want the patient cared for in hospital rather than at home. The healthcare worker needs to be familiar with both the patient and their situation in order to make a good assessment and so guide the patient and family.</li>
<li>Knowing the patient’s wishes is essential in deciding what will benefit them.</li>
<li>The patient needs truthful information from the health professional in order to make his or her own decisions.</li>
<li>Although palliative care is concerned with the care of both the patient and the family, the healthcare worker must be careful not to subordinate the interest of the patients to the anxieties of relatives.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>It is often the case that family members want ‘everything’ done for their patient, not appreciating that, in fact, prolonging the patient’s life with artificial hydration or other measures only acts to prolong their suffering.</li>
<li>Families need to be informed about the consequences of different treatments and they also need to be encouraged to listen to what the patient wants.</li>
<li>With regard to children, parents are presumed to have the ability to make decisions regarding a child’s ‘best interests’.</li>
<li>In general, the best interests of a child are presumed to be life preserving, but in the face of irreversible illness this presumption requires careful exploration. ‘Best interests’ may require a plan that focuses on the child’s need for comfort and symptom relief to ease the process of dying in a way that promotes the safety, comfort and dignity of the child.</li>
<li>Palliative care is neither about shortening life nor prolonging the dying period.</li>
<li>It is of great importance that the health care professional establish, with the patient and the patient’s family, the clinical goals at which they are aiming.</li>
<li>One patient may desire only to die comfortably without pain, while another may want to live long enough to witness a particular event, a wedding, a birth etc. These different goals help the health worker to determine the best treatment decision to make in the case of each patient.</li>
<li>In order to ‘do good’, it is essential that the healthcare worker have the necessary degree of competence to address the various components of human suffering.</li>
<li>Health workers engaged in palliative care need to keep up-to-date with current knowledge in their field to be able to make judgements about the risks of interventions versus the benefits.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="non-maleficence">Non-maleficence<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#non-maleficence" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>To ‘do no harm’, a health worker needs to have adequate education and knowledge to ensure that the treatment they offer will not harm or endanger a patient.</li>
<li>In practice, many treatments carry some risk of harm and it is up to the health worker to weigh the risks versus the benefits.</li>
<li>The principle of non-maleficence is not absolute, and must be balanced against the principle of beneficence (doing good – see above).</li>
<li>In essence, the intended effect of treatment must be a good one. For instance: Artificial hydration at the end of life may appear to families to be good for a patient who is no longer taking oral fluids, whereas in fact it can cause great distress since the patient’s body can no longer cope with these fluids.</li>
<li>The principle of ‘double effect’ forbids the achievement of good ends by wrong means. It forbids doctors to relieve the distress of a dying patient by killing them, but it permits the use of drugs that relieve the distress of dying even when they may hasten death.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="justice">Justice<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#justice" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Justice is concerned with the correct use of resources and this is particularly pertinent when working in resource-poor settings such as in many areas of Africa.</li>
<li>It is the principle by which competing claims may be decided in fairness and is concerned with fair distribution of resources. Here are two examples:</li>
</ul>
<p>If a family has very limited resources, should the terminal patient be prescribed expensive treatment that will cause financial hardship for the rest of the family? In the days before anti-retrovirals became free or more affordable, individuals sometimes sold all the families property to buy drugs for a limited period of time. The family was eventually left impoverished.</p>
<p>&gt; Should patients with terminal cancer be started on ART? This is often seen with HIV-positive women being started on ART when they have advanced cancer of the cervix. In places where ARVs are scarce, this is a case where drugs would be better used for patients who have a longer prognosis.</p>
<p>This is also an example of futile treatment: ART is not going to have any curative effect on the cancer and in fact may prolong the woman’s suffering without just cause.</p>
<p>&gt; Prolonging the dying process may be justifiable if the patient and the family need that extra time to achieve important personal goals. However, the availability of medical technologies is not of itself an ethical command that these technologies be used.</p>
<p><strong>NB:</strong></p>
<ul>
<li>Ethics in palliative care is a matter of practical reasoning about individual patients, specific cases and unique situations.</li>
<li>What may be ethical in one case may be unethical in another.</li>
<li>A health professional at the bedside must understand the clinical situation in all its subtle medical and human complexity.</li>
<li>The fundamental moral attitudes orienting the contemporary practice of palliative care are an unconditional respect for the dignity of each person and the acceptance of finitude</li>
</ul>
<p><strong>Role of various health-care providers</strong></p>
<p>Health-care providers involved in palliative care may include physicians, nurses, social workers, psychologists, spiritual counsellors, volunteers, pharmacists and traditional healers. Each can play a useful role as following:</p>
<p><strong>Physicians</strong></p>
<p>Physicians play a crucial role in interdisciplinary palliative care. They must be competent in general medicine, competent in control of pain and other symptoms, and must also be familiar with the principles of management of the patient’s disease. Physicians working in palliative care may be responsible for assessment, supervision and management of many of the difficult treatment dilemmas. They may also be</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>responsible for leading the interdisciplinary teams. They clearly play an important educational role as they discuss medical management decisions, and should regard research, and the critical application of research findings, as an integral part of their work.</p>
<p>In countries where there are as few as one physician to 50 000 people, it is unrealistic to have this scarce resource devoted totally to palliative care. By incorporating palliative care into the services provided by all doctors dealing with cancer patients (gynaecologists, surgeons, radiotherapists, paediatricians etc.), as well as including it in the undergraduate curriculum, wider, but less expert coverage can be obtained.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="nurses">Nurses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nurses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The nurse is the team member who will typically have the greatest contact with the patient. This prolonged contact gives the nurse a unique opportunity to know the patient and the caregivers, to assess in depth what is happening and what is of importance to the patient, and to assist the patient to cope with the effects of advancing disease. The nurse's expertise in providing physical and emotional care to the patient, symptom management, patient and family education and in organizing the patient's environment to minimize loss of control, is critical to palliative care. Nurses are able to work closely with patients and families to make appropriate referrals to other disciplines and health-care services. In some settings, where the number of doctors is small, nurses may lead the multidisciplinary team and be responsible for the provision of all aspects of palliative care. In such settings, nurses need specialist training that is appropriate to the cultural and economic circumstances in which they work. Nurses in many settings play a role in providing public and volunteer education about palliative care.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="social-workers-and-psychologists">Social workers and psychologists<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#social-workers-and-psychologists" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The role of the social worker or psychologist is to help the family and patient deal with the personal and social problems of illness and disability, as well as to provide support during the progression of the disease and the bereavement process if the patient is at the end of life. The social worker's assessment helps define the patient's and family's needs from a psychosocial perspective, and helps anticipate problems within the family that may result from dysfunction and financial difficulties, particularly as the family begin planning for the future. Social work and psychology are both instrumental services. They may offer such interventions as referral to needed community services, emotional support (including individual counselling of patients and family members) and bereavement counselling.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="spiritual-counsellors">Spiritual counsellors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#spiritual-counsellors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The spiritual counsellor should be a skilled and non-judgemental listener, able to handle questions related to the meaning of life. Such questions invariably arise for patients and their families. The role of the spiritual counsellor is often one of listening, to facilitate recollection of the past and growing readiness for what lies ahead. The spiritual counsellor also often serves as a confidant and source of support for those with a</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>27</p>
<p>religious tradition, organizing religious rituals and sacraments that are meaningful to them. Spiritual counsellors need to be trained in end-of-life care.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="volunteers">Volunteers<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#volunteers" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The role of the volunteer within the palliative care team will vary according to the setting. In some low- or middle-resource settings, volunteers may provide most of the care for the patients. Volunteers are included in hospice and palliative care teams with the aim of assisting health-care professionals to provide the optimal quality of life for patients and families. Volunteers come from all sectors of the community, and often provide a link between health-care institutions and patients. Incorporating volunteers in a palliative care team brings in a dimension of community support and community expertise. With the appropriate training and support, volunteers can provide direct service to patients and families, help with administrative tasks, or even work as counsellors. They can also take on several other roles, such as raising awareness, providing health education, generating funds, helping with rehabilitation, or even delivering some types of medical care.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pharmacists">Pharmacists<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pharmacists" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Drug therapies are a major component of symptom management in palliative care, so the pharmacist plays an important role. The pharmacist ensures that patients and families have access to the essential drugs for palliative care. The pharmacist's expertise is also needed to support the health-care team by providing information on drug doses, drug interactions, appropriate formulations, routes of administration, and alternative approaches.</p>
<p>Morphine and other suitable medicines are necessary for palliative care. In many low- and middle-income countries, access to medicines is limited not only by the general lack of pharmacists to dispense medications, but also by the relatively high cost of medicines which makes them unaffordable for many cancer patients. For these reasons, pharmacists, even those with fairly basic skills and limited training are vital to palliative care service delivery. They can constitute analgesic medicines from the starting materials, like morphine powder, which is very cheap. Furthermore they can play a role in the management of an adequate distribution system for home care patients.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="traditional-healers">Traditional healers<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#traditional-healers" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The role of traditional medicine and traditional healers is well recognized. Worldwide, about two thirds of cancer patients resort to some form of complementary or alternative therapy (Ott, 2002). In most settings, traditional healers do not usually become members of the palliative care teams. Nevertheless, there should be scope for an open discourse between health-care providers and traditional healers with a view to coordinate their efforts to address the needs of patients and their families, in a sensitive and respectful way, taking into account the diverse cultures of communities and individuals.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="key-messages">Key messages<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#key-messages" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Palliative care is an urgent humanitarian need worldwide for people with cancer and other chronic fatal diseases. Palliative care is particularly needed in places where a high proportion of patients present in advanced stages and there is little chance of cure.</li>
<li>Ideally, palliative care services should be provided from the time of diagnosis of life-threatening illness, adapting to the increasing needs of cancer patients and their families as the disease progresses into the terminal phase. They should also provide support to families in their bereavement.</li>
<li>Effective palliative care services are integrated into the existing health system at all levels of care, especially community and home-based care. They involve the public and the private sector and are adapted to the specific cultural, social and economic setting.</li>
<li>In order to respond to the cancer priority needs in a community and make the best use of scarce resources, palliative care services should be strategically linked to cancer prevention, early detection and treatment services for both adults and children</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pain-and-pain-assessment">Pain and pain assessment<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pain-and-pain-assessment" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pain">Pain<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pain" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="definition">Definition:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#definition" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>An unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="impact-of-pain-on-patient">Impact of pain on patient<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#impact-of-pain-on-patient" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Reduced quality of life</li>
<li>Induce depression</li>
<li>Exacerbated anxiety</li>
<li>Interfere with social performance and impair the quality of relationships</li>
<li>Impact negatively on physical capability</li>
<li>Prevent work and reduce income</li>
<li>Challenge existence belief</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="causes-of-pain">Causes of Pain<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#causes-of-pain" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>The illness itself, e.g. bony, visceral or soft-tissue involvement or nerve compression</li>
<li>Complications of the illness, e.g. pressure sores, constipation or post-herpetic neuralgia</li>
<li>Treatment of the illness, e.g. neuropathy caused by chemotherapy or ART</li>
<li>Co-morbidities, e.g. sickle cell disease.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="physiology-of-pain">Physiology of Pain<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#physiology-of-pain" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Pain pathways involve the peripheral nervous system and central nervous system.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>The sensation of pain is made up of an initial fast, sharp pain and a later slow, dull, long-lasting pain and this is due to the difference in the speed of the nerve impulses in the different nerve-fibre types.</li>
<li>When cellular damage occurs, a number of chemical substances are produced or released which influence the degree of nerve activity and therefore the intensity of the pain sensation.</li>
<li>Pain from internal organs is perceived at a location that is not the source of the pain i.e. referred pain.</li>
<li>Chronic pain can result in an altered perception to pain, leading to increased sensitivity or abnormal sensations such as burning or numbness.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="definition-of-pain-terms">Definition of pain terms<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#definition-of-pain-terms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="acute-pain">Acute pain:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#acute-pain" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Pain due to a definable acute injury or illness</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="allodynia">Allodynia<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#allodynia" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Pain caused by a stimulus which does not normally provoke pain</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="analgesia">Analgesia<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#analgesia" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Absence of pain in response to stimulation which would normally be painful</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="breakthrough-pain">Breakthrough pain<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#breakthrough-pain" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>A transitory exacerbation of pain that occurs on a background of otherwise stable and controlled pain</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="causalgia">Causalgia<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#causalgia" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>A syndrome of sustained burning pain, allodynia and hyperpathia after a traumatic nerve lesion, often combined with vasomotor dysfunction and later trophic changes</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="central-pain">Central pain<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#central-pain" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Pain associated with a lesion in the central nervous system (brain and spinal cord)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="chronic-pain">Chronic pain<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#chronic-pain" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Results from a chronic pathological process</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="dysaesthesia">Dysaesthesia<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#dysaesthesia" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>An unpleasant abnormal sensation which can be either spontaneous or provoked</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="hyperaesthesia">Hyperaesthesia<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hyperaesthesia" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>An increased sensitivity to stimulation</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="hyperalgesia">Hyperalgesia<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hyperalgesia" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>An increased response to a stimulus that is normally painful</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="hyperpathia">Hyperpathia<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hyperpathia" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>A painful syndrome characterized by an increased reaction to a stimulus, especially a repetitive stimulus and an increased threshold</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="incident-pain">Incident pain<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#incident-pain" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Occurs only in certain circumstances, such as after a particular movement or on standing: it should be regarded as chronic pain but, as it is intermittent, it is better managed with local measures where possible</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="neuralgia">Neuralgia<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#neuralgia" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Pain in the distribution of a nerve</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="neuropathy">Neuropathy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#neuropathy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>A disturbance of function or pathological change in a nerve</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="neuropathic-pain">Neuropathic pain<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#neuropathic-pain" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Pain which is transmitted by a damaged nervous system, and which is usually only partially opioid-sensitive</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="nociceptor">Nociceptor<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nociceptor" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>A receptor preferentially sensitive to a noxious stimulus or to a stimulus which would become noxious if prolonged</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="nociceptive-pain">Nociceptive pain<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nociceptive-pain" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Pain which is transmitted by an undamaged nervous system and is usually opioid-responsive</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pain-threshold">Pain threshold<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pain-threshold" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>The least experience of pain which a subject can recognize</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pain-tolerance-level">Pain tolerance level<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pain-tolerance-level" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>The greatest level of pain which a subject is prepared to tolerate</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="procedural-pain">Procedural pain<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#procedural-pain" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Pain related to procedures / interventions: this is especially important in children with chronic illnesses. E.g HIV and malignancies and is an important cause of anxiety in children that can be prevented</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="sympathetic-pain">Sympathetic pain<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sympathetic-pain" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Pain caused by damage to sympathetic nerves</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="types-of-pain">Types of pain<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types-of-pain" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Pain can be classified according to:</p>
<ol>
<li>Underlying mechanism</li>
<li>Duration</li>
<li>Situation</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="nb">NB:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nb" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Different types of pain respond differently to different types of analgesia, hence the importance for clinicians to determine the type of pain that a patient is experiencing in order to prescribe the most appropriate analgesia</li>
<li>Patients with life-threatening illnesses will often have both nociceptive and neuropathic pain and many will also have more than one cause of pain</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pain-due-to-underlying-mechanism">Pain due to underlying mechanism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pain-due-to-underlying-mechanism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-nociceptive-pain">I) Nociceptive pain<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-nociceptive-pain" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>This type of pain is produced by stimulation of specific sensory receptors in the viscera and somatic structures (the nerves are intact). Its characteristics are:</p>
<ul>
<li>Somatic pain: superficial (cutaneous) in skin, subcutaneous tissue or mucous membranes: sharp and well localised pain, deep muscles, tendons, joints: more diffuse and dull</li>
<li>Visceral pain from organs: dull and poorly localised i.e the sensation of pain may be referred to a cutaneous site, · often associated with autonomic responses (e.g. sweating, nausea).</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="ii-neuropathic-pain">ii) Neuropathic pain<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-neuropathic-pain" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>This type of pain is produced by damage to the central or peripheral nervous system (the nerves are abnormal). Its characteristic are:</p>
<ul>
<li>Burning pain or shooting pain</li>
<li>Aching sensation relieved by pressure applied to the affected area</li>
<li>Increased sensitivity to a pain stimulus or to a stimulus that is not normally painful</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pain-described-in-terms-of-duration">Pain described in terms of duration<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pain-described-in-terms-of-duration" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>i) Acute</p>
<ul>
<li>This pain is associated with E.g tissue damage, inflammation, brief disease process, surgical procedure</li>
<li>The time is limited to a brief duration of hours, days, weeks or few months</li>
<li>Also serves as a warning of wrong happening.</li>
</ul>
<p>ii) Chronic</p>
<ul>
<li>Chronic pain can also be termed as persistent</li>
<li>Worsens and intensify with passage of time</li>
<li>Last for extended period of months, years or lifetime</li>
<li>Adversely affect patients functions or wellbeing</li>
<li>Classified as chronic malignant or chronic non malignant</li>
<li>May be related to E.g primary or metastatic process of a disease, treatment, side effects of drugs or infections</li>
<li>Common in HIV/AIDS, Arthritis or degenerative joint diseases, chronic obstructive pulmonary diseases, heart failures, neurological disorders(CVA, multiple sclerosis, fibromyalgia), sickle cell disease, cystic fibrosis, and diabetes</li>
<li>Associated with pain that fails to resolve within an expected time E.g. backache, trauma, spinal cord injury, reflex sympathetic dystrophy, or phantom pains</li>
</ul>
<p>Classification of chronic pain in pathophysiological terms</p>
<p>This is according to American Geriatric Association</p>
<ul>
<li>Norciceptive</li>
<li>Visceral or somatic resulting from stimulation of pain receptors</li>
<li>Neuropathic</li>
<li>Caused by peripheral or Central nerves system stimulation</li>
<li>Mixed (unspecified) pain</li>
<li>unknown pain mechanism</li>
</ul>
<p>Pain due to psychological disorders</p>
<p>Pain due to situation</p>
<ul>
<li>Breakthrough – a transitory exacerbation of pain that occurs on a background of otherwise controlled pain.</li>
<li>Incident pain – occurs only in certain circumstances (e.g. after a particular movement).</li>
<li>Procedural pain – related to procedures or intervention</li>
</ul>
<p>Other factors that contribute to pain perception</p>
<p>A) Psychological factors</p>
<ul>
<li>Pain is influenced by psychological factors as it affects the human consciousness</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Psychological factors are just as important in managing pain as the physical cause of the pain.</li>
<li>Psychological pain related to chronic pain often shows itself as depression or anxiety.</li>
<li>Distress associated with chronic pain may present as anger, frustration, hopelessness, denial, grief, sadness or withdrawal.</li>
<li>Avoiding activities and social contact affects the patient themselves and leads to less activity, more social isolation and a focus on the pain leading to:</li>
<li>a vicious circle of pain</li>
<li>lack of activity</li>
<li>fear</li>
<li>depression</li>
<li>more pain</li>
</ul>
<p>It has been shown that negative feelings, such as rejection or loss create neuronal stimulation patterns similar to those created by noxious stimuli.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-spiritual-factors">B) Spiritual factors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-spiritual-factors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Spiritual and existential distress may manifest themselves in physical problems and are an important source of clinical suffering that can aggravate and even cause pain.</li>
<li>Spiritual pain may or may not have a religious component and often reflects the patient questioning of the meaning of life generally and that of his or her own life in particular.</li>
<li>Hopelessness and despair make pain difficult to bear and a sense of peace and strength from faith will help to make pain easier to live with.</li>
<li>Spiritual pain may prompt in the patient a re-evaluation of their life that lead to the recovery of values and beliefs. This maybe a transition point along their journey towards greater self-understanding.</li>
<li>Recognition and support for spiritual issues is an integral part of pain assessment and management.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="c-cultural-factors">C) Cultural factors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-cultural-factors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Cultural factors play a major role in how we view health and illness and therefore pain.</li>
<li>A sensitive approach to culture, ethnicity and language will prevent the aggravation of pain and help reduce emotional distress.</li>
<li>Many cultures believe in ‘supernatural’ powers that can cause pain.</li>
<li>Different cultures respond differently to pain and it is important to recognise the different behaviours such as shouting and crying, or being stoical.</li>
<li>How we see the family and community respond to pain will affect how we as individuals respond to pain.</li>
<li>Language may also be a challenge, with the patient being unable to communicate effectively with the health professional and visa versa.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="d-social-factors">D) Social factors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-social-factors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Unresolved social factors can aggravate pain and management of such issues can facilitate pain control</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Factors influencing pain may include the lack of aids for daily living, the lack of accessibility to community and local resources and services, along with financial and legal issues.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="principles-of-management-of-pain">Principles of management of pain<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#principles-of-management-of-pain" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>The management of pain is based on the type and cause of pain and needs to be holistic.</li>
<li>It is important to treat the underlying cause of the pain if it is treatable (e.g. an opportunistic infection).</li>
<li>The aims of pain management are:</li>
<li>Prompt relief of pain</li>
<li>Prevention of recurrence.</li>
<li>In the management of pain, the goals are for the patient to be pain free at night, then at rest during the day, and then pain free on movement.</li>
<li>It is important to discourage the acceptance of pain by health care workers as well as the patient and their family.</li>
<li>Both pharmacological and non-pharmacological methods should be used to manage pain.</li>
<li>Pain can be managed across a range of settings, including the home. It is only in severe cases where an individual may need to be hospitalized in order to get their pain under control.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pain-assessment">Pain Assessment<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pain-assessment" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>As pain is subjective, self-reporting is central to assessment. Comprehensive clinical assessment is vital for effective pain management.</li>
<li>A standard assessment guideline for pain is important to measure change over time.</li>
<li>Several pain assessment tools are available, for instance:</li>
<li>Body diagrams to document the site of pain and pain, rating scales to follow pain and the effect of treatment (which are useful in managing difficult pain).</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="goals-of-pain-assessment">Goals of pain assessment<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#goals-of-pain-assessment" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>To understand the experience of the patient and the underlying holistic factors and pathophysiology contributing to the pain</li>
<li>To prevent the onset of detrimental effects (both psychological and physical) as a result of untreated pain.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="goals-of-measuring-pain">Goals of measuring pain<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#goals-of-measuring-pain" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>To determine the presence, intensity and duration of pain</li>
<li>To determine the location of pain</li>
<li>To determine treatment efficacy.</li>
</ul>
<p>NB:</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Assessment should not be confused with measurement, where a score is indicative of pain intensity and treatment efficacy.</li>
<li>All findings or relevant information should be clearly documented.</li>
<li>Of particular interest would be information obtained during initial assessment, pain scores, intervention and intervention efficacy.</li>
<li>Clear and precise notes should be kept in a place easily accessible to other health professionals involved in caring for the patient.</li>
<li>Several pain assessment and measurement tools are available, e.g. body diagrams to document the site of pain; and pain rating scales to follow the patient's pain and the effect of treatment (useful in managing difficult pain).</li>
</ul>
<p>Use the PQRST tool for questions to assess pain: The PQRST of Pain is a good tool for organizing an assessment</p>
<ul>
<li>P- Precipitating and relieving factors: What makes your pain better/worse?</li>
<li>Q - Quality of pain: How would you describe your pain?</li>
<li>R - Radiation of pain: Is the pain in one place or does it move?</li>
<li>S - Site and severity of pain: Where is your pain? How bad is it?</li>
<li>T - Timing and previous treatment: How often do you get the pain? When? Are you on pain treatment? Does it help?</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="assessment-of-pain-requires-four-steps">Assessment of pain requires Four steps:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#assessment-of-pain-requires-four-steps" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="step-1-determine-the-nature-and-possible-causes-of-pain">Step 1: Determine the nature and possible causes of pain<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#step-1-determine-the-nature-and-possible-causes-of-pain" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Identifying the aetiology of pain is essential to its management.</li>
<li>Prompt diagnosis and treatment of these syndromes can reduce morbidity associated with unrelieved pain. In the great majority of patients, the history, physical examination and, occasionally, an x-ray, are adequate to appropriately assess the pain.</li>
<li>In most cases, the pain is caused by direct tumour involvement.</li>
<li>Psychological, cultural, and chemical addiction factors can further influence a patient's pain experience.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="step-2-measuring-pain-intensity">Step 2: Measuring pain intensity<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#step-2-measuring-pain-intensity" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>This assists in understanding the underlying pathology.</li>
<li>Certain types of pain such as neuropathic pain and incidental pain can be difficult to control and may require higher doses of opioids, trials of different opioids or the addition of appropriate adjuvant analgesics.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="step-3-perform-a-multidimensional-assessment">Step 3: Perform a multidimensional assessment<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#step-3-perform-a-multidimensional-assessment" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Terminally ill patients need to be assessed regularly since symptoms can change rapidly.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>
<p>Keep in mind that there are three steps in the pain experience:</p>
</li>
<li>
<p>Production of pain: This occurs at the site of the cancer. This cannot be measured directly and can be (nociception) different from cancer to cancer, site to site, etc.</p>
</li>
<li>
<p>Perception: This occurs at the level of the central nervous system/brain. This component too, cannot be measured and is also subject to the influence of modulation.</p>
</li>
<li>
<p>Expression: The expression of pain is the main target of all our assessments and treatment. Two patients with the same level of perception may express dramatically different pain intensity. Therefore, we should not equate the intensity of pain expression directly with nociception. Doing this would be a one-dimensional approach that ignores the complexity of the pain experience.</p>
</li>
</ul>
<p>Appropriate pain assessment requires us to consider the multiple dimensions of certain patient’s expression of pain</p>
<p>Some of the components of a multi-dimensional pain assessment include:</p>
<p>a) Pain syndrome</p>
<p>Type of pain</p>
<ul>
<li>Location, radiation, intensity (use scale), triggers</li>
<li>Bone pain</li>
<li>Visceral pain</li>
<li>Neuropathic pain</li>
<li>Incidental</li>
<li>Are there other symptoms that need controlling?</li>
</ul>
<p>b) Drug</p>
<p>Dosage</p>
<ul>
<li>Are there indications of tolerance?</li>
<li>Are there signs of toxicity?</li>
<li>What has been the response to individual opioids?</li>
<li>What other treatments have been/are being used for pain relief?</li>
<li>Effectiveness?</li>
</ul>
<p>c) Patient</p>
<p>Underlying metabolic abnormalities (e.g. renal impairment, hypercalcemia, hepatic encephalopathy, etc)</p>
<ul>
<li>Is there significant psychological distress?</li>
<li>How has the patient coped previously with life stressors?</li>
<li>Is there a history of drug/alcohol addiction? Is the patient cognitively impaired / delirious? (Use screening tools such as Folstein MMSQ to assess cognition)</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Are there spiritual issues that need to be addressed (e.g. what is the meaning of pain to the patient?)
d) Social</li>
<li>Influence of pain on the patient’s daily living</li>
<li>What are the family and social support systems?</li>
<li>Is there severe family dysfunction?</li>
<li>Are there financial concerns?</li>
<li>Are there cultural issues influencing the illness experience?</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="step-4-identify-poor-prognostic-factors">Step 4: Identify poor prognostic factors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#step-4-identify-poor-prognostic-factors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The following are ‘red flags’ to alert the possibility that difficulties may be encountered in trying to control pain;</p>
<ul>
<li>Neuropathic pain</li>
<li>Incidental pain (pain severely exacerbated by an incident such as movement, coughing, etc.).</li>
<li>Impaired cognitive functioning.</li>
<li>Major psychological distress.</li>
<li>Positive history of alcohol abuse or drug addiction (indicates poor coping strategies).</li>
<li>Somatization factor - Pain that has a large psychosocial or spiritual component is often referred to as “total pain” or “total suffering.”</li>
</ul>
<p>HCW should suspect somatization if:</p>
<ul>
<li>Significant psychosocial or spiritual issues are identified</li>
<li>The patient describes pain as “all over” (in absence of physical cause for “all over” pain such as widespread skeletal metastases or accumulation of opioid metabolites)</li>
<li>Pain appears to improve with socialization, physical activity or other distraction, and increases when alone</li>
<li>Escalating doses of opioids produce toxicity with little or no pain relief; or there is a history of somatization under stress.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pain-measurement">Pain measurement<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pain-measurement" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Pain measurement is complicated and requires:
a) Knowledge on the correct use of the measurement tool
b) Understanding of the scoring process
c) The ability to correctly interpret a score</li>
<li>Obtaining an initial score is vitally important:
a) For comparison with other scores after intervention
b) To determine treatment efficacy.</li>
<li>Ideally, carry out pain measurements at regular intervals, either six or four measurements per week.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Remember that most measurement instruments do not acknowledge the presence of anxiety and can therefore produce false high or false low scores. The behavioural indicators of anxiety are more or less the same as for pain and it is possible to measure anxiety instead of pain.</li>
<li>There are a number of different measurement tools available both for adults and children.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="guidelines-for-selecting-a-measurement-tool-characteristics-of-the-tool">Guidelines for selecting a measurement Tool / Characteristics of the tool<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#guidelines-for-selecting-a-measurement-tool-characteristics-of-the-tool" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Should be age appropriate</li>
<li>Should have tested psychometric properties of validity and reliability</li>
<li>Should be able to measure different pain levels</li>
<li>Should be easy to use, many measurement tools are complicated and time consuming and not recommended in all situations</li>
<li>Should be able to produce an easily understandable score</li>
<li>Should have clear instruction on application and interpretation.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="barriers-to-optimal-pain-assessment">Barriers to optimal pain Assessment<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#barriers-to-optimal-pain-assessment" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-health-care-professional-barriers">A) Health care professional barriers<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-health-care-professional-barriers" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Lack of identification of pain assessment and relief as a priority in patient care</li>
<li>Inadequate knowledge on performance of pain assessment</li>
<li>Failure to use validated pain measurement tool</li>
<li>Inability of clinicians to empathize or establish rapport with patients</li>
<li>Lack of continuity of care</li>
<li>Lack of communication among health care professionals</li>
<li>Prejudice and bias in dealing with clients</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="b-health-care-system-barriers">B) Health care system barriers<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-health-care-system-barriers" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Failure of HS to hold professionals accountable for pain assessment</li>
<li>Lack of criteria or culturally sensitive instruments for pain assessment in health care setting</li>
<li>Lack of institutional policies for performance and documentation of pain assessment</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="c-patient-family-societal-barriers">C) Patient/family/ Societal barriers<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-patient-family-societal-barriers" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Highly subjective and personal nature of pain experience</li>
<li>Lack of patient/family awareness about the importance of speaking out about pain</li>
<li>Lack of patient communication with care providers about pain</li>
<li>Reluctance to talk about pain</li>
<li>Not wanting to bother staff</li>
<li>Fear of not being believed</li>
<li>Age related stoicism</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Lack of common language to describe pain</li>
<li>Presence of unfounded beliefs and myths about pain and its management</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="process-of-pain-assessment">Process of Pain Assessment<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#process-of-pain-assessment" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Accurate pain assessment is the basis of pain treatment.</li>
<li>Must address sensation, intensity and patient’s response to pain management.</li>
<li>The extent of assessment is dictated by</li>
<li>It’s purpose</li>
<li>Patients’ condition (stage of illness)</li>
<li>Clinical setting</li>
<li>Feasibility</li>
<li>Relevance of a particular dimension to the patients or health care provider</li>
<li>Is a continuous process involving multi-dimensional factors to include:</li>
<li>Detailed history of Pain intensity, characteristics, effects on function, history of previous substance abuse.</li>
<li>Physical examination with pertinent neurological examination if neuropathic pain is suspected. Attention focused on the painful areas and common referred pain locations</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="nb">NB:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nb" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>In frail patients, physical examination should be done only if:</li>
</ol>
<ul>
<li>The findings will potentially change or facilitate treatment plan.</li>
<li>The potential benefit of information obtained outweighs the burden and Potential discomfort of the diagnostic test</li>
</ul>
<ol start="2">
<li>On going and subsequent evaluation of pain is done to:</li>
</ol>
<ul>
<li>Determine the effectiveness of treatment measures</li>
<li>Identify new pain</li>
</ul>
<ol start="3">
<li>Frequency of pain assessment and reassessment is individualized and determined by the patients’ clinical situations.</li>
<li>Pain is assessed on first encounter and one hour after administration of analgesics or other non-pharmacologic intervention.</li>
<li>Documentation is necessary for the multidisciplinary continuity of care.</li>
<li>Quality and usefulness of assessment is only good if the assessor is patient focused:</li>
<li>Listening empathically</li>
<li>Maintaining open communication</li>
<li>Validating and legitimizing concerns of patient and significant others</li>
<li>These confirm genuine personal interest in facilitating a positive pain management outcome</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3296ba3a">Sources of information about patient’s pain<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3296ba3a" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Verbal self report</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Observation</li>
<li>Interviews with patient and significant other</li>
<li>Review of medical data</li>
<li>Feedback from health care providers</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="models-of-pain-assessment">Models of pain assessment<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#models-of-pain-assessment" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>This is a Multi-factorial model for pain assessment</p>
<p>It considers three components:</p>
<ul>
<li>Physiologic/Sensory/discriminative (selection and modulation of pain sensation)</li>
<li>Motivational/affective (reaction to pain via the brain reticular formation and limbic system)</li>
<li>Cognitive (past and present experience with pain)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="hns-424-pain-assessment">HNS 424: PAIN ASSESSMENT<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hns-424-pain-assessment" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="multi-factorial-pain-assessment-table-6-2">Multi-factorial pain assessment table 6-2<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#multi-factorial-pain-assessment-table-6-2" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<table><thead><tr><th>Factor</th><th>Question</th></tr></thead><tbody><tr><td>Physiologic/sensory</td><td>What is causing the patient pain</td></tr><tr><td>How does the patient describe his/her pain</td><td></td></tr><tr><td>Affective</td><td>How does the patient's emotional state affect his report of pain</td></tr><tr><td>Cognitive</td><td>How do the patient's knowledge, attitude, and belief affect their pain experience</td></tr><tr><td>What is the meaning of pain to the patient</td><td></td></tr><tr><td>How does patients past experience with the pain influence the pain</td><td></td></tr><tr><td>Behavioral</td><td>How do you know the patient is in pain</td></tr><tr><td>What patient pain behaviour or or non verbal cues inform you that pain is being experienced</td><td></td></tr><tr><td>What is the patient doing to decrease his/her pain</td><td></td></tr><tr><td>Sociocultural</td><td>How does patient's sociocultural background affect the pain experience, expression and coping</td></tr><tr><td>Environmental</td><td>How does the patient environment affect the pain experience or expression.</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="physiologic-sensory-factors">Physiologic/Sensory factors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#physiologic-sensory-factors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Explains the cause of pain and characterizes the person's pain</li>
<li>Words for nature</li>
<li>Grade for intensity</li>
<li>Position for location</li>
<li>Duration for temporal pattern</li>
<li>Effects for aggravating and relieving factors</li>
<li>Patients are asked to use words or qualifier</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="affective-factor">Affective factor<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#affective-factor" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Emotional response associated with pain experience and associated reactions such as:</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>≻</mo></mrow><annotation encoding="application/x-tex">\succ</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.5782em; vertical-align: -0.0391em;"></span><span class="mrel">≻</span></span></span></span></span> Depression
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>≻</mo></mrow><annotation encoding="application/x-tex">\succ</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.5782em; vertical-align: -0.0391em;"></span><span class="mrel">≻</span></span></span></span></span> Anger
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>≻</mo></mrow><annotation encoding="application/x-tex">\succ</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.5782em; vertical-align: -0.0391em;"></span><span class="mrel">≻</span></span></span></span></span> Distress
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>≻</mo></mrow><annotation encoding="application/x-tex">\succ</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.5782em; vertical-align: -0.0391em;"></span><span class="mrel">≻</span></span></span></span></span> Anxiety
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>≻</mo></mrow><annotation encoding="application/x-tex">\succ</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.5782em; vertical-align: -0.0391em;"></span><span class="mrel">≻</span></span></span></span></span> Decreased ability to concentrate
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>≻</mo></mrow><annotation encoding="application/x-tex">\succ</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.5782em; vertical-align: -0.0391em;"></span><span class="mrel">≻</span></span></span></span></span> Mood disturbances, loss of control
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>≻</mo></mrow><annotation encoding="application/x-tex">\succ</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.5782em; vertical-align: -0.0391em;"></span><span class="mrel">≻</span></span></span></span></span> Lack of involvement in the plan of care</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="cognitive-factor">Cognitive factor<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cognitive-factor" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>How pain influences the patients’ thought process.</li>
<li>How one views self in relation to pain</li>
<li>Knowledge, belief and attitude one has on pain</li>
<li>Meaning of pain</li>
<li>Past experience with pain</li>
<li>How other person believe or not believe in his/her pain</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="behavioral-factor">Behavioral factor<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#behavioral-factor" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>A way of expressing or coping response.</li>
<li>Are exhibited actions related to pain: verbal complain, crying, groaning, facial expression, posturing, splinting, lying down, pacing, rocking or suppressing the expression of pain etc.</li>
<li>Cues include insomnia, anxious behaviour, boredom, inability to concentrate, restlessness, fatigue etc.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="sociocultural-factor">Sociocultural factor<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sociocultural-factor" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>All the demographic variables of the patient experiencing pain</li>
<li>The impact of age, gender ethnicity, spirituality, marital status, social support on pain assessment, treatment and outcomes is positive</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="environmental-factor-in-which-patient-receive-pain-management">Environmental factor (in which patient receive pain management)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#environmental-factor-in-which-patient-receive-pain-management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>The Physical environment E.g</li>
<li><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>≻</mo></mrow><annotation encoding="application/x-tex">\succ</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.5782em; vertical-align: -0.0391em;"></span><span class="mrel">≻</span></span></span></span></span> Free from bright light</li>
<li><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>≻</mo></mrow><annotation encoding="application/x-tex">\succ</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.5782em; vertical-align: -0.0391em;"></span><span class="mrel">≻</span></span></span></span></span> Extreme noise</li>
<li><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>≻</mo></mrow><annotation encoding="application/x-tex">\succ</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.5782em; vertical-align: -0.0391em;"></span><span class="mrel">≻</span></span></span></span></span> Moderate temperature</li>
<li>Context</li>
<li>Pain assessment findings in relation to patients report</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pain-assessment">PAIN ASSESSMENT<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pain-assessment" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="quantitative-assessment-of-pain">Quantitative assessment of pain<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#quantitative-assessment-of-pain" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>It is necessary to monitor patients’ response to analgesics.</li>
<li>Done using an Assessment tool termed as Pain Scales</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="types-of-pain-scales-assessment-tool">Types of pain scales / Assessment tool<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types-of-pain-scales-assessment-tool" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>There are several well-designed pain scales that are used to help assess the extent of one's pain, all of which help improve communication between healthcare providers and patients</li>
<li>Some of these tools are most suited for people of certain ages, while others are more useful for people who are highly involved in their own healthcare</li>
<li>Pain scale results can help guide the diagnostic process, track the progression of a condition and more.</li>
</ul>
<p>These pain scales (assessment tools) fall into the following categories:</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="a-numerical-rating-scales-nrs">a) Numerical rating scales (NRS)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-numerical-rating-scales-nrs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Use numbers to rate pain, the patient is asked to make three pain ratings, corresponding to current, best and worst pain experienced over the past 24 hours, on a scale of 0 = No pain, 1-3 = Mild pain, 4-6 = Moderate, 7-10 = Severe pain. The average of the 3 ratings is used to represent the patient's level of pain over the previous 24 hours.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-visual-analogue-scales-vas">b) Visual analogue scales (VAS)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-visual-analogue-scales-vas" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>This is a measurement instrument that tries to measure a characteristic or attitude that is believed to range across a continuum of values and cannot easily be directly measured. E.g the amount of pain that a patient feels ranges across a continuum from none to an extreme amount of pain.</p>
<p>Operationally a VAS is usually a horizontal line, 100 mm in length, anchored by word descriptors at each end, i.e one end marked ,No pain, the other end, very severe pain. The patient marks on the line the point that they feel represents their perception of their current state. The VAS score is determined by measuring in millimetres from the left hand end of the line to the point that the patient marks.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="c-categorical-scales">c) Categorical scales<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-categorical-scales" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Use words as the primary communication tool and may also incorporate numbers, colour or relative location to communicate pain</p>
<p><strong>NB:</strong> No one particular pain scale is considered ideal or better than the other for every situation.</p>
<ul>
<li>Qualitative scales are especially useful in assessing the response to treatment because they can clearly define whether the pain has improved or worsened</li>
<li>Qualitative pain scales are helpful in giving the healthcare provider an idea about the cause of the pain and whether it is associated with medical problem or resulting from the treatment itself</li>
<li>Most pain scales have quantitative features and qualitative features but numerical scales are more quantitative</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="other-examples-of-pain-scales">Other examples of pain scales<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#other-examples-of-pain-scales" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>
<p>Verbal Descriptor Scale (VDS)</p>
</li>
<li>
<p>Wong-Maker FACES pain scale(FPS-R)</p>
</li>
<li>
<p>Pain Thermometer</p>
</li>
<li>
<p>Critical-Care Observation Tool (CPOT)</p>
</li>
<li>
<p>FLACC Scale ( FLACC stands for, face, legs, activity, crying, consolability</p>
</li>
<li>
<p>CRIES Scale- Assess crying, oxygenation, vital signs, facial expression and sleeplessness</p>
</li>
<li>
<p>COMFORT Scale</p>
</li>
<li>
<p>McGill Pain Scale</p>
</li>
<li>
<p>Colour Analogue Scale</p>
</li>
<li>
<p>Mankoski Pain Scale</p>
</li>
<li>
<p>Brief pain Inventory scale</p>
</li>
<li>
<p>Descriptor Differential scale of pain Intensity</p>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="end-of-life-care">END-OF-LIFE CARE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#end-of-life-care" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>This is the term used to describe the support and medical care given during the time surrounding death so as the individual can live as well as possible and die with dignity</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="goal-of-end-of-life-care">Goal of End- of life care<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#goal-of-end-of-life-care" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>To provide comfort, guidance and help in understanding the unfamiliar territory of death</li>
<li>To prevent or relieve suffering as much as possible and to improve quality of life while respecting the dying person’s wishes.</li>
</ul>
<p><strong>NB:</strong> To provide comfort care is an essential part of medical care at the end of life. It is care that helps or soothes a person who is dying</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="the-4-areas-the-dying-need-care-in-and-their-management">The 4 areas the dying need care in and their management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#the-4-areas-the-dying-need-care-in-and-their-management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Physical Comfort</li>
<li>Mental and Emotional Needs</li>
<li>Spiritual Issues</li>
<li>Practical Tasks</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="a-physical-comfort">a) Physical comfort<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-physical-comfort" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>There are ways to make a person who is dying more comfortable. Discomfort can come from a variety of problems. For each, there are things you or a healthcare provider can do, depending on the cause. E.g a dying person can be uncomfortable because of:</p>
<ul>
<li>Pain</li>
<li>Breathing problems</li>
<li>Skin irritation</li>
<li>Digestive problems</li>
<li>Temperature sensitivity</li>
<li>Fatigue</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>&gt; Pain</p>
<ul>
<li>
<p>Watching someone you love die is hard enough, but thinking that person is also in pain makes it worse. Not everyone who is dying experiences pain, but there are things you can do to help someone who does. Experts believe that care for someone who is dying should focus on relieving pain without worrying about possible long-term problems of drug dependence or abuse.</p>
</li>
<li>
<p>Don’t be afraid of giving as much pain medicine as is prescribed by the doctor. Pain is easier to prevent than to relieve and severe pain is hard to manage. Try to make sure that the level of pain does not get ahead of pain-relieving medicines. Medicines can be increased or changed. If this doesn’t help, then ask for consultation with a palliative medical specialist who has experience in pain management for seriously ill patients.</p>
</li>
<li>
<p>Struggling with severe pain can be draining. It can make it hard for families to be together in a meaningful way. Pain can affect mood, being in pain can make someone seem angry or short-tempered. Although understandable, irritability resulting from pain might make it hard to talk, hard to share thoughts and feelings.</p>
</li>
</ul>
<p>&gt; Breathing problems</p>
<ul>
<li>
<p>Shortness of breath or the feeling that breathing is difficult is a common experience at the end of life. The doctor might call this dyspnea. Worrying about the next breath can make it hard for important conversations or connections. Try raising the head of the bed, opening a window, using a humidifier, or having a fan circulating air in the room. Sometimes, morphine or other pain medications can help relieve the sense of breathlessness.</p>
</li>
<li>
<p>People very near death might have noisy breathing, sometimes called a death rattle. This is caused by fluids collecting in the throat or by the throat muscles relaxing. It might help to try turning the person to rest on one side. There is also medicine that can be prescribed that may help clear this up.</p>
</li>
</ul>
<p>NB: Not all noisy breathing is a death rattle. It may help to know that this noisy breathing is usually not upsetting to the dying person, even if it is to family and friends.</p>
<p>&gt; Skin irritation</p>
<ul>
<li>
<p>Skin problems can be very uncomfortable. With age, skin naturally becomes drier and more fragile, so it is important to take extra care with an older person’s skin. Gently applying alcohol-free lotion can relieve dry skin and be soothing.</p>
</li>
<li>
<p>Dryness on parts of the face, such as the lips and eyes, can be a common cause of discomfort near death. A lip balm could keep this from getting worse. A damp cloth placed over closed eyes might relieve dryness.</p>
</li>
<li>
<p>If the inside of the mouth seems dry, giving ice chips (if the person is conscious) or wiping the inside of the mouth with a damp cloth, cotton ball, or specially treated swab might help.</p>
</li>
</ul>
<p>45</p>
<ul>
<li>Sitting or lying in one position puts constant pressure on sensitive skin, which can lead to painful bed sores (sometimes called pressure ulcers). When a bed sore first forms, the skin gets discolored or darker. Watch carefully for these discolored spots, especially on the heels, hips, lower back and back of the head.</li>
<li>Turning the person from side to back and to the other side every few hours may help prevent bed sores. Try putting a foam pad under an area like a heel or elbow to raise it off the bed and reduce pressure. Ask if a special mattress or chair cushion might also help.</li>
</ul>
<p>NB: Keeping the skin clean and moisturized is always important.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="digestive-problems">Digestive problems<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#digestive-problems" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Nausea, vomiting, constipation, and loss of appetite are common issues at the end of life. The causes and treatments for these symptoms are varied. There are medicines that can control nausea or vomiting or relieve constipation, a common side effect of strong pain medications.</li>
<li>If someone near death wants to eat but is too tired or weak, you can help with feeding. To address loss of appetite, try gently offering favorite foods in small amounts. Or, try serving frequent, smaller meals rather than three big ones.</li>
<li>You don't have to force a person to eat. Going without food and/or water is generally not painful, and eating can add to discomfort. Losing one's appetite is a common and normal part of dying. Swallowing may also be a problem, especially for people with dementia. A conscious decision to give up food can be part of a person's acceptance that death is near.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="temperature-sensitivity">Temperature sensitivity<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#temperature-sensitivity" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>People who are dying may not be able to tell you that they are too hot or too cold, so watch for clues. E.g, someone who is too warm might repeatedly try to remove a blanket. You can take off the blanket and try a cool cloth on his or her head.</li>
<li>If a person is hunching his or her shoulders, pulling the covers up, or even shivering those could be signs of cold. Make sure there is no draft, raise the heat, and add another blanket.</li>
</ul>
<p>NB: Avoid electric blankets because they can get too hot.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="fatigue">Fatigue<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#fatigue" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>It is common for people nearing the end of life to feel tired and have little or no energy. Keep activities simple. E.g, a bedside commode can be used instead of walking to the bathroom. A shower stool can save a person's energy, as can switching to sponging off in bed.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-mental-and-emotional-needs">b) Mental and Emotional Needs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-mental-and-emotional-needs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Complete end-of-life care also includes helping the dying person manage mental and emotional distress. Someone who is alert near the end of life might understandably feel depressed or anxious.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>
<p>It is important to treat emotional pain and suffering. Encouraging conversations about feelings might help. You might want to contact a counselor, possibly one familiar with end-of-life issues. If the depression or anxiety is severe, medicine may help.</p>
</li>
<li>
<p>A dying person may also have some specific fears and concerns. He or she may fear the unknown or worry about those left behind. Some people are afraid of being alone at the very end. This feeling can be made worse by the understandable reactions of family, friends, and even the medical team. E.g when family and friends do not know how to help or what to say, sometimes they stop visiting. Or, someone who is already beginning to grieve may withdraw.</p>
</li>
<li>
<p>Doctors may feel helpless because they can't cure their patient. Some seem to avoid a dying patient. This can add to a dying person's sense of isolation. If this is happening, discuss your concerns with the family, friends, or the doctor.</p>
</li>
<li>
<p>The simple act of physical contact e.g holding hands, a touch, or a gentle massage can make a person feel connected to those he or she loves. It can be very soothing. Warm your hands by rubbing them together or running them under warm water.</p>
</li>
<li>
<p>Try to set a comforting mood. Remember that listening and being present can make a difference. E.g Patient X loved a party, so it is natural for him to want to be around family and friends when he was dying, Patient K always liked spending quiet moments with one or two people at a time, so she is most comfortable with just a few visitors.</p>
</li>
<li>
<p>Some experts suggest that when death is very near, music at a low volume and soft lighting are soothing. In fact, near the end of life, music therapy might improve mood, help with relaxation and lessen pain. Listening to music might also evoke memories those present can share. For some people, keeping distracting noises like televisions and radios to a minimum is important.</p>
</li>
</ul>
<p>NB: Often, just being present with a dying person is enough. It may not be necessary to fill the time with talking or activity. Your quiet presence can be a simple and profound gift for a dying family member or friend.</p>
<p>c) Spiritual issues</p>
<ul>
<li>
<p>People nearing the end of life may have spiritual needs as important as their physical concerns. Spiritual needs include finding meaning in one's life and ending disagreements with others, if possible. The dying person might find peace by resolving unsettled issues with friends or family. Visits from a social worker or a counselor may also help.</p>
</li>
<li>
<p>Many people find solace in their faith. Others may struggle with their faith or spiritual beliefs. Praying, talking with someone from one's religious community (such as a minister, priest, rabbi, or imam), reading religious texts, or listening to religious music may bring comfort.</p>
</li>
<li>
<p>Family and friends can talk to the dying person about the importance of their relationship. E.g, adult children can share how their father has influenced the course of their lives. Grandchildren can let their grandfather know how much he has meant to them. Friends can relate how they value years of support</p>
</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>and companionship. Family and friends who can't be present could send a recording of what they would like to say or a letter to be read out loud.</p>
<ul>
<li>Sharing memories of good times is another way some people find peace near death. This can be comforting for everyone. Some doctors think it is possible that even if a patient is unconscious, he or she might still be able to hear. It is probably never too late to say how you feel or to talk about fond memories.</li>
<li>Always talk to, not about, the person who is dying. When you come into the room, it is a good idea to identify yourself, saying something like, "Hi, John/Mary etc. It's so and so, and I've come to see you."</li>
<li>Another good idea is to have someone write down some of the things said at this time both by and to the person who is dying. In time, these words might serve as a source of comfort to family and friends. People who are looking for ways to help may welcome the chance to aid the family by writing down what is said.</li>
<li>There may come a time when a dying person who has been confused suddenly seems clear-thinking. Take advantage of these moments, but understand that they might be only temporary, not necessarily a sign he or she is getting better.</li>
<li>Sometimes, a dying person may appear to see or talk to someone who is not there. Try to resist the temptation to interrupt or say they are imagining things. Give the dying person the space to experience their own reality.</li>
</ul>
<p>d) Practical Tasks</p>
<ul>
<li>Many practical jobs need to be done at the end of life, both to relieve the person who is dying and to support the caregiver. Everyday tasks can be a source of worry for someone who is dying and they can overwhelm a caregiver. Taking over small daily chores around the house such as picking up the mail or newspaper, writing down phone messages, doing a load of laundry, feeding the family pet, taking children to soccer practice, or picking up medicine from the pharmacy can provide a much-needed break for caregivers.</li>
<li>A person who is dying might be worried about who will take care of things when he or she is gone. Offering re-assurance, "I'll make sure E.g your daughter clears her studies," "Jane has promised to take care of the unfinished building," and this might provide a measure of peace. Reminding the dying person that his or her personal affairs are in good hands can also bring comfort.</li>
<li>Everyone may be asking the family, "What can I do for you?" It helps to make a specific offer. Say to the family, "Let me help with . . ." and suggest something like bringing meals for the caregivers, paying bills, talking care of domestic animals or babysitting. If you're not sure what to offer, talk to someone who has been through a similar situation. Find out what kind of help was useful.</li>
<li>If you want to help but can't get away from your own home, you could schedule other friends or family to help with small jobs or to bring in meals. This can allow the immediate family to give their full attention to the person who is dying.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>
<p>If you are the primary caregiver, ask for help when you need it and accept help when it's offered. Don't hesitate to suggest a specific task to someone who offers to help. Friends and family are probably anxious to do something for you and/or the person who is dying, but they may be reluctant to repeatedly offer when you are so busy.</p>
</li>
<li>
<p>Keeping close friends and family informed can feel overwhelming. Setting up an outgoing voicemail message, a blog, an email list, a private Facebook page, or even a phone tree can reduce the number of calls you have to make. Some families create a blog or website to share news, thoughts, and wishes, for organizations that make setting up such webpages easy and secure. Or, you can assign a close family member or friend to make the updates for you. These can all help reduce the emotional burden of answering frequent questions.</p>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="differences-between-children-s-and-adults-palliative-care">Differences between children's and adults' palliative care<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#differences-between-children-s-and-adults-palliative-care" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>
<p>An understanding of developmental issues is essential when providing children's palliative care.</p>
</li>
<li>
<p>Infants and young children are completely dependent on adults and so depend on other people to make decisions for them.</p>
</li>
<li>
<p>As children grow and develop, their capacity to care and to decide for themselves increases. Therefore care that is appropriate for a child of 11 years may be inappropriate two years later.</p>
</li>
<li>
<p>The natural desire of family and carers to protect a child with a devastating illness can lead to that child feeling stifled</p>
</li>
<li>
<p>The child's developmental level will particularly influence:</p>
</li>
<li>
<p>The communication of wishes, fears and symptoms</p>
</li>
<li>
<p>Their understanding of illness and death</p>
</li>
<li>
<p>An assessment of symptoms</p>
</li>
<li>
<p>The management of symptoms</p>
</li>
<li>
<p>Decision making</p>
</li>
<li>
<p>The importance of play as a means of understanding the world</p>
</li>
<li>
<p>The importance of school</p>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="care-options-at-the-end-of-life">Care options at the End of Life<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#care-options-at-the-end-of-life" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-palliative-care">a) Palliative care<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-palliative-care" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>This is a resource for anyone living with a serious illness, such as heart failure, chronic obstructive pulmonary disease, cancer, dementia, Parkinson's disease, and many others. Palliative care can be helpful at any stage of illness and is best provided from the point of diagnosis.</p>
<p>A palliative care consultation team is a multidisciplinary team that works with the patient, family and the patient's other health care providers to provide medical, social, emotional and practical support.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="b-hospice">b) Hospice<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-hospice" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>This is an approach to care, so it is not tied to a specific place. It can be offered in two types of settings, at home or in a facility such as a nursing home, hospital, or even in a separate hospice center.</p>
<p>Hospice care brings together a team of people with special skills among them nurses, doctors, social workers, spiritual advisors and trained volunteers. Everyone works together with the person who is dying, the caregiver, and/or the family to provide the medical, emotional, and spiritual support needed.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="c-hospital">c) Hospital<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-hospital" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>In a hospital setting, medical professionals are available who know what needs to be done for someone who is dying. This can be very reassuring. In addition to the regular care team, some hospitals may have palliative care teams that can assist with managing uncomfortable symptoms and making medical decisions for patients who may or may not be at the end of life.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="d-nursing-homes">d) Nursing Homes<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-nursing-homes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>More and more people are in nursing homes at the end of life. In a nursing home, nursing staff are always present. Unlike a hospital, a doctor is not in the facility all the time, but may be available by phone. Plans for end-of-life care can be arranged ahead of time, so when the time comes, care can be provided as needed without first consulting a doctor.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="e-home">e) Home<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-home" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Home is likely the most familiar setting for someone who needs end-of-life care. Family and friends can come and go freely. Care at home can be a big job for family and friends i.e physically, emotionally and financially. But, there are benefits too, and it is often a job caregivers are willing to take on. Hiring a home nurse is an option for people who need additional help and have the financial resources.</li>
<li>Talk with your healthcare provider about the kind of care needed. Frequently, this care does not require a nurse but can be provided by nursing assistants or family and friends without medical training.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="emergency-care-principles">Emergency care principles<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#emergency-care-principles" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A palliative care emergency:</p>
<ul>
<li>This is any change in a patient’s condition that requires urgent and immediate intervention.</li>
<li>Assessment must be prompt and complete if good results are to be achieved.</li>
</ul>
<p>The following should be considered during the management of a palliative care emergency:</p>
<ul>
<li>The nature of the emergency</li>
<li>The general condition of the patient</li>
<li>The stage of the disease and prognosis</li>
<li>The availability of possible treatments</li>
<li>The affordability of possible treatments</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>The likely effectiveness and toxicity of available treatments
The patient's wishes
The carer's wishes.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="palliative-care-emergencies-and-their-management">Palliative care emergencies and their management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#palliative-care-emergencies-and-their-management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-bone-fractures">a) Bone fractures<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-bone-fractures" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Bone fractures can occur with no or minimal trauma, especially to weight-bearing bones such as the femur or vertebrae.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="causes">Causes<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#causes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ul>
<li>Fractures are common when there are widespread bone mestastases in cancers such as lung cancer, breast cancer, renal cancer and myeloma.</li>
<li>Bone fracture may also be due to osteoporosis or trauma.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="signs-and-symptoms">Signs and symptoms<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#signs-and-symptoms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ul>
<li>Severe pain around the site</li>
<li>Deformed limb</li>
<li>Pain on movement</li>
<li>Bone grating</li>
<li>Inability to use the limb</li>
<li>Patient may go into acute confused state.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="assessment-and-management">Assessment and management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#assessment-and-management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ul>
<li>Analgesia and efforts to immobilise the site of fracture comprise the first remedial steps</li>
<li>Immobilise the limb where possible. This may mean applying a splint or a plaster-of-paris cast, though if the patient is fit enough it may be possible to surgically stabilise the fracture.</li>
<li>Internal or external fixation may be required.</li>
<li>Radiotherapy can be given and even a single fractional dose may be of benefit as it prevents further, progression of bone metastasis.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="b-hypercalcaemia">b) Hypercalcaemia<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-hypercalcaemia" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Hypercalcaemia is a threatening metabolic disorder associated with cancer.</li>
<li>It is common in patients with breast cancer, multiple myeloma, and head, neck and renal tumours.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="causes">Causes<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#causes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<p>Lytic bone lesions, thus causing calcium to be released from the bone, along with a decrease in the excretion of urinary calcium</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="signs-and-symptoms">Signs and symptoms<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#signs-and-symptoms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>General malaise</li>
<li>Nausea and vomiting</li>
<li>Anorexia</li>
<li>Constipation</li>
<li>Bone pain</li>
<li>Thirst and polyuria</li>
<li>Polydypsia</li>
<li>Severe dehydration</li>
<li>Drowsiness</li>
<li>Confusion and coma</li>
<li>Cardiac arrhythmias</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="assessment-and-management">Assessment and management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#assessment-and-management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Treatment of hypercalcaemia can markedly improve symptoms even in patients with advanced disease. ,</li>
<li>Proper management of hypercalcaemia makes end-of-life care and management less traumatic for the patient and the carer.</li>
<li>The patient may be admitted for hydration and bisphosphonate therapy (e.g. disodium pamidronate 60–90mg, in sodium chloride 0.9%, 500ml over 2–4hr).</li>
<li>However, this treatment might not be available due to cost.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="c-seizures">c) Seizures<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-seizures" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Seizures can be frightening and their occurrence is often unpredictable. .</li>
<li>People may attach significance to these events, such as being bewitched. .</li>
<li>Seizures can be generalised, with jerking of the whole body, or limited to a specific area such as an upper limb or face.</li>
<li>The period of jerking is often followed by a period of unconsciousness.</li>
<li>Most seizures are self-limiting and efforts can be made to prevent or limit future seizures. .</li>
<li>A prolonged seizure lasting more than 10 minutes or one that does not terminate needs more urgent treatment.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="cause">Cause<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cause" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Pre-existing epilepsy</li>
<li>Stroke</li>
<li>Trauma, including subdural haematoma</li>
<li>Primary or secondary brain tumour</li>
<li>Intracranial bleed</li>
<li>Biochemical disturbance, eg. hyponatraemia, hypoglycaemia, uraemia or hypercalcaemia</li>
<li>Infections such as cerebral toxoplasmosis, meningitis, malaria or encephalitis</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Alcohol withdrawal</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="general-care">General care<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#general-care" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Keep the patient safe and free of hazards until the seizure is complete.</li>
<li>Protect the airway of the patient so they can breathe but do not place anything in their mouth (eg spoons, spatulas).</li>
<li>Loosen any tight clothing if possible.</li>
<li>After the seizure is over, place the patient in the recovery position and ensure someone stays with them.</li>
<li>Observe and record the length and frequency of the seizures.</li>
<li>Support the family and patient, and address their fears and concerns.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="assessment-and-management">Assessment and management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#assessment-and-management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>No treatment is needed for self-limiting seizures that last less than five minutes</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="to-stop-more-prolonged-seizures">To stop more prolonged seizures:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#to-stop-more-prolonged-seizures" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Diazepam 10mg given per rectum or IM; repeat after 10 minutes</li>
<li>Midazolam 5mg sc is available; may also be given buccally</li>
<li>Paraldehyde 5–10mls diluted in saline as a rectal enema</li>
<li>Phenobarbitol 200mg IM if patient not responding to diazepam.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="to-prevent-seizures-or-reduce-their-intensity-and-frequency">To prevent seizures or reduce their intensity and frequency:,<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#to-prevent-seizures-or-reduce-their-intensity-and-frequency" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Phenytoin 150–300mg daily and titrate gradually, watching for toxicity and drug interactions</li>
<li>Sodium valproate 600mg daily in divided doses and titrate to maximum 1500mg; this is the medication of choice when there is concern about drug interactions, including those in patients on ARVs.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="d-severe-pain">d) Severe pain<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-severe-pain" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>This should be assessed and managed as per the WHO analgesic ladder</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="e-spinal-cord-compression-scc">e) Spinal cord compression (SCC)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e-spinal-cord-compression-scc" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>In SCC, the spinal cord is compressed causing neurological symptoms.</li>
<li>Cord compression occurs when there is extrinsic or intrinsic obstruction to the spinal cord.</li>
<li>If it is not managed quickly, it progressively turns into irreversible neurological damage (paralysis).</li>
<li>Be alert for patients with new thoracic back pain.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="causes">Causes:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#causes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Vertebral metastases, leading to collapse, is the most common cause</li>
<li>Epidural infiltration</li>
<li>TB should be considered</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Less often, there is a vascular interruption.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="signs-and-symptoms">Signs and symptoms<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#signs-and-symptoms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Backache – which may radiate circumferentially and where the patient may complain of a tight band around the waist</li>
<li>Weakness in the lower limbs</li>
<li>Abnormal sensation in the lower limbs, pins and needles, tingling sensations, crawling insects, etc.</li>
<li>Bladder symptoms</li>
<li>Constipation.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="assessment">Assessment<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#assessment" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>A quick yet proper assessment can help to arrive at an accurate diagnosis, which can help to maintain or restore motor functions in patients who would otherwise face disability for the rest of their life.</li>
<li>SCC is common in patients with advanced cancer of the breast, lungs or prostate gland.</li>
<li>A careful history and neurological examination should be made, including looking for what sensory level applies.</li>
<li>Ask about bladder and bowel sphincter function.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="management">Management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Most important is to think of the diagnosis and to start treatment before irreversible neurological loss occurs. Start high-dose steroid dexamethasone 16mg in divided doses.</li>
<li>Arrange appropriate investigations such as x-ray, bone scan, CT myelogram or MRI scan, depending on availability.</li>
<li>Refer for urgent (within 1 day) radiotherapy if available.</li>
<li>Surgery may also be considered, depending on the patient’s condition and the availability of facilities and surgeons.</li>
<li>Once neurological loss has occurred it is often irreversible, but good rehabilitation will maintain function and prevent complications.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="f-stridor">f) Stridor<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#f-stridor" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>A stridor is a high-pitched sound of breathing in partial laryngeal or major-way obstruction.</li>
<li>It is common in head and neck tumours or mediastinum.</li>
<li>It causes exhaustion from laboured breathing and anoxia.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="causes">Causes<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#causes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Pressure on the upper airways by extrinsic compression caused by such things as enlarged lymph nodes or primary tumour in the lungs, head or neck</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="management">Management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>If impending obstruction is diagnosed, consider whether pre-emptive treatment with radiotherapy or tracheostomy is indicated.</li>
<li>Discuss the possible events with the patient and their family.</li>
<li>Offer sedation with morphine and benzodiazepines; 5–10mg morphine and 5–10mg diazepam given PO/SC/IV/PR depending on the patient’s condition.</li>
<li>In hospital, and if facilities are available and the condition of the patient allows, consider:</li>
<li>Bronchoscopy.</li>
<li>Chemotherapy</li>
</ul>
<p>g) Superior vena cava obstruction (SVCO)</p>
<ul>
<li>SVCO is the partial or complete obstruction of blood flow through the superior vena cava into the right atrium.</li>
<li>SVCO usually results in impairment of the venous return.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="causes">Causes<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#causes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>External compression by tumour or lymph nodes, or thrombosis as a result of compression</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="signs-and-symptoms">Signs and symptoms<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#signs-and-symptoms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Dyspnoea</li>
<li>Facial/upper body including arms swell</li>
<li>Headaches</li>
<li>Visual changes</li>
<li>Unclear mind (muzziness)</li>
<li>Cough., Dysphagia.</li>
<li>Some patients may complain of a sensation of drowning.</li>
</ul>
<p>This condition is common in patients with tumours within the mediastinum, i.e. bronchial carcinoma, cancer of the breast and lymphoma.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="assessment">Assessment<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#assessment" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Examination may reveal engorged conjunctivae, periorbital oedema, dilated neck veins and the collateral veins on the arms and chest wall. Late signs include; pleural effusions, pericardial effusion and stridor.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="management">Management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>In advanced disease the patient needs relief of their acute symptoms.,</li>
<li>Give high-dose corticosteroids (e.g. dexamethasone 16mg PO/IV) and, if available, urgent radiotherapy</li>
<li>At the same time, treat dyspnoea symptomatically with morphine (5mgs 4hrly) and/or a benzodiazepine. Practical management of dyspnoea is also important – e.g., teach the patient how to breathe slowly, and, encourage a calm environment.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Without treatment, SVCO carries a very poor prognosis.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="h-choking">h) Choking<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#h-choking" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Choking is the inability to breathe as a result of acute obstruction of the pharynx, larynx or trachea.</p>
<p>This can be due to local tumour or neurological swallowing difficulties, as well as a more general obstruction.</p>
<p><strong>Assessment and management of choking from local tumours</strong></p>
<ul>
<li>Acknowledge the patient’s and family’s fears</li>
<li>Discuss interventions truthfully with the patient and family.</li>
<li>High-dose steroids may be useful to reduce the swelling around the obstructing tumour</li>
<li>Palliative radiation, if available, may also help</li>
<li>Midazolam 5mg sc can help to sedate the patient and reduce anxiety</li>
<li>Rectal diazepam can be used, especially in the community.</li>
</ul>
<p>In children, especially with a sudden onset of choking, think about foreign bodies!</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="i-haemorrhage">i) Haemorrhage<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-haemorrhage" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Haemorrhage is profuse bleeding from one of the major blood vessels, e.g. the carotid artery.</p>
<ul>
<li>While uncommon, haemorrhage can be a frightening event for patient and carers.</li>
<li>Haemorrhage is, however, often predictable and needs to be proactively managed, e.g., make medicines available in the home care setting in case the possible emergency occurs.</li>
</ul>
<p><strong>Causes</strong></p>
<ul>
<li>Catastrophic bleeding from a large blood vessel due to tumour erosion from areas such as the head and neck, stomach, pelvis, bladder or lungs.</li>
<li>Patients with cirrhosis may also have torrential bleeding from oesophageal varices.</li>
<li>Many patients also have disorders of their blood-clotting systems.</li>
<li>Low platelets associated with malignancies (bone marrow infiltration) and HIV.</li>
</ul>
<p><strong>Assessment and management</strong></p>
<ul>
<li>Communicate gently and truthfully and stay with the patient.</li>
<li>Use dark cloths to soak up the blood.</li>
<li>Pack a bleeding nose with gauze and BIPP or use nasal tampons.</li>
<li>Adrenalin-soaked ribbon gauze may also help as it causes local vasoconstriction.</li>
<li>For small oral bleeds, crushed cyclocapron may help.</li>
<li>Sedation (such as diazepam 10mg PO/PR) is indicated if the patient is distressed.</li>
<li>Remember that if the bleeding is torrential, the blood pressure will drop quickly and so medications will not be effective.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>The family or staff of a patient having the likelihood of a haemorrhage should be counselled about that „ possibility and advised what they should do in such a situation as well as being offered support after the event if it occurs.</li>
</ul>
<p>j) Epistaxis (severe nose bleed)</p>
<ul>
<li>This is particularly prevalent in children with haematological malignancies.</li>
<li>In children, aim for rapid and complete sedation with benzodiazepines and/or opioids if available; use parenteral routes.</li>
<li>If able to swallow, give children double the usual dose of morphine with or without diazepam.</li>
<li>If unable to swallow, give large doses of morphine and diazepam rectally.</li>
<li>Rectal valium dose: If weight is not known: &lt;3years 5mg; &gt;3years up to 10mg., If weight known: 0.5–1mg/kg up to a maximum of 10kg</li>
</ul>
<p>THE DYING PROCESS</p>
<ul>
<li>This is a period of time when the body begins to shut down and prepare for death. It is an important moment of time for the dying person and their loved ones during which they can express their feelings and show their love</li>
</ul>
<p>Changes that maybe noticed during the dying process and what to do to help</p>
<p>&gt; Appetite and thirst</p>
<ul>
<li>The person’s appetite and thirst may decrease, and they may have little desire to eat or drink. This concerns many carers, but it is a natural process and it is not painful for the person.</li>
</ul>
<p>Remedy: Sips of water or a moist mouth swab will help provide comfort.</p>
<p>NB: Attempting to feed someone who is unable to swallow may make them distressed and cause harm.</p>
<p>&gt; Sleep and alertness</p>
<ul>
<li>Changes in the person’s body mean that they may spend a lot of time asleep, may be drowsy or difficult to wake up.</li>
</ul>
<p>Remedy: It is best to talk to the person when they seem most alert, and allow them to sleep when they want to. There is no need to shake the person or to speak loudly. It is best to speak softly and naturally.</p>
<p>&gt; Temperature</p>
<ul>
<li>The body’s temperature may change. Sometimes the person’s hands, feet and legs may be increasingly cool to the touch and at other times they may feel hot and clammy. Sometimes, parts of the person’s body may become blotchy and darker in colour. This is due to the circulation of the blood slowing down and is a normal part of the dying process.</li>
</ul>
<p>Remedy</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>If the person indicates that they feel cold, use light bedding to keep them warm.</li>
<li>Too many bed clothes or an electric blanket may make them hot and restless.</li>
<li>Provide good ventilation; a fan to circulate the air and cool damp towels can help if the person seems hot.</li>
</ul>
<p>&gt; <strong>Breathing</strong></p>
<ul>
<li>Regular breathing patterns may change. Sometimes the breathing may be fast and at other times there may be long gaps between breaths.</li>
<li>Breathing may be shallow or noisy. This is a normal part of the dying process and is not painful or distressing for the person.</li>
</ul>
<p>&gt; <strong>Secretions</strong></p>
<ul>
<li>As coughing and swallowing reflexes slow down, saliva and mucus may collect in the back of the person’s throat, causing a gurgling, bubbling or other noises. These noises can be a concern to carers, but do not usually cause distress to the person.</li>
</ul>
<p><strong>Remedy</strong></p>
<ul>
<li>To help improve the situation, one can turn the person on their side or lift their head supported with pillows, so that their head is turned to one side in a comfortable position.</li>
<li>Medications can also be given to slow down the production of saliva and mucus and thus improve comfort.</li>
</ul>
<p>&gt; <strong>Restlessness</strong></p>
<ul>
<li>Due to the decrease in circulation of blood to the brain and to other changes happening in the body, the person may become restless or agitated.</li>
</ul>
<p><strong>Remedy</strong></p>
<ul>
<li>To have a calming effect, speak in a quiet natural way, lightly massage the person’s hand or forehead, or softly play familiar music.</li>
<li>Let a palliative care team member know if the person becomes restless or agitated.</li>
<li>Medications can be given to reduce the problem.</li>
</ul>
<p>&gt; <strong>Incontinence</strong></p>
<ul>
<li>The amount of urine that the body is producing decreases due to the reduced amount of fluid the person is drinking. The urine may become stronger smelling and darker in colour.</li>
<li>Many carers are concerned that the person will lose control of their bladder and bowels.</li>
</ul>
<p><strong>Remedy</strong></p>
<ul>
<li>This does not happen to all people, but if it does, there are pads, easy to use equipment, and special absorbent sheets, to enhance comfort and hygiene.</li>
<li>A member of the palliative care team can advise of about what is needed.</li>
</ul>
<p><strong>How to know that death has occurred</strong></p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Breathing stops</li>
<li>No heartbeat or pulse can be felt</li>
<li>The person cannot be woken up</li>
<li>Eyelids may be half open</li>
<li>Their mouth may be open</li>
<li>Pupils are fixed</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="the-process-of-grief">THE PROCESS OF GRIEF<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#the-process-of-grief" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p><strong>Definition:</strong> Grief is a type of stress reaction, a highly personal and subjective response that an individual makes to a real perceived or anticipated loss</p>
<ul>
<li>Grief reaction may occur in any loss situation be it, physical or tangible loss, e.g. death, significant injury, property loss or symbolic and intangible loss e.g. a dream loss</li>
<li>The intensity of grief varies depending on many variables e.g. meaning of loss to the individual experiencing it</li>
<li>Grief is a process not a state</li>
<li>It takes time to work through</li>
<li>Grief is a natural response to a significant loss.</li>
<li>The most extreme of such losses is experienced through death of someone close with whom we had a meaningful relationship.</li>
<li>We can also experience significant grief through other losses, through divorce, separation, abortion and even our lifestyle or a job.</li>
</ul>
<p>However, the response to these losses is similar.</p>
<p><strong>Why death maybe most significant, this might be due to:</strong></p>
<ul>
<li>The finality</li>
<li>Death confronts one’s own mortality or finiteness.</li>
</ul>
<p><strong>Grief will be dependent on a number of factors including:</strong></p>
<ul>
<li>Degree of attachment to the person lost.</li>
<li>Degree to which person enriched your life.</li>
<li>Quality and length of relationship.</li>
<li>Nature of death.</li>
</ul>
<p><strong>Other factors that may influence grief</strong></p>
<ul>
<li>Understanding the Process of Grief</li>
<li>Common Individual Responses to Grief</li>
</ul>
<p><strong>Normal reactions to grief:</strong></p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>i) Fear:</p>
<ul>
<li>Of one’s own mortality</li>
<li>For the safety of oneself or one’s family</li>
<li>Apparently unrelated fears Anger:</li>
<li>At the injustice and senselessness of it all</li>
<li>Generalised anger and irritability</li>
<li>How this could happen to such a good person</li>
</ul>
<p>ii) Sadness:</p>
<ul>
<li>About the loss both personally and professionally</li>
<li>Flash backs or triggers to previous grief and loss</li>
<li>About the loss of feeling safe and secure</li>
<li>Feeling depressed or “flat” for no reason Guilt:</li>
<li>For having appeared helpless or emotional</li>
<li>For not behaving as you would have liked</li>
<li>For unresolved issues or conflict with the person</li>
<li>For not doing upon reflection what you feel might have the process.</li>
</ul>
<p>Physical Sleep:</p>
<ul>
<li>Difficulty getting off to sleep because of intrusive thoughts</li>
<li>Restless and disturbed sleep</li>
<li>Feeling tired and fatigued Physical problems:</li>
<li>General agitation and muscle tension</li>
<li>Headaches or general aches and pains</li>
<li>Feeling generally unwell</li>
<li>Other physical signs and symptoms</li>
</ul>
<p>Thinking memories:</p>
<ul>
<li>Frequent thoughts or images of the person</li>
<li>Flashbacks or feelings of “reliving” past grief and loss experiences</li>
<li>Attempts to shut-out the painful memories</li>
<li>Real or imagined pictures of what happened “jumping” into your head E.g</li>
</ul>
<p>i) Dreams</p>
<ul>
<li>Dreams and nightmares about what happened</li>
<li>Unpleasant dreams of other frightening thoughts</li>
</ul>
<p>ii) Confusion</p>
<ul>
<li>Difficulty making simple decisions</li>
<li>Inability to concentrate and memory problems</li>
<li>Not being able to express yourself fluently verbally</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Feeling confused generally</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="behaviour-social">Behaviour social:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#behaviour-social" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Withdrawal from others and a need to be alone</li>
<li>Easily irritated by other people</li>
<li>Feelings of detachment from others</li>
<li>Loss of interest in normal activities and hobbies such as:</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-work">i) Work<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-work" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Not wanting to go to work, poor motivation</li>
<li>Poor concentration and attention</li>
<li>Sense of lost purpose in your work</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="ii-habits">ii) Habits<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-habits" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Increased use of alcohol, cigarettes or other drugs</li>
<li>Loss of appetite or increased eating</li>
<li>Loss of interest in enjoyable activities</li>
</ul>
<p>Some most important needs of the person experiencing grief can be summarised as follows:</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="i-to-feel-support">i) To feel support<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-to-feel-support" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ul>
<li>We need to recognise that bereavement raises all sorts of feelings, and that to cope people need the care, love, support and understanding of others.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="ii-to-face-reality">ii) To face reality<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-to-face-reality" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ul>
<li>The process of recovery is linked directly to acceptance of the loss.</li>
<li>Acceptance will not come until reality is faced.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="iii-to-express-feelings-emotional-release">iii) To express feelings (emotional release).<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-to-express-feelings-emotional-release" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ul>
<li>It seems important to many grieving people that emotional release be encouraged.</li>
<li>Grieving people should be helped, encouraged and allowed to express their feelings. This may mean tears, talking and other acting out.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="nb">NB:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nb" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Too often “would be helpers” suppress rather than encourage and facilitate emotional release.</li>
<li>In some communities, people often get uncomfortable if you demonstrate your reaction to loss and pain openly and they may have some comments such as:</li>
<li>“Buck-up”</li>
<li>“It’s time to get over it …”</li>
<li>“It’s God’s will.”</li>
<li>“Brighten-up, you’re upsetting the team.”</li>
</ul>
<p>Although these comments are well-intentioned, they may prevent one from expressing his/her feelings. We need to recognise that “being upset” is healthy and helpful rather than harmful.</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>iv) To move towards the re-establishment of self (on going living).</p>
<ul>
<li>For many this is difficult and for a period of time, often many months, painful and at times unthinkable.</li>
<li>Grieving people need all the care, encouragement and support they can get to enable on-going living to be increasingly possible.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="seeking-extra-support-and-assistance">Seeking extra Support and Assistance<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#seeking-extra-support-and-assistance" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Some people benefit from extra help in overcoming the effects of grief and loss.</li>
<li>One should not be reticent to get help if one thinks he/she needs it. This is not a sign of weakness or an indication that one is not in control.</li>
<li>Often, the help one receives will be short and simple and will prevent you from having longer term problems.</li>
</ul>
<p>One may need further assistance if:</p>
<ul>
<li>The problems are particularly severe, or if they continue for more than five or six weeks.</li>
<li>One feels numb or empty and do not have appropriate feelings, one may find her/himself keeping busy all the time in order to avoid the unpleasant thoughts and feelings.</li>
<li>One has no friends / family to whom one can talk about the experience and how one feels</li>
<li>One is using alcohol or drugs to help he/she cope.</li>
<li>If one has any other concerns about the way he/she or colleagues are coping and would like to discuss the matter.</li>
<li>If one feels he/she would benefit from further support consider accessing the People Assist (EAP) Program or speaking to a doctor/ nurse/health care provider</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="summary">Summary<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#summary" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Some DO’s and DON’TS for assisting others through the Grief Process</p>
<p>a. DO listen and hear what is being said.
b. DO acknowledge that each person’s experience of grief and loss will be unique.
c. DO remember that nobody has to justify their feelings to you.
d. DO realise the person has suffered a loss, even if you don’t perceive it as such.
e. DO allow the person time to grieve.
f. DO encourage those who have a common grief to support one another if they can.
g. DO encourage the griever to express emotion and to work through the grief.
h. DO remember that many who give support immediately after a death may be delayed in working through their own grief.
i. DO recognise the intensity of grief that will be experienced at certain significant times, eg, anniversaries, Christmas functions.
j. DON’T personalise knock-backs to your efforts to assist.
k. DON’T prevent the person from expressing their guilt or anger if they need to.</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol>
<li>DON'T stifle the person’s desire to talk about the deceased
m. DON'T give trite answers to the ‘Why?’ question.</li>
</ol>
<p>In conclusion as far as grief is concerned:</p>
<p>Be Aware: Remember that working through grief is a normal and necessary process.</p>
<p>Be There: Learn to be with the person, not to solve the problem.</p>
<p>Be Sensitive: Allow the distress and do not try to take it away.</p>
<p>Be Human: Allow expression of feelings (guilt, anger, sorrow, depression) without judgement.</p>
<p>Be Ready: To listen when the story is told over and over again.</p>
<p>Be Patient: Remember that the process of mourning takes time.</p>
<p>BEREAVEMENT AND STAGES / PHASES OF GRIEF</p>
<p>Bereavement</p>
<ul>
<li>This is the period of mourning or state of intense grief especially following the death of a loved one or having lost something very dear</li>
</ul>
<p>Purpose</p>
<ul>
<li>Is not to let go of the deceased and move on, but to find ways to remember the dead person that are safe, healthy and less painful as time goes on (Thomas and Jay, 1997)</li>
</ul>
<p>Principles</p>
<ul>
<li>Helping the family, including children, to cope with grief and loss forms an integral part of palliative care.</li>
<li>A comprehensive assessment undertaken at initial contact with the family will provide information on family deaths, other losses, quality of relationships, coping mechanisms, depression, and any alcohol or substance abuse.</li>
</ul>
<p>Bereavement in general</p>
<ul>
<li>Bereavement is the normal process through which people adapt to a life without a loved one. However, complicated grief can lead to serious illness and requires professional intervention.</li>
<li>Bereavement is a complex mix of individual feelings (grief) and a process that we show to others in ways that are strongly influenced by environment, culture and society (mourning).</li>
<li>Feelings of grief during bereavement can be painful physically, socially, spiritually and emotionally.</li>
<li>Risk factors for complicated grief include multiple losses and dysfunctional relationships.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>
<p>There are three main areas relating to bereavement needs in palliative care:</p>
</li>
<li>
<p>Living with a life-threatening illness means facing loss of life and loss of a future.</p>
</li>
<li>
<p>Patients may have lost children, spouses and other relatives in the course of their lives from many causes. Emotional, social and spiritual care during the illness will explore bereavement for patient and family members so as to provide peace and resolution during the dying process.</p>
</li>
<li>
<p>Emotional, spiritual and practical support is provided to all family members who require help after the „death of the patient for as long as is necessary.</p>
</li>
<li>
<p>Periods of bereavement vary according to:</p>
</li>
<li>
<p>The manner of death (long illness, sudden death or traumatic death such as car accident, murder, medical mistake)</p>
</li>
<li>
<p>The age of the person who dies (a child’s death often feels out of place; an older person has often had „longer relationships)</p>
</li>
<li>
<p>The age of the bereaved (child development affects reaction; life stage is relevant)</p>
</li>
<li>
<p>Gender (women are often allowed more emotional expression than men)</p>
</li>
<li>
<p>Previous experiences of loss and their impact</p>
</li>
<li>
<p>Support systems,</p>
</li>
<li>
<p>Personal coping styles</p>
</li>
<li>
<p>Family and cultural rules</p>
</li>
<li>
<p>In sub-Saharan Africa, the high incidence of cancer- and AIDS-related deaths means that many families experience multiple losses and hardships, such as unemployment, poverty and malnutrition, during their bereavement</p>
</li>
<li>
<p>Adults and children react differently in bereavement because of different levels of understanding of death and the ability to express things differently at various stages of life. By the time late childhood is reached, most people understand that death is:</p>
</li>
<li>
<p>Permanent and irreversible (the body cannot be revived)</p>
</li>
<li>
<p>Unavoidable (death is inevitable and cannot be escaped)</p>
</li>
<li>
<p>Universal (death happens to everyone)</p>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="common-reactions-in-bereavement">Common reactions in bereavement<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#common-reactions-in-bereavement" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>There are physical, emotional, social and spiritual reactions to loss.</li>
<li>These are experienced in a complex mix and change over time.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="physical-reactions">Physical reactions:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#physical-reactions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Aches and pains</li>
<li>Nausea and/or vomiting</li>
<li>Headaches</li>
<li>Confusion</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>weakness and numbness</li>
<li>Change in sexual needs (loss/increase of libido)</li>
<li>Vulnerability to infections, cold, illness (low immunity)</li>
<li>Changes in eating and sleeping patterns</li>
<li>Shortness of breath</li>
<li>Dry mouth, Sweating</li>
<li>Frequent urination</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="emotional-reactions">Emotional reactions:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#emotional-reactions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Disbelief</li>
<li>Numbness</li>
<li>Sadness</li>
<li>Crying, even sobbing</li>
<li>Unexpected thoughts and feelings, often painful</li>
<li>Guilt</li>
<li>Panic and fear</li>
<li>Appearing distracted</li>
<li>Feelings of helplessness</li>
<li>Anger (at self and others)</li>
<li>Blame</li>
<li>Regret</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="social-reactions">Social reactions:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#social-reactions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Needing to say goodbye (stay with the body, view the body)</li>
<li>Interaction with people at public gathering, funeral</li>
<li>Selecting and undertaking rituals</li>
<li>Self-absorption and anti-social behaviour</li>
<li>Needing to talk of the deceased</li>
<li>A sense of isolation from the world ('in a bubble')</li>
<li>Attempting to carry on as usual (social face)</li>
<li>Needing to be alone or need to be with others.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="spiritual-reactions">Spiritual reactions:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#spiritual-reactions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Questioning why this has happened</li>
<li>Challenging the belief system (strengthening, decrease or change in beliefs)</li>
<li>Bargaining with a higher power</li>
<li>Talking to the deceased</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Dreams that may have significance about the deceased</li>
<li>Review of the meaning of life</li>
<li>Consideration of ending own life</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="bereavement-and-children">Bereavement and children<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#bereavement-and-children" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Children’s reactions will depend on age, personal development and environment.</li>
<li>An understanding of the meaning of death changes as a child gets older:</li>
<li>Children 0–2 years of age (infants and toddlers)</li>
<li>Miss the physical contact, security and comfort if a main caregiver dies.</li>
<li>Show upset by changes in sleeping or eating patterns, crying or irritability, and becoming withdrawn.</li>
<li>When toddlers, may be angry and have tantrums or go back to baby behaviour.</li>
<li>Children 3–6 years of age</li>
<li>Are unable to understand that death is for ever and may ask when the dead person is coming back.</li>
<li>Confuse fact and fantasy and may think the death was caused by magic.</li>
<li>Grieve in bits and pieces, at times appearing to have forgotten about the death and able to play, happily, then becoming upset again.</li>
<li>Children 6–9 years of age:</li>
<li>Are able to understand that death is for ever (permanent) and it happens to everyone (universal) but still imagine that death is avoidable.</li>
<li>Are interested in practical matters, for example what happens to the dead person’s body.</li>
<li>May feel responsibility for causing the death because of behaviour or thoughts.</li>
<li>Children 9–12 years of age:</li>
<li>Have approximately the same understanding of death as adults: death will happen to everyone sooner or later (universal); no-one escapes it, including them (unavoidable); and death is for ever (permanent).</li>
<li>Understand that death can be sudden and can happen at any time (not just for the elderly and sick); may fear their own death.</li>
<li>Begin to think about the meaning of life and what happens after death.</li>
<li>Adolescents</li>
<li>Have as much understanding of death as adults.</li>
<li>May take risks to ‘test’ life</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="management-of-bereavement">Management of bereavement<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#management-of-bereavement" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Ideally, bereavement planning starts before the death of the patient.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Make contact as soon as possible to acknowledge the death and to offer condolences according to personal and cultural norms and customs.</li>
<li>Some help with documentation such as a will or death certificate may be needed.</li>
<li>Give information about the illness and the process of death if there is confusion about what happened.</li>
<li>Use simple explanations and avoid medical jargon.</li>
<li>Be there to listen, even when there is repetition the latter is necessary for bereaved people to accept the reality of the death.</li>
<li>Inform all family members about the bereavement process and what to expect physically, emotionally, socially and spiritually in this.</li>
<li>Do not discourage the bereaved from expressing sadness, depression or anger by trying to comfort.</li>
<li>These and other extreme emotions are all normal, although they can be distressing to witness. Allow periods of silence.</li>
<li>Encourage talk of the deceased as much as is needed.</li>
<li>Ask about the deceased and use their name to make it personal.</li>
<li>Share memories by asking questions such as: ‘Where did you meet?’, ‘What kind of child was she?’, ‘Can you tell me about him?’</li>
<li>Explore the spiritual needs of each family member and facilitate discussion, networking with a traditional healer or religious leader as required.</li>
<li>Do not assume faith will have remained the same as before the death.</li>
<li>Some people express the pain of grief in tears, which can be very helpful.</li>
<li>Others feel unable to cry easily. E.g. men are often discouraged from crying and it is important to help them find alternative forms of emotional release.</li>
<li>Physical activity is especially helpful, and may include walking, playing sports, hitting a punch bag, or gardening.</li>
<li>Encourage regular physical activity for all bereaved persons as this helps the mind and body to process emotional pain.</li>
<li>Suggest the family use journals and art, or create a memory book to share and express memories.</li>
<li>Do not offer platitudes. These include ‘It was for the best,’ or ‘He is in a better place now.’</li>
<li>Also, do not say, ‘I know exactly what you are going through,’ because you do not know that this is true and it may certainly not be how the bereaved person is feeling.</li>
<li>Bereavement can take a very long time, much longer than people imagine.</li>
<li>Let bereaved persons know to expect that they may perhaps still be struggling some months or years later. Prepare families for times that may be especially hard, such as birthdays, death anniversaries, family celebrations and school/university events.</li>
</ul>
<p>NB:</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Adults need to provide children with explanations, reassurance and the freedom to express emotions about · death and loss.</li>
<li>Encourage family members to include children in rituals, depending on cultural expectations.</li>
<li>Guide adults away from using euphemisms such as ‘she has gone to sleep’ or ‘he has gone away’, because · children will understand these literally.</li>
<li>Encourage family members to use drawing and play with children to assist them in expressing confusion and · pain at the loss.</li>
<li>Help adolescents to talk when it is convenient for them.</li>
<li>Often, a school friend or another adult will be chosen as a confidant.</li>
<li>Orphans may need extra bereavement care because of their living conditions, as well as the emotional burden · they bear without the support of close family elders.</li>
<li>Establish and strengthen child-to-child activities, such as support or discussion groups, a ‘buddy’ or friend · programme, sports and play activities, music, dancing and drama.</li>
<li>Child committees can plan these activities either with or without the help of adults.</li>
<li>Use traditional approaches to providing emotional support to children, E.g storytelling by elders and · mentoring.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="assessment-of-difficulties-in-bereavement">Assessment of difficulties in bereavement<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#assessment-of-difficulties-in-bereavement" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Occasionally, people have complications that prevent a healthy resolution of the bereavement process and that · require referral to a specialist.</li>
<li>A few indicators include:</li>
<li>After a couple of years the bereaved cannot speak of the deceased without experiencing intense and fresh grief each time.</li>
<li>Material possessions belonging to the deceased remain totally untouched as a shrine.</li>
<li>A history of depression which may make bereavement difficult to resolve.</li>
<li>Suicidal thoughts continue after a couple of years.,</li>
<li>Phobias about illness or death intrude upon the daily life of the bereaved.</li>
<li>A comprehensive psychosocial assessment and genogram of the family will highlight possible areas of concern.</li>
<li>Complicated bereavements should be referred, with the consent of the bereaved, to a health practitioner and, · where possible, someone trained in bereavement counselling.</li>
</ul>
<p>Risk factors for complicated grief include:</p>
<ul>
<li>multiple losses</li>
<li>dysfunctional relationships</li>
</ul>
<p>When a person dies, we say that their family and friends are ‘bereaved’. This means they have lost something precious to them and are grieving. Grieving may take place before death for instance -:</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>When someone is told they have an incurable illness</li>
<li>When told that their e.g. cancer treatment has not worked</li>
<li>When they become unable to care for themselves</li>
<li>When they and their family may grieve the loss of their independence, their health or their future.</li>
</ul>
<p>NB: “Suffering is not a problem that demands a solution, it is not a question that demands an answer; it is a mystery that demands a presence.”( John Wyatt, 1998)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="mourning">Mourning<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mourning" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Mourning is often used interchangeably with grief, but mourning more specifically refers to the public expression of grief.</li>
<li>This public expression, perhaps crying or wailing does not necessarily relate to the significance of the loss, it is usually related to cultural and religious values and encourages social support for the mourner.</li>
<li>While we grieve internally we mourn externally</li>
<li>Complicated mourning arises from an interrupted or obstructed grief process and can result in potentially harmful outcomes, from somatic discomfort to chronic emotional distress and even the possibility of death</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="the-4-tasks-of-mourning">The 4 tasks of mourning<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#the-4-tasks-of-mourning" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>William Worden created a theory called “Tasks of Grief” which are the experiences that we go through after the death of someone we care about.</p>
<ol>
<li>To accept the reality of the Loss</li>
<li>To experience the pain of Grief</li>
<li>To adjust to the new environment where the deceased person is missing</li>
<li>To reinvest energy in life, loosen ties to the deceased and forge a new type of relationship with them based on memory, spirit and love</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="task-1-accept-the-reality-of-the-loss">Task 1: Accept the Reality of the Loss<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#task-1-accept-the-reality-of-the-loss" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The first task of mourning is to acknowledge and accept the reality that the person is dead and will not return.</p>
<ul>
<li>This can take time, as the bereaved often experience a period of numbness, shock, and disbelief even if the death was expected.</li>
<li>The bereaved may experience a period of searching or yearning for their loved one.</li>
<li>Some people report that they expect to see their loved one when they arrive at home, calling out before remembering that the person is gone.</li>
<li>Others find themselves continuing their old routine, such as setting the table for two.</li>
<li>The bereaved may even refer to the deceased loved one in the present tense or use the present and past tense together in the same conversation.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Traditional rituals such as funerals or memorial services can help people accomplish this task.</li>
<li>This public good-bye helps people confront the finality of the death.</li>
<li>Often the first visit to the cemetery reinforces the finality of the loss as well.</li>
<li>The primary aim of grief support at this task is to help people accept the reality of the loss in their own time and at their own pace. It may take days or weeks for the reality to be accepted, even longer for it to be fully absorbed.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="task-2-experience-the-pain-of-grief">Task 2: Experience the Pain of Grief<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#task-2-experience-the-pain-of-grief" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>The second task of mourning is to express the pain of grief in a healthy way.</li>
<li>The pain of grief includes physical, emotional, behavioural, cognitive, spiritual, and social responses to the loss. This task is crucial because if the bereaved cannot, or does not, acknowledge the pain of grief in some way, these responses could manifest themselves in unhealthy ways.</li>
<li>Coping with the pain of grief is unique for each individual.</li>
<li>Sleep disturbances and appetite changes are the most common behavioural responses.</li>
<li>The cognitive responses to loss may be the primary way some people experience grief.</li>
<li>Initially many bereaved report a fear of ‘going crazy’, education and normalization of the grief process may help assuage this fear.</li>
<li>Spiritual responses to loss are also highly individual.</li>
<li>Even those who have a strong spiritual or religious belief system may not be comforted by their beliefs.</li>
<li>One of the crucial aspects of the spiritual response to loss is the ability to make meaning from the experience.</li>
<li>The social response to loss is often overlooked. But in AIDS-related deaths, people may be coping with social isolation due to stigmatization.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="task-3-adjust-to-the-loss">Task 3: Adjust to the Loss<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#task-3-adjust-to-the-loss" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>The third task of mourning is to develop the skills and fill the roles needed to move forward without the physical presence of the deceased.</li>
<li>This can usually begin only after several months of dealing with the loss.</li>
<li>It may include adjusting to living alone, being a single parent, getting a job, learning to manage finances, or taking on household tasks.</li>
<li>For those dealing with HIV themselves, it can also mean needing to find other caregivers.</li>
<li>Part of adjusting to the loss is facing all the significant ‘firsts’ that occur in the first year of bereavement.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="task-4-reinvesting-energy">Task 4: Reinvesting Energy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#task-4-reinvesting-energy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>From the Deceased into New Life</li>
<li>The fourth and final task of mourning entails transferring the emotional energy invested in the relationship with the deceased into new, healthy approaches to life.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Reinvesting the emotional energy into new life may include gestures such as considering the deceased’s perspective in a difficult situation or wearing a locket with a picture of the deceased.</li>
<li>Others may reinvest this energy outward in socio-political activity such as becoming active in an AIDS organisation or creating a memorial for the deceased.</li>
<li>In general the signs that bereaved people are learning to accommodate their grief include:</li>
<li>A return to good health (or their health status before the death of their loved one)</li>
<li>Acknowledgment of the reality of the loss</li>
<li>Redefined identity</li>
<li>Emergence of new skills or roles</li>
<li>Establishment of or reconnection with a social support system</li>
<li>Ability to cope effectively with temporary upsurges of grief</li>
<li>Comfort with the quest to find meaning</li>
<li>Personal growth/transformation</li>
</ul>
<p>It is important to understand that those who grieve the death of a loved one never truly ‘get over’ the loss. Even after people accomplish the tasks of mourning, the pain of the loss is still present though hopefully less intense and more manageable (Worden, 1991)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="phases-of-grief">Phases of grief<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#phases-of-grief" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-denial">a) Denial<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-denial" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>This first stage of grieving helps us to survive the loss. In this stage, the world becomes meaningless and overwhelming. Life makes no sense. We are in a state of shock and denial. We go numb. We wonder how we can go on, if we can go on, why we should go on. We try to find a way to simply get through each day.</p>
<p>Denial and shock help us to cope and make survival possible. Denial helps us to pace our feelings of grief. There is a grace in denial. It is nature’s way of letting in only as much as we can handle. As you accept the reality of the loss and start to ask yourself questions, you are unknowingly beginning the healing process. You are becoming stronger, and the denial is beginning to fade. But as you proceed, all the feelings you were denying begin to surface.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="b-anger">b) Anger<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-anger" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Anger is a necessary stage of the healing process. Be willing to feel your anger, even though it may seem endless. The more you truly feel it, the more it will begin to dissipate and the more you will heal. There are many other emotions under the anger and you will get to them in time, but anger is the emotion we are most used to managing. The truth is that anger has no limits. It can extend not only to your friends, the doctors, your family, yourself and your loved one who died, but also to God. You may ask, "Where is God in this?</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Underneath anger is pain, your pain. It is natural to feel deserted and abandoned, but we live in a society that fears anger. Anger is strength and it can be an anchor, giving temporary structure to the nothingness of loss. At first grief feels like being lost at sea i.e no connection to anything.</p>
<p>Then you get angry at someone, maybe a person who didn't attend the funeral, maybe a person who isn't around, maybe a person who is different now that your loved one has died. Suddenly you have a structure - - your anger toward them. The anger becomes a bridge over the open sea, a connection from you to them. It is something to hold onto and a connection made from the strength of anger feels better than nothing. We usually know more about suppressing anger than feeling it. The anger is just another indication of the intensity of your love.</p>
<p>c) Bargaining</p>
<p>Before a loss, it seems like you will do anything if only your loved one would be spared. "Please God," you bargain, "I will never be angry at my e.g wife again if you'll just let her live." After a loss, bargaining may take the form of a temporary truce. "What if I devote the rest of my life to helping others. Then can I wake up and realize this has all been a bad dream?" We become lost in a maze of "If only..." or "What if..." statements. We want life returned to what is was; we want our loved one restored.</p>
<p>We want to go back in time e.g find the tumor sooner, recognize the illness more quickly, stop the accident from happening...if only, if only, if only. Guilt is often bargaining's companion. The "if only" cause us to find fault in ourselves and what we "think" we could have done differently. We may even bargain with the pain. We will do anything not to feel the pain of this loss. We remain in the past, trying to negotiate our way out of the hurt. People often think of the stages as lasting weeks or months. They forget that the stages are responses to feelings that can last for minutes or hours as we flip in and out of one and then another. We do not enter and leave each individual stage in a linear fashion. We may feel one, then another and back again to the first one.</p>
<p>d) Depression</p>
<p>After bargaining, our attention moves squarely into the present. Empty feelings present themselves, and grief enters our lives on a deeper level, deeper than we ever imagined. This depressive stage feels as though it will last forever. It's important to understand that this depression is not a sign of mental illness. It is the appropriate response to a great loss. We withdraw from life, left in a fog of intense sadness, wondering, perhaps, if there is any point in going on alone? Why go on at all?</p>
<p>Depression after a loss is too often seen as unnatural, a state to be fixed, something to snap out of. The first question to ask yourself is whether or not the situation you're in is actually depressing. The loss of a loved one is a very depressing situation, and depression is a normal and appropriate response. To not experience depression after a loved one dies would be unusual. When a loss fully settles in your soul, the realization that your loved one didn't get better this time and is not coming back is understandably depressing. If grief is a process of healing, then depression is one of the many necessary steps along the way.</p>
<p>e) Acceptance</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Acceptance is often confused with the notion of being “all right” or “OK” with what has happened. This is not the case.</p>
<p>Most people don't ever feel OK or all right about the loss of a loved one. This stage is about accepting the reality that our loved one is physically gone and recognizing that this new reality is the permanent reality. We will never like this reality or make it OK, but eventually we accept it. We learn to live with it. It is the new norm that with which we must learn to live. We must try to live now in a world where our loved one is missing. In resisting this new norm, at first many people want to maintain life at it was before a love one died. In time, through bits and pieces of acceptance, however, we see that we cannot maintain the past intact. It has been forever changed and we must readjust. We must learn to reorganize roles, re-assign them to others or take them on ourselves.</p>
<p>Finding acceptance may be just having more good days than bad ones. As we begin to live again and enjoy our life, we often feel that in doing so, we are betraying our loved one. We can never replace what has been lost, but we can make new connections, new meaningful relationships, new inter-dependencies. Instead of denying our feelings, people should:</p>
<ul>
<li>listen to their needs</li>
<li>move on</li>
<li>change</li>
<li>grow</li>
<li>evolve</li>
</ul>
<p>We may start to reach out to others and become involved in their lives. We invest in our friendships and in our relationship with ourselves. We begin to live again, but we cannot do so until we have given grief its time.</p>
<p><strong>NB:</strong> In talking about phases or stages of grief, it is important to acknowledge the individuality of each grieving person and to be careful not to impose some pattern of grieving on others.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="breaking-bad-news">Breaking bad news<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#breaking-bad-news" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Nobody finds this easy. Telling someone that they have e.g. cancer or HIV, or that there is no cure for their illness, can be traumatic as we don't like causing pain. We may feel we won't know how to handle their reaction. However, the good news is that it is a skill we can learn. There will be differences in how it is done in different cultures, but here are some general guidelines, to remember them by the spelling <strong>BREAK NEWS</strong></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="be-prepared">Be prepared<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#be-prepared" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Make sure you have read or heard all the information that is available about the patient. Make sure you have enough time, do not start to break bad news when you only have a few minutes. Try to prevent interruptions, e.g. if you have a phone, turn it off.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="relatives">Relatives<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#relatives" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>It is usually best to give bad news when the patient has a close family member with them for support and to share the information most people only remember a small part of what is said when they are anxious or upset. It is important to check first who should be there to receive the news; this will vary according to the patient's culture and the setting. You might say: "We have some important things to discuss; are you happy for your mother to stay?" or "Who would you like to have with you while we talk?"</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="expectations">Expectations<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#expectations" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>What is the patient expecting to hear? Find out what they already know: "What have you been told about your illness? How do you think things are going?" This is very important even if it seems obvious to us, or even if we know they have already been told something by someone else. What has been said and what has been heard are not always the same. Listening to their thoughts will tell us what level of understanding they have, and what sort of language they use to talk about their illness.</p>
<p>Assess what is appropriate Try to assess how much they would like to know: "Have you been wondering what this is about? Would you like me to tell you what I think is going on?" It is not right to force information on someone who is not ready to hear it, just as it is not right to withhold information from someone who does want to know. We don't have to say everything in one visit – they may be ready to hear more next time.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="knowledge-sharing">Knowledge sharing<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#knowledge-sharing" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Share the knowledge you have slowly and gently, being careful to avoid words they won't understand. It is often helpful to let patients know you are about to tell them something important, you can give a warning such as: "We need to sit down and talk, things are quite serious". As you talk, give them time to absorb what you are saying and at the end, check they have understood.</p>
<p>People often want to know how much longer they will live. They may ask about this directly: "How long have I got left?" or indirectly: "When will I be able to go back to work?" It is usually unwise to give a precise answer because people are all individuals and often surprise us. However, it is helpful to give a rough idea to help people to plan realistically. Generally, if the patient's condition is deteriorating each month, they probably have some months left; if it is changing week by week, then it will be a matter of weeks; and if they are deteriorating every day, they may only have a few days left.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="never-say-there-is-nothing-we-can-do">Never say "there is nothing we can do"<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#never-say-there-is-nothing-we-can-do" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>There is always something we can do and it is important to give positives as well as negatives: "We cannot cure the cancer, but we have medicine that will stop the pain." "We are always here to help if new problems arise".</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="nb">NB:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nb" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Failure to break bad news lead to anxiety and complicating thing more</li>
<li>The breaking of bad news also need support and sharing of your feelings with colleague</li>
<li>Whenever bad news is explained completely and compassionately anxiolytics are usually rarely needed.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="care-after-death-last-offices">CARE AFTER DEATH / LAST OFFICES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#care-after-death-last-offices" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>This is the care given to a body after death</li>
<li>It demonstrates continued respect for the patient as an individual and in contemporary society is focused on fulfilling religious and cultural beliefs as well as health and safety and legal requirements (Lister and Dougherty, 2008).</li>
<li>Practices relating to care after death will vary depending on the patient’s religious and cultural background</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="factors-which-may-need-consideration-include">Factors which may need consideration include:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#factors-which-may-need-consideration-include" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Referral to e.g pathologist</li>
<li>Suspicious deaths</li>
</ul>
<p>&gt; If a person has died in suspicious circumstances and a police investigation is likely, then the following procedure should be observed to preserve forensic evidence and minimize cross contamination:</p>
<ul>
<li>
<p>The body should not be washed or cleaned, unless express permission has been given by the senior police officer in charge of the investigation</p>
</li>
<li>
<p>The body should not be touched by family and friends, unless express permission is given as above. The police will often allow supervised touching by the family.</p>
</li>
<li>
<p>E.g A catholic priest should be permitted to anoint the forehead and administer the sacrament of the last rights to a dying person, or the recently deceased. It would be rare for the police to refuse permission for this</p>
</li>
<li>
<p>Clothing should only be removed after expressed permission from the police if removed clothing and property (including cash and valuables) of the deceased should be listed as per Trust Policy, bagged and handed to the police if requested. A signature of receipt should be obtained from the police.</p>
</li>
<li>
<p>High risk infections</p>
</li>
<li>
<p>Organ/Tissue donation</p>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="equipment-needed-for-procedure">Equipment needed for procedure<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#equipment-needed-for-procedure" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="nb-refer-to-nursing-procedure-manual">NB: Refer to Nursing procedure manual<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nb-refer-to-nursing-procedure-manual" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="self-care">SELF-CARE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#self-care" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>The care we give to self is directly proportional to the quality of care we are able to give others. All caregivers therefore need to accept the responsibility for self-care.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="self-care-principle">Self-care principle<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#self-care-principle" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>75</p>
<ul>
<li>The holistic approach that incorporates physical, emotional, social and spiritual components pertains as much to self-care as it does to patient and family care.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="aim-of-self-care">Aim of self-care<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#aim-of-self-care" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>It is to prevent burnout and to build resilience that enables caregivers to remain healthy, happy and compassionate even in the face of on-going suffering, stigma, poverty and loss. There are several aspects to self-care as described below:</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="types-aspect-of-self-care">Types / Aspect of self-care<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types-aspect-of-self-care" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="physical">Physical<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#physical" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>A healthy lifestyle that includes a balanced diet, getting enough sleep, rest and exercise.</li>
<li>Knowing one’s e.g HIV and TB status, regular medical check-ups as indicated.</li>
<li>Preventing infection by putting universal precautions into practice, especially hand washing.</li>
<li>Knowing and using correct techniques when lifting or moving patients.</li>
<li>Knowing and responding to signs of bodily tension.</li>
<li>Balancing work, play and rest.</li>
<li>Being vigilant and taking sensible safety and security precautions.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="emotional">Emotional<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#emotional" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Acknowledging and processing feelings associated with grief and loss.</li>
<li>Practising active relaxation and stress management.</li>
<li>Using self-reflection and acknowledging the positive impact of one’s input on a daily basis.</li>
<li>Letting go of work after hours.</li>
<li>Being assertive and able to set personal boundaries and to say ‘no’ when indicated.</li>
<li>Never making unrealistic promises.</li>
<li>Celebrating your successes.</li>
<li>Accepting and loving yourself, “warts and all” i.e. accepting yourself the way you are.</li>
<li>Seeking professional counsel if emotional distress persists.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="social">Social<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#social" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Making time for family and friends.</li>
<li>Contributing generously to the team, helping co-workers and giving credit where it is due.</li>
<li>Finding a mentor and arranging regular meetings.</li>
<li>Implementing good interpersonal communication skills.</li>
<li>Caring enough to confront, and practising constructive conflict management.</li>
<li>Building your own support network.</li>
<li>Asking for help when needed.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Implementing good time management</li>
<li>Having fun and committing to at least one enjoyable interest that has nothing to do with work.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="spiritual">Spiritual<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#spiritual" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Respecting your own dignity and worth</li>
<li>Developing/using your own spiritual resources</li>
<li>Praying and meditating</li>
<li>Joining a prayer group</li>
<li>Participating in religious services</li>
<li>Actively forgiving ‘those who have trespassed against you’</li>
<li>Forgiving your own frailty and mistakes</li>
<li>Creating and nurturing inner peace</li>
<li>Seeking help from your religious/spiritual adviser</li>
<li>Spending time appreciating nature</li>
<li>Listening to sacred music</li>
<li>Surrounding yourself with people who have sound ethical principles</li>
<li>Using gentle humour with oneself and others</li>
<li>Actively striving for wholeness</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="nb-psychosocial-support">NB: Psychosocial Support<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nb-psychosocial-support" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The term can be broken down into three parts and these are:</p>
<ul>
<li>Psycho - this refers to anything that involves what an individual feels, thinks and their emotions</li>
<li>Social – this refers to the community in which the individual lives and the various players that have contact with them. These include relatives, teachers, classmates, friends, church members and neighbours.</li>
<li>Support – this refer to how an individual is assisted by their people surrounding them to face challenges that affect their emotions, feelings and thoughts</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="identifying-symptoms-pointing-to-burn-out">Identifying symptoms pointing to burn out<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#identifying-symptoms-pointing-to-burn-out" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Decreased motivation</li>
<li>An unwillingness to make decisions</li>
<li>Diminished accomplishment and efficacy</li>
<li>Overly critical of self and others</li>
<li>Feeling exhausted and unable to sleep restoratively</li>
<li>Frequent physical ailments</li>
<li>Feelings of being trapped and helpless</li>
<li>A poor self-image</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Crying frequently for no apparent reason</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="addressing-symptoms-pointing-to-burn-out">Addressing symptoms pointing to burn out<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#addressing-symptoms-pointing-to-burn-out" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-prioritising-a-few-realistic-life-affirming-activities">a) Prioritising a few realistic life-affirming activities<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-prioritising-a-few-realistic-life-affirming-activities" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Take time off or going on holiday.</li>
<li>Plan an enjoyable outing with friends or family.</li>
<li>Spend time appreciating nature.</li>
<li>Tap into your spiritual resources.</li>
<li>Read uplifting material.</li>
<li>Work at a creative hobby.</li>
<li>Listen to your favourite music, or join a choir.</li>
<li>Claim acknowledgement for yourself and give it to others when it is due.</li>
<li>Let go of some areas of your work.</li>
<li>Delegate to others as appropriate.</li>
<li>Trust colleagues and show yourself to be trustworthy.</li>
<li>Guard against the need to maintain total control at all costs.</li>
<li>Actively seek help for difficult physical, emotional, social or spiritual problems.</li>
<li>Maintain competence.</li>
<li>Ask for additional training.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="b-encouraging-healthy-thought-processes">b) Encouraging healthy thought processes<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-encouraging-healthy-thought-processes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Think things through before acting.</li>
<li>Prioritise and plan activities carefully.</li>
<li>Allow sufficient time for preparation.</li>
<li>Critically evaluate results in relation to the amount of time and emotional energy invested.</li>
<li>Learn from experience and try not to repeat the same mistakes.</li>
<li>Consider your energy levels as a valuable resource that deserves to be managed well.</li>
<li>Guard against doubts and negative thoughts.</li>
<li>Visualise a positive outcome in your mind.</li>
<li>Get to the bottom of fears and anxieties, and face up to them.</li>
<li>Think about the consequences of your actions before you take them, and how they could affect your well-being and the well-being of others.</li>
<li>Accept responsibility for your actions and deal with the consequences constructively.</li>
<li>Accept blame when you are in the wrong and then move on.</li>
<li>Focus on hopeful thoughts.</li>
<li>Accept the limitations of any given situation.</li>
<li>Realise that you are never totally alone and there is always some help available</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="examples-of-tools-used-in-palliative-care">Examples of Tools used in Palliative Care<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#examples-of-tools-used-in-palliative-care" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Pain assessment tool</li>
<li>Palliative care patient register</li>
<li>Home visit record for care providers</li>
<li>Patient-held drug chart</li>
<li>Patient-held morphine dose record</li>
<li>Community care volunteer kit / Health care kit</li>
<li>Referral to palliative care team</li>
<li>Palliative care monthly report</li>
<li>Sample letter requesting morphine</li>
<li>Confidence rating scale</li>
<li>Basic drugs for palliative care / Additional drugs for palliative care</li>
<li>Paediatric drug doses</li>
<li>Patient-held morphine dose record</li>
<li>Patient-held drug chart</li>
<li>Patient-held record for community care</li>
<li>Palliative care patient assessment</li>
<li>Etc</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="supportive-supervision-monitoring-and-evaluation-in-palliative-care">Supportive supervision, monitoring and evaluation in palliative care<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#supportive-supervision-monitoring-and-evaluation-in-palliative-care" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="definition">Definition<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#definition" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Supervision is the overall range of measures to ensure that the caregivers involved carry out their activities effectively and efficiently and become better and more competent to carry out assigned roles.</li>
<li>It entails enabling people to do their work in a better way.</li>
<li>It involves the ability to see something from a higher level or the ability to see more than others.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="purpose">Purpose<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#purpose" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>For promoting continuing improvement in service delivery.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="importance-of-supervision">Importance of supervision<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#importance-of-supervision" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>There is a need for a supervision checklist and guidelines that cover :</p>
<ul>
<li>availability of service</li>
<li>quality of care/services</li>
<li>scope and competence of provider</li>
<li>gaps identification</li>
<li>quality of supervision</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="supervision-involves">Supervision involves:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#supervision-involves" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol>
<li>People in order to establish if they are doing their work well, their skills, attitude, interest and knowledge. Interventions are planned according to gaps identified.</li>
<li>Activities: to establish if activities are being correctly implemented; if everything is going as planned and whether tasks are well coordinated</li>
<li>Materials: Whether the required materials are available at the right time and whether they are being put to proper use.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="role-of-the-supervisor">Role of the Supervisor<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#role-of-the-supervisor" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>To enable staff:</p>
<ul>
<li>To manage the quality-improvement process</li>
<li>To meet the needs of their clients</li>
<li>To implement institutional goals. This approach emphasizes mentoring, joint problem solving, and two-way communication.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="styles-of-supervision">Styles of Supervision<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#styles-of-supervision" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Traditional (Autocratic)</li>
<li>Facilitative (Supportive)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="traditional-control-supervision">Traditional (control) supervision<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#traditional-control-supervision" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Focuses on helping staff solve problems through the use of quality- improvement tools.</li>
<li>Focuses on processes rather than individuals.</li>
<li>Assists staff in planning for future quality-improvement goals.</li>
<li>Is continuous and builds on past gains while setting higher quality- improvement goals.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="disadvantages-of-traditional-supervision">Disadvantages of Traditional supervision<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#disadvantages-of-traditional-supervision" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>It is superficial</li>
<li>It is often punitive, fault-finding and critical</li>
<li>Focuses on individuals rather than on processes</li>
<li>Focuses on control, not teamwork</li>
<li>Emphasizes the past rather than the future</li>
<li>Is not continuous</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="facilitative-supervision">Facilitative Supervision<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#facilitative-supervision" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>It is a system of management whereby supervisors at all levels in an institution focus on the needs of the staff they oversee. Supervisors consider their staff as their customers</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="benefits-of-facilitative-supportive-supervision">Benefits of facilitative (supportive) supervision<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#benefits-of-facilitative-supportive-supervision" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Fewer problems to solve by yourself</li>
<li>Less need to provide technical assistance</li>
<li>Gain of good reputation</li>
<li>Being more welcome at sites</li>
<li>Satisfaction of success</li>
<li>More fulfilling job</li>
</ul>
<p>The following are NOT included in facilitative supervision</p>
<ul>
<li>Hiring staff</li>
<li>Developing job descriptions</li>
<li>Conducting performance evaluations</li>
<li>Reprimanding staff</li>
<li>Firing staff</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="monitoring-evaluation-and-reporting-m-e-r">Monitoring, Evaluation and Reporting (M,E,R)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#monitoring-evaluation-and-reporting-m-e-r" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="overview">Overview<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#overview" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Monitoring, evaluation and reporting (M, E &amp; R) is critical for ensuring that successful interventions become part of an integrated health service. M, E &amp; R offers powerful tools to ensure that funders, policy makers, implementers, and researchers remain abreast of the impact, efficacy, efficiency, and the overall success of a program.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="what-is-monitoring-and-evaluation">What is Monitoring and Evaluation?<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#what-is-monitoring-and-evaluation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Monitoring and evaluation form the essential elements of a control and reporting system.</li>
<li>Monitoring is an ongoing assessment of progress of implementation of planned activities to achieve goals and objectives.</li>
<li>It helps to determine whether any change that has occurred due to a program has been worthwhile or effective.</li>
<li>Evaluation is a point assessment of actual progress towards goals and impact to targets groups. It is scheduled (midterm or end term evaluation)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="importance-of-m-e-r">Importance of M, E &amp; R<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#importance-of-m-e-r" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>It is important for organizations to assess whether and how well they are achieving their aims and objectives.</li>
<li>M, E &amp; R often is seen purely as a requirement of funding agencies and therefore as an external necessity. But the goals are much broader than that, and should be seen as a strategic system for assessing organizational capacity and economic effectiveness and predicting future sustainability.</li>
</ul>
<p>81</p>
<p>An effective M, E &amp; R system gives palliative care organizations the ability to:</p>
<ul>
<li>Evaluate how effectively they promote change.</li>
<li>Monitor how efficiently they promote change.</li>
<li>Foster public and political cooperation and support particular information needs for target audiences</li>
<li>Equip managers with a tool to gain timely information on the progress of activities, allowing comparison of what was planned to what is occurring.</li>
<li>Promote organizational learning and encourage adaptive management.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="goals-of-m-e-r-for-palliative-care">Goals of M, E &amp; R for Palliative Care<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#goals-of-m-e-r-for-palliative-care" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Achieving the best possible care for consumers/program improvement</li>
<li>Measuring palliative care and training activity</li>
<li>Cost effectiveness</li>
<li>Feedback for staff (based on successes, achievements, needs, inventory of Palliative care and training successes within the region)</li>
<li>Reappraising objectives</li>
<li>Course correction and program improvement/improving efficiency</li>
<li>Program decision-making - determining what works and what doesn't work (Fast-tracking and scaling-up effective programs)</li>
<li>Learning from mistakes, training other programs in best practices and proven models in Kenya and beyond</li>
<li>Accountability to donors • Increased credibility to obtain additional resources • Advocacy for funding/policy</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="oncology-nursing">Oncology nursing<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#oncology-nursing" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="oncology-nursing-overview">Oncology nursing overview:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#oncology-nursing-overview" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Oncology nurses work in a multi-disciplinary team, in a variety of settings, with a variety of patients, from children to the elderly, from outpatients through to palliative care.</li>
<li>One of the primary roles of the oncology nurses is patient assessment. They are responsible for assessing patients who have been presented due to treatment side effects, as well as assessing patients status, prechemotherapy, during chemotherapy and post-chemotherapy.</li>
<li>The oncology nurse must be able to understand pathology results and their implications and have an in-depth knowledge of the expected side effects of cancer treatments.</li>
<li>The oncology nurse must also use her interpersonal skills to listen to the patient, assessing their understanding of the disease and its process as well as the patient's emotional state.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>The oncology nurse plays a part in ensuring each cancer patient is educated about their disease, its treatments and expected side effects. They must ascertain the level of understanding each patient and their families both have and would like to have and then educate accordingly.</li>
<li>The oncology nurse must be sensitive to the patient’s needs, understanding that not everyone likes full disclosure of information.</li>
<li>The oncology nurse may play a large role in coordinating the care of the cancer patient, including different treatments and tests. They must clearly document all patient cares, keeping updated medical records to ensure continuity of care both within the nursing team and across the multi-disciplinary group that is responsible for each patient.</li>
<li>Oncology nurses are responsible for organising relevant referrals for patients to other healthcare providers such as dieticians, social workers or speech and pathologists.</li>
<li>Oncology nurses are often responsible for the administration of chemotherapy drugs to patients. They must be educated on safe handling, cytotoxic spills and management of allergic reactions.</li>
<li>The oncology nurse may be responsible for following the medical oncologist’s prescriptions, ensuring the correct drug dose is administered to the correct patient via the correct route.</li>
<li>Oncology nurses must manage both the symptoms of a patient’s disease and the side effects of various cancer treatments. They must be able to evaluate each patient and initiate appropriate cares. This may involve administering drugs or arranging for the patient to see the oncologist.</li>
<li>Oncology nurses must have a deep understanding of nausea, vomiting and fatigue, as these are three of the most common side effects of cancer treatments, especially chemotherapy.</li>
<li>Oncology nurses play a role in supporting the patient throughout their cancer journey. They must be educated on pain assessment and management through both pharmacological and non-drug related methods.</li>
<li>They must have compassion and strong interpersonal skills. Part of their role is to listen to the emotional concerns and anxieties of the patient and refer them appropriately if needed.</li>
<li>Oncology nurses may decide to become clinical nurse specialists. They may become involved in educating and assessing patients in radiation therapy, brachytherapy or gynaecological specialities. Oncology nurses can become involved in research and clinical trials as well participating in in-house on-going education.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="definition-of-terms">Definition of terms:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#definition-of-terms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="cancer">Cancer<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cancer" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Cancer is a disease process that begins when an abnormal cell is transformed by the genetic mutation of the cellular DNA.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="oncology">Oncology<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#oncology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Branch of medicine that deals with the study, prevention, detection, treatment and management of cancer.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="oncology-nursing">Oncology nursing<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#oncology-nursing" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Branch of medicine that deals with the study, detection, treatment and management of cancer and neoplasia.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="neoplasia">Neoplasia<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#neoplasia" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Is a new, uncontrolled growth of cells that is not under physiologic control. Neoplasm can be classified as either benign or malignant</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pre-cancerous-neoplasms">Pre-cancerous neoplasms<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pre-cancerous-neoplasms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>These are growths that have not spread and show the potential to become cancer. This is usually diagnosed based on a microscopic examination of the neoplasm.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="metastasis">Metastasis<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#metastasis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>The spread of cancer cells from the place where they first formed to other parts of the body</li>
<li>In metastasis, cancer cells break away from where they first formed (primary cancer), travel through the blood or lymph system, and form new tumors (metastatic tumors) in other parts of the body. The metastatic tumor is the same type of cancer as the primary tumor.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="malignant">Malignant<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#malignant" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Cancerous meaning that these cells can invade and destroy nearby tissues even spread to other parts of the body</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="primary-tumour">Primary tumour<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#primary-tumour" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Is the name for where a cancer starts.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="secondary-tumour-or-a-metastasis">Secondary tumour or a metastasis<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#secondary-tumour-or-a-metastasis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>This is when cancer spreads to other parts of the body</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="some-duties-and-responsibilities-of-oncology-nursing-professionals-include-the-following">Some duties and responsibilities of oncology nursing professionals include the following:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#some-duties-and-responsibilities-of-oncology-nursing-professionals-include-the-following" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Develop individualized care plans for patients under their care.</li>
<li>Collaborate with a multidisciplinary health care team to share knowledge and expertise.</li>
<li>Identify and treat cancer-related health issues.</li>
<li>Perform cancer research to improve treatment protocols provided to cancer patients.</li>
<li>Provide supportive resources for patients and their families to foster positive outlook and morale.</li>
<li>Educate patients and their families with regard to treatment expectations.</li>
<li>Monitor and record the progress of patients on an on-going basis.</li>
<li>Document patient’s response to medication and all treatment.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="cancer-overview">Cancer overview<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cancer-overview" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Cancer, also called malignancy, is an abnormal growth of cells.</li>
<li>There are more than 100 to 200 types of cancer, E.g breast cancer, skin cancer, lung cancer, colon cancer, prostate cancer and lymphoma.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Cancer is when abnormal cells divide in an uncontrolled way. Some cancers may eventually spread into other tissues</li>
<li>Cancer starts when gene changes, make one cell or a few cells begin to grow and multiply too much. This may cause a growth called a tumour. Cancer grows as cells multiply over and over</li>
<li>Symptoms and signs vary depending on the type of cancer.</li>
<li>Cancer treatment may include chemotherapy, radiation, and/or surgery.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="cancer-facts">Cancer facts<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cancer-facts" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Cancer cells do not invade the body like an infection but rather arise from normal cells that are changed or ‘transformed’ by contact with carcinogen (substance that damages cellular DNA and alters cell growth).</li>
<li>Most cancers start due to gene changes that happen over a person’s lifetime.</li>
<li>More rarely, cancers start due to inherited faulty genes passed down in families</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="cancer-processes">Cancer processes<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cancer-processes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>For cancer cells to become transformed, a cell must go through a series of processes consisting of:</p>
<ul>
<li>Initiation</li>
<li>Promotion</li>
<li>Progression</li>
<li>Metastasis</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="risk-factors">Risk factors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#risk-factors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>There various risk factors as follows:</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-endogenous-factors">A. Endogenous factors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-endogenous-factors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="i-age">i) Age<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-age" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ul>
<li>Older people tend to have increased risk for development of cancer due to the longer time of exposure to harmful agents</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="ii-genetic-factors">ii) Genetic factors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-genetic-factors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ul>
<li>Most cancers are not inherited but occur because of random genetic mutations in people with little or no relevant family history</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="iii-hormonal-factors">iii) Hormonal factors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-hormonal-factors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ul>
<li>Hormones such as estrogen do not appear to be primary carcinogens, but influences carcinogenesis</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="pre-cancerous-lesions">Pre-cancerous lesions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pre-cancerous-lesions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ul>
<li>This includes polyps of the colon and rectum, certain pigmented moles, dysplasias (presence of abnormal cells) of the cervical epithelium, and others</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="immunologic-factors">Immunologic factors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#immunologic-factors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Persons who have weaker immune system have increased risk for the development of cancers</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-exogenous-factors">B. Exogenous factors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-exogenous-factors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="drugs-and-chemicals">Drugs and chemicals<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drugs-and-chemicals" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Many chemicals, drugs and products in the environment are known to be carcinogenic and hundreds of others are considered to be associated with the development of cancers</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="radiation">Radiation<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#radiation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>i) Ionizing radiation</p>
<ul>
<li>Consists of electromagnetic waves or material particles that have sufficient energy to ionize atoms or molecules</li>
</ul>
<p>ii) Ultraviolet radiation (UVR)</p>
<p>UVR is produced by the sun or by artificial sources E.g. tanning beds also known as sun-bed which is a machine used to produce an artificial tan by imitating the sun's ultraviolet (UV) radiation or those in the industries. This type of radiation acts as an initiator, a promoter, a co-carcinogenic or an immuno-suppressive agent.</p>
<p>iii) Radon</p>
<p>A colorless, odourless, invisible and tasteless radioactive gas that results from the decay of uranium found in soil and in rocks. Prolonged breathing at high levels have been linked to an increased incidence of lung cancers.</p>
<p>iv) Electromagnetic radiation</p>
<p>Electromagnetic fields (EMF) are carcinogenic to humans and are have extremely low frequency energy fields, and exposure can come from household appliances, electrical power lines, and electricity-generating facilities. An example of EMF that people use daily is a cell-phone</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="c-lifestyle-practices">C. Lifestyle practices<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#c-lifestyle-practices" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>i) Smoking and tobacco use</p>
<p>Tobacco smoke is the single most lethal cause of cancer E.g. in the USA and is associated with at least 10 different cancers responsible for up to 30% of all cancer deaths</p>
<p>ii) Nutrition</p>
<p>The consumption of high fat diet has been researched as a risk factor in many common cancers, including cancers of the colon, prostate and breast</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="d-obesity">D. Obesity<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-obesity" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>This means that one has a lot of fat in the body and fat cells are known not to have large room for oxygen. As a result the low-oxygen environment triggers inflammation. The long-term inflammation caused by the excess fat can damage the body and increase risk for cancer.</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>E. Sexual and reproductive factors</p>
<p>Sexual practices E.g having multiple sexual partners play a role in the incidence of certain cancers because serial STDs have been linked to some cancers, including cervical cancer</p>
<p>F. Viruses and other microorganisms</p>
<p>Hepatitis B Virus and Hepatitis C Virus can cause chronic infections that are associated with hepatocellular carcinoma</p>
<p>G. Psychosocial factors</p>
<p>Stress that results from psychosocial trauma, loss of a significant other and personality variables, such as helplessness and repression have been suggested as etiologic factors in the development of cancer</p>
<p>Stages and grading of cancer</p>
<ul>
<li>Staging and grading give an idea of how quickly a cancer may grow and which treatments may work best</li>
<li>The stage of a cancer means how big it is and whether it has spread.</li>
<li>Grading looks at how abnormal the cancer cells are.</li>
</ul>
<p>Cancer stages</p>
<p>Cancer staging is carried out on the basis of:</p>
<ul>
<li>Size of tumor</li>
<li>Invasion</li>
<li>Lymph nodes</li>
<li>Metastasis</li>
</ul>
<p>Different types of staging systems are used for different types of cancer and below is an example of one common method of staging:</p>
<ul>
<li>Stage 0 – indicates that the cancer is where it started (in situ) and has not spread</li>
<li>Stage I – the cancer is small and has not spread anywhere else</li>
<li>Stage II – the cancer has grown, but has not spread</li>
<li>Stage III – the cancer is larger and may have spread to the surrounding tissues and/or the lymph nodes (part of the lymphatic system)</li>
<li>Stage IV – the cancer has spread from where it started to at least one other body organ, also known as "secondary" or "metastatic" cancer</li>
</ul>
<p>Cancer grades</p>
<ul>
<li>The grade of a cancer depends on what the cells look like under a microscope</li>
<li>In general, a lower grade indicates a slower-growing cancer and a higher grade indicates a faster-growing one.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>The grading system that's usually used is as follows:</li>
<li>grade I – cancer cells that resemble normal cells and are not growing rapidly</li>
<li>grade II – cancer cells that do not look like normal cells and are growing faster than normal cells</li>
<li>grade III – cancer cells that look abnormal and may grow or spread more aggressively</li>
<li>Grade IV – means the tissue appears more abnormal and generally is more aggressive</li>
</ul>
<p>Cancers are divided into groups according to the type of cell they start from. They include :</p>
<ul>
<li>Carcinomas</li>
<li>Lymphomas</li>
<li>Leukaemias</li>
<li>Brain tumours</li>
<li>Sarcomas</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="some-cancer-terminology">Some cancer terminology<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#some-cancer-terminology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>neo+ = new</li>
<li>+plasia = growth</li>
<li>+plasm = substance</li>
<li>+trophy = size</li>
<li>+oma = tumor</li>
<li>a+ = none</li>
<li>ana+ = lack</li>
<li>hyper+ = excessive</li>
<li>meta+ = change</li>
<li>dys+ = bad, impaired</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="a-neoplasm">A neoplasm<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-neoplasm" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>This is an abnormal growth of cells in the body</li>
<li>Is also described as a tumor.</li>
<li>Neoplasm comes to us from 'neo-', which means 'new' and '-plasm', which means 'cell' or 'tissue substance</li>
<li>A neoplasm can be a small growth, such as a mole, or a cancerous or pre-cancerous tumor.</li>
<li>Most of the time, neoplasms are not dangerous to own health</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="recognizing-a-neoplasm">Recognizing a neoplasm<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#recognizing-a-neoplasm" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>A visible neoplasm may look exactly like skin, or it may be a different color or texture.</li>
<li>They are usually painless, but they can hurt or bleed</li>
<li>Neoplasms may grow very slowly and it is rare for a neoplasm to grow rapidly.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>It may be noticed as small growths on the surface of the skin, or inside reachable areas of own body, such as ear canals or nostrils.</li>
<li>Neoplasms can also grow inside the body, where cannot be seen.</li>
<li>In some instances, internal neoplasms may cause noticeable bumps, but they are usually located deep beneath the surface of the skin, where they would not cause a change that could be seen from the outside.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="types-of-neoplasm">Types of Neoplasm<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types-of-neoplasm" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>In the human body, there are trillions of normal, healthy cells. These cells grow, divide, multiply, die and are replaced in a controlled, paced manner. However, in the case of a neoplasm, the cells may grow more rapidly or survive for longer than they are supposed to. Tumors can be cancerous, but they are not always</p>
<p>Neoplasms can be benign growths, pre-cancerous tumors, or cancer.</p>
<ul>
<li>A benign neoplasm is a growth that does not have cellular features of cancer or pre-cancer and is, thus, highly unlikely to become dangerous.</li>
<li>A pre-cancerous tumor has features of a malignant tumor, but has not yet developed into cancer and has not spread.</li>
<li>Cancer is a neoplasm that can grow rapidly, spread and cause damage to the body. A malignant neoplasm is cancerous, while a metastatic neoplasm is malignant cancer that has spread to nearby or distant areas of the body.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="benign-neoplasms">Benign neoplasms<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#benign-neoplasms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Benign neoplasms are often called birthmarks, and they may develop during late childhood or in adulthood.</li>
<li>Benign tumors usually grow slowly, if at all, and they are generally not life-threatening.</li>
<li>These are caused by a limited overgrowth of cells, usually without a known cause.</li>
</ul>
<p>Examples of benign neoplasm include:</p>
<ul>
<li>Skin moles</li>
<li>Skin tags (acrochordons)</li>
<li>Cysts in sebaceous glands (sweat glands)</li>
<li>Breast cysts that usually develop during pregnancy</li>
<li>Encapsulated skin growth, often triggered by an insect bite or infection</li>
<li>Raised scar tissue (keloids)</li>
<li>Uterine fibroids</li>
<li>The fact that benign tumors are not cancer doesn't mean that they can't cause problems.</li>
<li>Fibroids, for instance, can cause significant bleeding and pain that may require their removal.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="malignant-neoplasms">Malignant neoplasms<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#malignant-neoplasms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>A metastatic neoplasm is defined as cancer. It is most often associated with damage to a cell's DNA. This damage results in genetic mutations that cause abnormal cells to lose their normal function, multiply faster, live longer, and invade other cells and tissue.</li>
<li>Certain factors can trigger these mutations, including genetics, sun exposure, and toxic substances. Smoking, for instance, can increase a person's risk of lung cancer, while excessive alcohol use may lead to liver cancer.</li>
<li>A malignant neoplasm can grow in any part of the body and can metastasize (spread) to virtually any part of the body as well. A malignant neoplasm may begin as a physical mass, such as a tumor in the breast, or it can begin as an overproduction of a cell type, such as leukemia, a form of cancer characterized by overproduction of blood cells.</li>
<li>Pre-cancerous neoplasms are growths that have not spread and show the potential to become cancer. This is usually diagnosed based on a microscopic examination of the neoplasm.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="diagnostic-tests">Diagnostic tests<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#diagnostic-tests" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>
<p>History &amp; Physical Exam
(depend on clinical manifestations, index of suspicion for a particular cancer)</p>
</li>
<li>
<p>Lab Tests
&gt; Screening chemistry tests e.g., electrolytes (sodium, potassium, calcium), renal test BUN (blood urea nitrogen) test to determine how well kidneys are working i.e. measures the urea nitrogen in the blood, creatinine, liver test (bilirubin, AST, (aspartate aminotransferease), Alkaline Phosphate, LDH), bone test (calcium) depend on individual condition risk factors.
&gt; CBC with differential and platelets. May reveal anemia, changes in RBCs and WBC increased or decreased
&gt; Tumor Markers: For baseline and observation — to assess tumor burden and monitor levels of tumor and indicate a recurrence; prognosis (what treatment to use if the tumor should recur); most tumor markers are NOT specific, meaning that positive result does not necessarily mean that the primary site can be readily identified.</p>
</li>
<li>
<p>Imaging
&gt; Chest x-ray screens for primary or metastatic disease of lung</p>
</li>
<li>
<p>Endoscopy (used for direct visualization of body organs/cavities to detect abnormalities)</p>
</li>
<li>
<p>Scans (e.g. MRI, CT Gallium) and ultrasound: may be done for diagnostic purposes, identification of metastasis and evaluation of response to treatment.</p>
</li>
<li>
<p>Biopsy (fine needle aspiration FNA, needle core, incisional, excisional) done to differentiate and delineate treatment and may be taken from bone marrow, skin, organ.</p>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="foods-and-drinks-to-limit-in-diet-or-have-less-of-include">Foods and drinks to limit in diet or have less of include:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#foods-and-drinks-to-limit-in-diet-or-have-less-of-include" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Fatty red meats and processed meats</li>
<li>Highly processed foods that are low in fiber</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Heavily salted and pickled (preserved in a e.g salt) foods</li>
<li>Alcohol.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="foods-to-eat-more-include">Foods to eat more include:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#foods-to-eat-more-include" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The strongest protective anti-cancer effect has been shown with:</p>
<ul>
<li>Vegetables, especially raw vegetables or salads, such as leafy green vegetables and carrots</li>
<li>Foods high in dietary fibre, such as grains and cereals</li>
<li>Tomatoes</li>
<li>Citrus fruits</li>
<li>Cruciferous vegetables like broccoli, cabbage, Brussels sprouts, bok choy and other Asian greens.</li>
</ul>
<p>NB: Include more of these vegetables and fruits in your diet, along with other varieties.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="treatment-of-cancer">Treatment of cancer<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#treatment-of-cancer" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Treatment depends on:</p>
<ul>
<li>Type of cancer</li>
<li>Location</li>
<li>Extent of cancer</li>
<li>Stage at which has been diagnosed</li>
<li>Health and well-being of patient</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="oncological-treatment-modalities">Oncological treatment modalities<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#oncological-treatment-modalities" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The widely (traditional) used modalities are:</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-chemotherapy">i) Chemotherapy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-chemotherapy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>This is the use of drugs</li>
</ul>
<p>Goal of chemotherapy are:</p>
<ul>
<li>Curative treatment are aimed at total elimination of cancerous cells, including those may spread to other parts of the body.</li>
<li>Adjuvant chemotherapy is used in addition to surgery and/or radiation to eliminate systemic microscopic cancerous cells. The purpose of adjuvant therapy is to provide a complete cure or remission.</li>
<li>The intent of palliative chemotherapy is to reduce tumor size, extend life and improve the overall quality of life.</li>
</ul>
<p>Chemotherapy agent can be classified in one of two ways:</p>
<ul>
<li>The effect the agent has on the cell</li>
<li>The pharmacologic properties of the agent</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="ii-radiation-therapy">ii) Radiation therapy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-radiation-therapy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>This is the use of high-energy x-ray to treat cancer.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Radiation oncology is a subspecialty that incorporates the science and clinical application of therapeutic radiation in cancer therapy.</li>
</ul>
<p>Goals of radiation therapy:</p>
<ul>
<li>Treatment of cancer with ionizing radiation</li>
<li>Radiation destroys cells in the area being treated</li>
<li>Making it impossible for these cells to continue to grow.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="indications-for-radiation-therapy">Indications for radiation therapy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#indications-for-radiation-therapy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="cure">Cure:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cure" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Primary treatment for early stage of E.g Hodgkin's disease, cervical carcinoma</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="control">Control:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#control" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>To control the growth or spread of tumors/mass. Generally not a cure but may be curative and/or to allow less radical surgery</li>
</ul>
<p><strong>Neo-adjuvant</strong> (administration of therapeutic agents before the main treatment E.g to enhance the outcome of the primary treatment):</p>
<ul>
<li>To “downstage” bulky tumors, such as large breast or rectal tumors. Intent may be curative and/or to allow less radical surgery</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="adjuvant">Adjuvant:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#adjuvant" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>To reduce the risk of local recurrence at the site of tumor such as breast radiation is given after lumpectomy.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="palliation">Palliation:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#palliation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>This is to optimize quality of life and mitigate suffering hence make patient feel comfortable. E.g Pain control for sites of bony metastasis, control of bulky metastasis to reduce morbidity such as massive lymphadenopathy</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="oncologic-emergencies">Oncologic emergencies<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#oncologic-emergencies" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Oncological emergencies are a group of conditions that occur as a direct or indirect result of cancer or its treatment that are potentially life-threatening</li>
<li>They are classified as <strong>metabolic, hematologic, structural, or treatment related</strong>.</li>
</ul>
<p>These include:</p>
<ul>
<li>Hypercalcaemia</li>
<li>Neutropaenic sepsis</li>
<li>Tumour lysis syndrome</li>
<li>Leukostasis</li>
<li>Raised intracranial pressure</li>
<li>Spinal cord compression</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Cauda equina syndrome</li>
<li>Superior vena cava obstruction</li>
<li>Syndrome of inappropriate antidiuretic hormone secretion (SIADH)</li>
<li>Disseminated intravascular coagulation</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="iii-surgery">iii) Surgery<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-surgery" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>This is the removal of the tumor, the surrounding tissue and lymph nodes.</li>
<li>It can be conventional instruments or laser.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="some-other-modern-modalities">Some other modern modalities:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#some-other-modern-modalities" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="i-hormonal-therapy">i) Hormonal therapy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-hormonal-therapy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ul>
<li>Use of hormones to change the way hormones in the body help cancer to grow.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="ii-biological-therapy">ii) Biological therapy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-biological-therapy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<ul>
<li>Immunotherapy- makes use of the body’s immune system.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="iii-stem-cell-therapies-etc">iii) Stem cell therapies etc<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-stem-cell-therapies-etc" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="main-cancer-groups">Main cancer groups<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#main-cancer-groups" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Cancers are divided into groups according to the type of cell they start from. They include</p>
<ul>
<li>Carcinomas</li>
<li>Lymphomas</li>
<li>Leukaemias</li>
<li>Brain tumours</li>
<li>Sarcomas</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="classification-of-cancer-depending-on-the-cell-tissue-of-origin">Classification of cancer depending on the cell/tissue of origin<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#classification-of-cancer-depending-on-the-cell-tissue-of-origin" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>epithelial tissues (carcinoma)</li>
<li>glandular tissues (adenocarcinomas)</li>
<li>connective, muscle and bone tissues (sarcomas)</li>
<li>brain and spinal cord tissues (gliomas)</li>
<li>pigmented cells (melanomas)</li>
<li>plasma cells (myelomas)</li>
<li>lymphatic tissue (lymphomas)</li>
<li>leukocytes (leukemia)</li>
<li>erythrocytes (erythroleukemia)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="prevention-and-detection-of-cancer">Prevention and detection of cancer<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#prevention-and-detection-of-cancer" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>
<p>Promoting risk factors awareness</p>
</li>
<li>
<p>Promoting healthy behaviors</p>
</li>
<li>
<p>Limiting alcohol consumption</p>
</li>
<li>
<p>Hepatitis B virus infant vaccination</p>
</li>
<li>
<p>Control of STDs</p>
</li>
<li>
<p>Changing risk behaviors</p>
</li>
<li>
<p>Teaching skills for early detection programs</p>
</li>
<li>
<p>Promoting participation in early detection programs</p>
</li>
<li>
<p>Maintain a healthy weight throughout life.</p>
</li>
<li>
<p>Balance caloric intake with physical activity</p>
</li>
<li>
<p>Avoid excessive weight gain throughout the life cycle</p>
</li>
<li>
<p>Achieve and maintain a healthy weight if currently overweight or obese</p>
</li>
<li>
<p>Adopt a physically active lifestyle.</p>
</li>
<li>
<p>Adults: engage in at least 30 minutes of moderate to vigorous physical activity, above usual activities, on 5 or more days of the week; 45 to 60 minutes of intentional physical activity are preferable</p>
</li>
<li>
<p>Children and adolescents: engage in at least 60 minutes per day of moderate to vigorous physical activity at least 5 days per week</p>
</li>
<li>
<p>Consume a healthy diet, with an emphasis on plant sources</p>
</li>
<li>
<p>Choose foods and beverages in amounts that help achieve and maintain a healthy weight</p>
</li>
<li>
<p>Eat five or more servings of a variety of vegetables and fruits each day</p>
</li>
<li>
<p>Limit consumption of processed and red meats</p>
</li>
<li>
<p>If you drink alcoholic beverages, limit consumption.</p>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="basic-principles-of-nutrition-in-patients-with-cancer">Basic principles of nutrition in patients with cancer<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#basic-principles-of-nutrition-in-patients-with-cancer" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The nutrition status of patients with cancer can vary at presentation and through the continuum of cancer care. Many patients experience unintentional weight loss leading to a diagnosis of cancer. Studies have reported malnutrition in 30% to 85% of patients with cancer. Historically, weight loss, low body mass index (BMI) and serum albumin levels have been used as surrogate markers for malnutrition.</p>
<p>Emerging evidence supports that loss of lean body mass (sarcopenia) in patients with cancer is an independent risk factor for poorer outcomes and that in the setting of obesity, unlike in other diseases where weight loss may be welcomed, inappropriate loss of weight may lead to loss of muscle mass and poorer outcomes. However, there is no universal definition of sarcopenia, and there are no simple methods to identify the condition, limiting application in clinical practice.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="malnutrition">Malnutrition<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#malnutrition" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>In 2010, the American Society for Parenteral and Enteral Nutrition (ASPEN) and the European Society for Clinical Nutrition and Metabolism published their proposed etiology-based definitions of malnutrition. These have been accepted by both groups and the Academy of Nutrition and Dietetics.</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>The consensus statement provides the criteria for evaluating each of the following six potential indicators of malnutrition, with the recommendation that if two or more characteristics are present, the diagnosis of malnutrition is warranted and these are:</p>
<ul>
<li>Insufficient energy intake</li>
<li>Weight loss</li>
<li>Loss of muscle mass</li>
<li>Loss of subcutaneous fat</li>
<li>Localized or generalized fluid accumulation that may sometimes mask weight loss</li>
<li>Diminished functional status as measured by hand grip strength</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="nutrition-support">Nutrition support<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nutrition-support" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Nutrition support is the delivery of nutrition that bypasses oral intake. Every measure is employed to sustain patients and improve their condition through oral intake before consideration is given to nutrition support. Enteral nutrition (tube feeding) provides nutrition directly into the GI tract. Parenteral nutrition is the intravenous (IV) infusion of nutrients.</p>
<p>The use of enteral and parenteral nutrition in the oncology population may be indicated when oral nutrition strategies are not possible or fail because of tumor location or severe side effects. Although nutrition support is not recommended as standard treatment, it may be beneficial for patients who are malnourished and expected to become unable to take in adequate nutrition by mouth for an extended period of time. There are concerns that use of nutrition support will stimulate tumor growth and metastasis, but studies in humans are limited and show mixed results. However, if nutrition support is clinically indicated, it should not be withheld because of concerns about tumor promotion.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="why-enteral-nutrition-is-preferred-over-parenteral-nutrition-in-most-instances">Why Enteral nutrition is preferred over parenteral nutrition in most instances<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#why-enteral-nutrition-is-preferred-over-parenteral-nutrition-in-most-instances" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Enteral nutrition continues to use the gut</li>
<li>is associated with fewer infectious complications</li>
<li>is often easier to administer</li>
<li>is more cost-effective than parenteral nutrition</li>
</ul>
<p>Indications for nutrition support include the following:</p>
<ul>
<li>Patient is moderately to severely malnourished, will undergo major surgery and is anticipated to not achieve adequate oral nutrition for at least 7 to 14 days post-surgery.</li>
<li>Patient is malnourished and anticipated to have inadequate ingestion or absorption for 7 to 14 days or longer.</li>
<li>Patient has a mechanical obstruction preventing food from reaching the small bowel for proper digestion and absorption.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Providing nutrition support routinely to patients undergoing chemotherapy or radiation therapy is not recommended rather, nutrition support is reserved for patients who meet any of the criteria listed above. It is sometimes difficult to know which patients will have a prolonged period of inadequate oral intake or malabsorption and will benefit from nutrition support. For patients undergoing head and neck radiation, investigators have validated an evidenced-based protocol for determining which patients are at high risk of nutrition deficiency and therefore proactive placement of a gastrostomy tube</p>
<p>Although aggressive nutrition support has been shown to improve quality of life in patients with advanced cancer, it is generally not recommended if life expectancy is shorter than 40 to 60 days. For some patients who have incurable disease and are undergoing anticancer treatment, such as those with bowel obstruction, nutrition support may be appropriate. Investigators have suggested the following additional criteria for withholding nutrition support in patients with advanced disease:</p>
<ul>
<li>Short estimated life expectancy (fewer than 2–3 months)</li>
<li>Poor performance status as determined by a Karnofsky Performance Status score lower than 50% or an Eastern Cooperative Oncology Group Performance Status grade of 3 or 4</li>
<li>Severe organ dysfunction</li>
<li>Uncontrolled symptoms</li>
<li>Patient choice</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="initiating-nutrition-support">Initiating nutrition support<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#initiating-nutrition-support" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Despite established guidelines on optimal management of nutrition in patients with cancer, a wide range of opinions and practices exist among cancer practitioners. Lack of awareness among health professionals of the need for nutrition support in cancer patients has also been reported. Unfortunately, these gaps in care have led to reports of patients failing to receive adequate nutrition when appropriate.</li>
<li>Although the decision to initiate nutrition support in severely malnourished patients is simple, it becomes more complex in patients without a defined period of time for nutrition requirements, in patients with incurable disease, for immunosuppressed patients and for those who are borderline malnourished.</li>
<li>All patients with cancer should undergo nutritional screening throughout their treatment courses. Early screening provides a baseline value to identify nutritional needs over time. The scoring tools mentioned earlier, which have been validated in the oncology setting, can aid in such screening.</li>
<li>Counseling regarding adequate dietary intake and supplementation should be provided to all patients with adequate oral intake who are malnourished or at risk for poor nutrition.</li>
<li>Nutrition support should be initiated in patients with inadequate intake (&lt;60% of caloric requirements) for an expected duration not less than 7 days, and malnourished patients should be considered for nutrition support 7 days prior to surgery, as this may improve postoperative outcomes</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="nutrition-counseling">Nutrition counseling<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nutrition-counseling" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Initiate nutrition counseling as soon as such needs are identified, as there is strong evidence that nutrition counseling in patients with cancer can prevent and reduce malnutrition. Counseling should be provided</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>by nutritional support personnel with expertise in appropriate dietary intervention and monitoring in cancer care.</p>
<p>Nutritional plans should be individualized to meet the needs of the patient, taking into consideration their nutrition status, type and stage of disease, comorbid conditions, and overall medical treatment plan. One study in patients with head and neck cancer undergoing radiation demonstrated that nutritional counseling lead to improvement in anorexia, xerostomia (gry mouth), and dysgeusia. Quality-of-life outcomes were also improved in patients who received nutritional counselling</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="methods-of-nutrition-therapy">Methods of nutrition therapy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#methods-of-nutrition-therapy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Prompt and aggressive nutrition intervention is required for patients with pre-cachexia or cancer cachexia. Intervention is more likely to be effective when started early. Interventions include an individualized approach to oral, enteral and parenteral nutrition using evidence-based recommendations, guidelines and program and regulatory standards.</p>
<p>The dietician works with the patient, caregivers and members of the health care team to improve compliance and the effectiveness of pharmacotherapy interventions prescribed to manage cancer and cancer treatment-related symptoms and counsel patients about behavioral strategies to alleviate nutrition impact symptoms</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-enteral-route-and-administration">i) Enteral route and administration<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-enteral-route-and-administration" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Several effective methods for the delivery of enteral nutrition exist. Factors affecting a choice of the enteral route include:</p>
<ul>
<li>anticipated length of need,</li>
<li>aspiration risk, tumor location</li>
<li>side effects.</li>
</ul>
<p>Assessment of need is best performed early. If a malnourished patient requires surgery for an unrelated event, a feeding tube may be placed at that time to avoid an additional procedure.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="short-term-feeding">Short-term feeding<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#short-term-feeding" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>For short-term feeding (&lt;2 weeks), a naso-enteric tube may be best. The risk of aspiration is considered in the determination of the proper termination point of the tube; stomach (nasogastric tube), duodenum (naso-duodenal tube), or jejunum (naso-jejunal tube), with nasojejunal feeds recommended for patients with aspiration risk.</p>
<p>Tubes are constructed of silicone or polyurethane and can vary in length from 30 to 43 inches, with the shorter tubes used for nasogastric feedings. Diameters range from 5F catheters to 16F catheters. Tubes may have weighted tips to help passage through the gut. If a patient with cancer is at very high risk of aspiration, enteral nutrition may be contraindicated, and parenteral nutrition can be considered. Immuno-compromised patients with mucositis, esophagitis, and/or herpetic, fungal, or candidiasis lesions in the mouth or throat may not be able to tolerate the presence of a naso-enteric tube.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="longer-term-feeding">Longer-term feeding<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#longer-term-feeding" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>For longer-term feeding (&gt;4 weeks), direct enteral access is recommended. Percutaneous tubes may be placed endoscopically, surgically, or with fluoroscopy by interventional radiology.</p>
<p>Percutaneous tube placement has a number of advantages:</p>
<ul>
<li>the diameter of the tube may be larger (15F–24F catheters) allowing easier and faster passage of formulas and medications</li>
<li>the risk of aspiration is lower because of the decreased chance of migration of the tube into the esophagus;</li>
<li>the risk of sinusitis or naso-esophageal erosion is lower and this route is more convenient and aesthetically pleasing to patients because of their ability to conceal the tube.</li>
</ul>
<p>Conversion to a skin-level button gastrostomy or jejunostomy may also be considered when longer-term support is anticipated.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="infusion-methods-and-formulas">Infusion methods and formulas<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#infusion-methods-and-formulas" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Administration methods vary depending on where in the GI tract the tube terminates and may be affected by treatment side effects.</p>
<p>For tubes terminating in the stomach, a bolus or intermittent (gravity) drip may be possible and is preferable because it mimics normal feeding, requires less time and equipment and offers greater flexibility to the patient. For tubes terminating in the duodenum or jejunum, an infusion pump is required because a slower administration rate is necessary. Feedings via a pump may be administered cyclically (&lt;24 hours per day) or continuously</p>
<p>The following lists summarize infusion methods and considerations for initiation and administration of enteral nutrition:</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-bolus-and-intermittent-feeding">a) Bolus and intermittent feeding<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-bolus-and-intermittent-feeding" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Caloric/nutrient and free-water requirements need to be determined to plan the feeding schedule.</li>
<li>Bolus feedings can be offered several times (3–6 times) each day, as much as 250 to 500 cc can be given over 10 to 15 minutes.</li>
<li>Bolus feeding should be used only when the endpoint of the tube is in the stomach, it should never be used when feedings are delivered into the duodenum or jejunum. This precaution protects against gastric distension and dumping.</li>
<li>A gravity drip from a bag or syringe with a slow push can be used to administer the formula.</li>
<li>Diarrhea is a common side effect of this infusion method but can be controlled with a change in formula, additions to the formula, and a change in the amount of formula given over a finite period of time.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="b-continuous-or-cyclic-drip-feeding">b) Continuous or cyclic drip feeding<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-continuous-or-cyclic-drip-feeding" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Caloric/nutrient and free-water requirements need to be determined first to plan rate and time recommendations.</li>
<li>Enteral feeding pumps provide reliable, constant infusion rates and decrease the risk of gastric retention.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>When no compounding factors are present, feeding into the stomach (25–30 cc/h) can start at a higher rate than feeding into the jejunum (10 cc/h); rates can be increased, with tolerance, every 4 to 6 hours until the rate reaches that needed to deliver the required caloric/nutrient needs.</li>
<li>Continuous feeds can be cycled to run at night to allow greater flexibility and comfort. If it is physically possible, these nocturnal feeds can allow daytime oral or bolus feedings to meet nutrition goals and provide a more normal lifestyle.</li>
</ul>
<p>Enteral formulas vary in nutrient composition and source. Most commercially available formulas are lactose free, kosher, and halal. Standard/polymeric formulations are appropriate for most patients. Semi-elemental and elemental formulas are available for patients with mal-absorption who do not or will not tolerate standard formulas. In some cases, disease-specific (renal, pulmonary, and diabetic) formulas may be appropriate and are available but in general are not necessary unless the patient has a demonstrated "failure" with standard formulas.</p>
<p>The use of whole-food blenderized formulas is gaining in popularity. Some products are commercially available and there are published recipes for home-made formula. It is important for a dietician to thoroughly review the nutrient content of these home-blenderized formulas to ensure adequacy.</p>
<p>For patients in the perioperative setting, evidence supports the use of IE formulas. The most widely studied formula in this category contains a combination of arginine, omega-3 fatty acids, and nucleotides. Studies suggest that use of these formulas for a very narrow period of time can reduce the incidence of surgical complications (infectious and non-infectious) and decrease the length of hospital stays</p>
<p>ii) Parenteral route and administration</p>
<p>&gt; If parenteral nutrition is determined to be beneficial and appropriate, it can be administered via central or peripheral venous access. Many patients with cancer already have central IV catheters to accommodate multiple IV therapies. For patients who do not already have central line access or will not have it for a period of time, a peripheral catheter can be placed, however, care must be taken to avoid overuse of the peripheral IVs, as this can result in vessel sclerosis. To minimize venous complications, the use of peripheral parenteral nutrition is limited</p>
<p>&gt; Parenteral nutrition is a combination of:
&gt; - dextrose (carbohydrate)
&gt; - amino acids (protein)
&gt; - lipid emulsions (fat)
&gt; - added electrolytes
&gt; - vitamins
&gt; - trace elements.</p>
<p>It is recommended that parenteral nutrition management include clinicians with expertise in nutrition support and be made up of a multidisciplinary team, including a registered dietician and clinical pharmacist</p>
<p>&gt; Parenteral nutrition is typically initiated as a 24-hour infusion. After tolerance is established and generally after daily macronutrient goals are achieved, parenteral nutrition may be cycled (typically to an</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>infusion time of 10–14 hours). For patients who will be receiving home parenteral nutrition, a cyclic infusion is preferred</p>
<p>&gt; It is generally recommended that parenteral nutrition be initiated in the hospital and not at home. Only if the benefits of home initiation far outweigh the risks should it be considered, and only for patients who are hemo-dynamically stable, at low risk of re-feeding syndrome and non-diabetic</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="impediments-to-adequate-nutrition">Impediments to adequate nutrition<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#impediments-to-adequate-nutrition" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Influences on nutrition status and risk of malnutrition include:</p>
<ul>
<li>Baseline nutrition status</li>
<li>Disease site</li>
<li>Stage of disease</li>
<li>Treatment approach</li>
</ul>
<p>Treatment approaches, including surgery, chemotherapy and radiation therapy, can have a direct (mechanical) negative effect and/or an indirect (metabolic) negative effect on nutrition status. The success of anticancer therapy is affected by the patient's nutrition status before and during treatment, which influences the patient's ability to tolerate therapy.</p>
<p>Oral intake is impeded by nutrition impact symptoms, including:</p>
<ul>
<li>anorexia</li>
<li>alterations in taste and smell</li>
<li>mucositis</li>
<li>dysphagia</li>
<li>stomatitis</li>
<li>nausea</li>
<li>vomiting</li>
<li>diarrhea</li>
<li>constipation</li>
<li>malabsorption</li>
<li>pain</li>
<li>depression and anxiety</li>
</ul>
<p>Pre-existing comorbidities may also play a role in the development of cancer, e.g., alcohol abuse and obesity or may increase the risk of malnutrition at presentation (Bozzetti F, et al, 2012)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="tumor-induced-effects-on-nutrition-status">Tumor-induced effects on nutrition status<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#tumor-induced-effects-on-nutrition-status" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Tumors may have systemic or local effects that affect nutrition status, including hyper-metabolism, malabsorption, dysmotility and obstructions.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="tumor-metabolism">Tumor metabolism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#tumor-metabolism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Nutrition status can be compromised in direct response to tumor-induced alterations in metabolism (i.e., cachexia). Tumor-induced weight loss occurs frequently in patients with solid tumors of the lung, pancreas, and upper gastrointestinal (GI) tract and less often in patients with breast cancer or lower Gastro-intestinal cancer. Cachexia is also more common with more-advanced disease (Baldwin C, et al, 2012)</p>
<p>In 2011, an international group of experts developed a consensus definition of cachexia as "a multifactorial syndrome defined by an on-going loss of skeletal muscle mass that cannot be fully reversed by conventional nutrition support and leads to progressive functional impairment." The classified three stages of cachexia:</p>
<ul>
<li>Precachexia: early signs (clinical and metabolic) that precede substantial weight loss.</li>
<li>Cachexia: the presence of significant weight loss or sarcopenia in the absence of simple starvation.</li>
</ul>
<p>&gt; Weight loss &gt;5% over the past 6 months or
&gt; Body mass index &lt;20 and degree of weight loss &gt;2% or
&gt; Sarcopenia and any degree of weight loss &gt;2%.</p>
<ul>
<li>Refractory cachexia: cachexia that is clinically refractory is usually associated with advanced-stage cancer or rapid progression of disease that is unresponsive to treatment.</li>
</ul>
<p>Although anorexia may also be present, the energy deficit alone does not explain the pathogenesis of cachexia. The etiology of cancer cachexia is not entirely understood, but several factors have been proposed including:</p>
<p>&gt; cytokines,
&gt; neuropeptides,
&gt; neurotransmitters,
&gt; tumor-derived factors. All these are postulated to contribute to the syndrome products of host tissues (e.g., tumor necrosis factor-alpha) and have a direct catabolic effect on host tissues.</p>
<p>Altered metabolism of fats, proteins and carbohydrates is evident in patients with cancer cachexia. Tumors may impair glucose uptake and glucose oxidation, leading to an increased glycolysis.</p>
<p>Weight loss can occur from a decrease in energy intake and/or an increase in energy expenditure. Although anorexia is a common symptom of patients with cancer, studies have shown that increased caloric intake, whether by the oral route or by supplementation with total parenteral nutrition, has failed to counteract the wasting process. This aberrant metabolic rate appears to be a direct response by the tumor and immune system to disrupt the pathways that regulate the body-weight regulation homeostasis loop.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="treatment-induced-effects-on-nutrition-status">Treatment-induced effects on nutrition status<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#treatment-induced-effects-on-nutrition-status" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Cancer treatments may cause acute and chronic effects. Nutrition intervention is based on symptom management. Patients who maintain good nutrition are more likely to tolerate the side effects of treatment. Adequate calories and protein can help maintain patient strength and prevent body tissues from further catabolism. Side effects of cancer treatments vary among patients, depending on:</p>
<ul>
<li>the type of treatment</li>
<li>length of treatment</li>
<li>dose of treatments</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>the type of cancer being treated</li>
</ul>
<p>Cancer treatment has toxic effects on the GI tract, including nausea, vomiting, constipation, diarrhea, xerostomia, mucositis, dysphagia and loss of appetite.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="chemotherapy-and-hormone-therapy">Chemotherapy and hormone therapy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#chemotherapy-and-hormone-therapy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Chemotherapy and hormone therapy can be used as single agents or in combination, depending on the disease type and patient's health condition. These agents are divided into several functional categories. For instance, chemotherapy is a systemic treatment (not a localized treatment) that affects the whole body (not just a specific part) and potentially causes more side effects when compared with localized treatments such as surgery and radiation therapy.</p>
<p>Common nutrition-related side effects include:</p>
<ul>
<li>anorexia</li>
<li>taste changes</li>
<li>early satiety</li>
<li>nausea</li>
<li>vomiting</li>
<li>mucositis/esophagitis</li>
<li>diarrhea</li>
<li>constipation</li>
</ul>
<p>Cancer and the side effects of chemotherapy can greatly affect nutrition status, so health care providers must anticipate possible problems and formulate a plan with the patient to prevent malnutrition and weight loss. Malnutrition and weight loss can affect a patient's ability to regain health and acceptable blood counts between chemotherapy cycles and this can directly affect the patient's ability to stay on treatment schedules, which is important in achieving a successful outcome.</p>
<p>Patients receiving hormone suppression therapies are at risk of weight gain rather than weight loss. These patients may benefit from directed education to minimize weight gain and help reduce the risk of developing comorbidities associated with excess body weight.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="radiation-therapy">Radiation therapy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#radiation-therapy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Radiation therapy causes localized symptoms. Some of the common nutrition-related side effects caused by irradiation include:</p>
<ul>
<li>changes in taste</li>
<li>ability to swallow,</li>
<li>nausea/vomiting,</li>
<li>changes in bowel movements (usually diarrhea),</li>
<li>GI symptoms such as gas.</li>
</ul>
<p>The side effects of radiation therapy depend on:</p>
<ul>
<li>the area that is irradiated</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>total dose</li>
<li>fractionation</li>
<li>duration</li>
<li>volume irradiated</li>
</ul>
<p>Most side effects are acute, begin around the second or third week of treatment and diminish 2 or 3 weeks after radiation therapy is completed. Some side effects can be chronic and continue or occur after treatment has been completed.</p>
<p>Nutrition support during radiation therapy is vital. The effect of radiation therapy on healthy tissue in the treatment field can produce changes in normal physiologic function that may ultimately diminish a patient's nutrition status by interfering with ingestion, digestion,</p>
<p>or absorption of nutrients.</p>
<p>Many nutrition-related side effects result from radiation therapy. Quality of life and nutrition intake can be improved by managing these side effects through appropriate medical nutrition therapy and dietary modifications. For example, medications such as pilocarpine (Salagen) may be useful in treating the xerostomia that accompanies radiation therapy targeting the head and neck. This medicine may reduce the need for artificial saliva agents or other oral comfort agents such as hard candy or sugarless gum.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="surgery">Surgery<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#surgery" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>For patients with most types of solid tumors, surgery is the only chance for a cure. Although a tumor may be technically resectable, a meaningful recovery can depend on a patient's preoperative nutrition status. Patients who are malnourished at the time of surgery are at higher risk of postoperative morbidity and mortality and longer hospital stays. If time permits or if the surgical procedure may be delayed safely, steps can be taken to identify patients who are moderately to severely malnourished before surgery and to correct macronutrient and micronutrient deficiencies before surgery. Choosing the best method to correct a nutrition deficiency depends on GI tract function; options include oral liquid nutrition supplements, and enteral or parenteral nutrition support.</p>
<p>Surgical treatment can increase occurrence of malnutrition or worsen malnutrition. Common side effects of surgery, especially to the GI tract or head and neck, include:</p>
<ul>
<li>decreased appetite,</li>
<li>decreased ability to take food by mouth,</li>
<li>early satiety, all of which can lead to worsening pre-existing malnutrition or may cause previously adequately nourished patients to become malnourished after surgery</li>
</ul>
<p>Depending on the procedure, surgery can cause mechanical or physiologic barriers to adequate nutrition, such as a short gut that results in mal-absorption after bowel resection. In addition to these mechanical barriers, surgery frequently leads to an immediate catabolic response and changes the nutrient requirements necessary for wound healing and recovery at a time when baseline needs and requirements are often not being met.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="biotherapy">Biotherapy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#biotherapy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Bicameral, Bicameral, and Bicameral</p>
<p>Biotherapy is treatment to boost the immune system to help enhance the body's own response against cancer or to help repair normal cells damaged as a side effect of treatment. Biotherapy includes growth factors, monoclonal antibodies, and vaccines. The symptoms of biotherapy that are most likely to impact nutrition status are:</p>
<ul>
<li>fatigue,</li>
<li>fever,</li>
<li>nausea,</li>
<li>vomiting,</li>
<li>diarrhea.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="hemopoietic-cell-transplantation-hct">Hemopoietic cell transplantation (HCT)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hemopoietic-cell-transplantation-hct" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>HCT patients can have special nutrition requirements. Before cell transplant, patients receive high-dose chemotherapy and may be treated with total-body irradiation. In addition to the medications used during transplantation, these treatments frequently result in nutrition-related side effects, including mucositis and significant diarrhea, which may affect the ability of patients to consume an adequate diet. Patients may also experience acute or chronic graft-versus-host disease (GVHD). GVHD may target the GI tract, liver, or skin, altering the body's ability to ingest and process adequate calories and protein</p>
<p>The goal of nutrition support is to maintain adequate nutrition status and protein stores. The American Society for Parenteral and Enteral Nutrition recommends that patients undergoing HCT who are malnourished and anticipated to be unable to ingest or absorb adequate nutrients for a prolonged period of time (&gt;7–14 days) receive nutrition support; if a patient has a functioning GI tract, enteral nutrition is recommended.</p>
<p>In addition, transplant patients are at very high risk of neutropenia, an abnormally small number of neutrophils in the blood that increases susceptibility to multiple infections. To reduce the risk of infections related to HCT, patients can receive dietary counseling regarding safe food handling and avoidance of foods that may pose an infection risk.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="nutrition-screening-and-assessment">Nutrition screening and assessment<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nutrition-screening-and-assessment" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Optimizing nutrition for patients with cancer involves early detection of malnutrition or risk of malnutrition so that intervention may be initiated in the early stages of disease or treatment. The goal of nutrition screening is to rapidly identify patients who are at risk of developing malnutrition and refer them to a health care professional, ideally a registered dietician, who can perform a complete nutrition assessment and implement a nutrition care plan (Levin R, et al, 2018)</p>
<p>There are no standard definitions or indices of malnutrition. Historically, loss of weight or body mass index (BMI), low BMI, and low serum protein (e.g., albumin) have been used to identify patients with malnutrition. Without more context, these characteristics are not acceptable measures by which to determine malnutrition. Weight changes alone cannot be used to determine nutrition status because weight changes do not account for fluid changes (dehydration, ascites, and edema) or disproportionate loss of lean body mass. Likewise, evidence demonstrates that BMI is deceiving because it does not account for body composition (lean body mass vs. fat mass), and many patients with cancer may present with a normal or high body weight/BMI but have severe</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>muscle depletion (i.e., sarcopenia) The use of albumin, which is now recognized as being significantly influenced by inflammation, is also a poor measure of nutrition status and more likely suggestive of disease severity, not nutrition status. Standardized definitions and cut-off points that designate malnutrition or cachexia are being developed, however, the true prevalence of malnutrition in the oncology population is unknown (August DA et al, 2014)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="assessment">Assessment<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#assessment" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Nutrition assessment is a comprehensive approach to evaluating and diagnosing nutrition problems and designing interventions. A full nutrition assessment involves evaluation of six components:</p>
<ul>
<li>Food- and nutrition-related history</li>
<li>Anthropometric measurements.</li>
<li>Biochemical data, medical tests, and procedures.</li>
<li>Nutrition-focused physical assessment.</li>
<li>Medical history.</li>
<li>Treatment plan.</li>
</ul>
<p>Within the nutrition assessment, the following factors are considered in making a diagnosis of malnutrition</p>
<ul>
<li>Insufficient energy intake</li>
<li>Weight loss</li>
<li>Loss of muscle mass</li>
<li>Loss of subcutaneous fat</li>
<li>Localized or generalized fluid accumulation</li>
<li>Diminished functional status (e.g., grip strength).</li>
</ul>
<p>The assessment of anthropometric measurements evaluates weight loss, takes into account the time frame of weight loss and is considered in the context of physical findings such as dehydration or fluid retention. Evaluation of food- and nutrition-related history ideally involves a dietician obtaining a diet history and comparing intake with the patient's calculated energy needs. The nutrition-focused physical assessment evaluates loss of muscle mass and subcutaneous fat, fluid accumulation and potential micronutrient deficiencies. The physical examination of the following areas determines loss of subcutaneous fat or muscle:</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="subcutaneous-fat-loss">Subcutaneous fat loss<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#subcutaneous-fat-loss" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Orbit.</li>
<li>Upper arm</li>
<li>Thoracic and lumbar regions</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="subcutaneous-muscle-loss">Subcutaneous muscle loss<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#subcutaneous-muscle-loss" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Temple.</li>
<li>Clavicle.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Clavicle and acromion.</li>
<li>Scapula.</li>
<li>Dorsal hand.</li>
<li>Patella.</li>
<li>Anterior thigh.</li>
<li>Posterior calf.</li>
</ul>
<p>In addition to the issues described above, the oncology nutrition assessment also takes into account the following:</p>
<ul>
<li>Tumor location (current or anticipated mechanical function impairment).</li>
<li>Current side effects/symptoms.</li>
<li>Anticipated treatment/side effects.</li>
<li>Anticipated duration of symptoms.</li>
<li>Intent of treatment.</li>
</ul>
<p>The goal of an oncology nutrition assessment is to collect the information necessary to determine current or anticipated nutrition issues and to formulate a plan with the patient, caregivers and other members of the health care team involved with nutrition interventions. Additionally, this multidisciplinary team approach may also include metabolic, pharmacologic and functional interventions to address and prevent the identified or anticipated nutrition issues (Levin R., et al, 2018)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="behavioral-strategies-for-symptom-management">Behavioral strategies for symptom management<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#behavioral-strategies-for-symptom-management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Cancer and cancer treatment result in a range of side effects, described as nutrition impact symptoms, that impede oral intake. While some patients experience few of these effects, others may have multiple symptoms, including anorexia, early satiety, constipation, diarrhea, dysphagia, fatigue, mucositis, nausea, taste and smell changes, and xerostomia. These symptoms can result in a decline in nutrition status and quality of life. Behavioral strategies are essential in alleviating the impact of these symptoms and promoting adequate nutrient intake; pharmacologic interventions may be used in combination with these strategies to minimize symptom severity.</p>
<p>The following lists describe behavioral strategies to help alleviate nutrition-related symptoms of cancer treatment..</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="behavioral-strategies-to-alleviate-nutrition-related-symptoms">Behavioral strategies to alleviate nutrition-related symptoms<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#behavioral-strategies-to-alleviate-nutrition-related-symptoms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Loss of Appetite and Weight Loss</li>
<li>Eat small, frequent meals and healthy snacks throughout the day.</li>
<li>Eat foods that are high in protein and calories.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>&gt; Eat high-protein foods first in your meal while your appetite is strongest, foods such as beans, chicken, fish, meat, yogurt and eggs.
&gt; Add extra protein and calories to food.
&gt; Cook with protein-fortified milk.
&gt; Drink milkshakes, smoothies, juices, or soups if you do not feel like eating solid foods.
&gt; Prepare and store small portions of favorite foods.
&gt; Seek foods that appeal to the sense of smell.
&gt; Experiment with different foods.
&gt; Eat larger meals when you feel well and are rested.
&gt; Sip only small amounts of liquids during meals.
&gt; Eat your largest meal when you feel hungriest, whether at breakfast, lunch, or dinner.
&gt; Be as active as possible to help develop a bigger appetite.
&gt; Consider asking your health practitioner about blenderized drinks with a high nutrient density.
&gt; Tell your doctor if you are having eating problems such as nausea, vomiting, or changes in how foods taste and smell.
&gt; Perform frequent mouth care to relieve symptoms and decrease aftertastes.
&gt; Consider tube feedings if you are unable to sustain a certain amount of caloric intake to maintain strength.</p>
<ul>
<li>
<p>Constipation
&gt; Drink plenty of fluids each day, including water, warm juices and prune juice.
&gt; Be active each day; take walks regularly.
&gt; Eat more fiber-containing foods.
&gt; Drink hot liquids to help relieve constipation, including coffee, tea and warm milk.
&gt; Talk with your doctor before taking laxatives, stool softeners, or any medicine to relieve constipation.
&gt; Limit certain foods if you develop gas, including broccoli, cabbage, cauliflower, beans and cucumbers.
&gt; Eat a large breakfast, including a hot drink and high-fiber foods.
&gt; Consider a fiber supplement.</p>
</li>
<li>
<p>Diarrhea
&gt; Drink plenty of fluids to replace those lost from diarrhea, including water, ginger ale and sports drinks.</p>
</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>&gt; Let carbonated drinks lose their fizz before you drink them.
&gt; Eat foods and liquids that are high in sodium and potassium.
&gt; - Liquids: E.g bouillon or fat-free broth.
&gt; - Foods: E.g bananas; canned apricots; and baked, boiled, or mashed potatoes.
&gt; Eat low-fiber foods.
&gt; Have foods and drinks at room temperature (neither too hot nor too cold).
&gt; Avoid foods such as:
&gt; - High-fiber foods.
&gt; - High-sugar foods.
&gt; - Very hot or cold drinks.
&gt; - Greasy, fatty and fried foods.
&gt; - Foods that can cause gas, such as carbonated beverages, cruciferous vegetables, legumes and lentils and chewing gum.
&gt; - Milk products (unless low lactose or lactose free).
&gt; - Alcohol.
&gt; - Spicy foods.
&gt; - Caffeinated drinks.
&gt; - Sugar-free products sweetened with xylitol or sorbitol.</p>
<ul>
<li>Dry Mouth
&gt; - Sip water throughout the day.
&gt; Have very sweet or tart foods and drinks – such as lemonade, to help make more saliva.
&gt; - Chew gum or suck on hard candy, ice pops, or ice chips; sugar free is best, but consult your doctor if you also have diarrhea.
&gt; Eat foods that are easy to swallow.
&gt; - Moisten food with sauce, gravy, or salad dressing.
&gt; - Do not drink any type of alcohol, beer, or wine.
&gt; - Avoid foods that can hurt your mouth, i.e., spicy, sour, salty, hard, or crunchy foods.
&gt; - Keep your lips moist with lip balm.
&gt; - Rinse your mouth every 1 to 2 hours.
&gt; - Do not use mouthwash that contains alcohol.
&gt; - Do not use tobacco products, and avoid second-hand smoke.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>&gt; Talk with your doctor or dentist about artificial saliva or other products to coat, protect and moisten your throat and mouth.</p>
<ul>
<li>
<p>Lactose intolerance
&gt; Prepare your own low-lactose or lactose-free foods.
&gt; Choose lactose-free or low-lactose milk products. Most grocery stores carry products (such as milk and ice cream) labelled "lactose free" or "low lactose."
&gt; Try products made with soy or rice (such as soy or rice milk and frozen desserts). These products do not contain any lactose.
&gt; Choose milk products that are low in lactose. Hard cheeses (such as cheddar) and yogurt are less likely to cause problems.
&gt; Try using lactase tablets when consuming dairy products. Lactase is an enzyme that breaks down lactose.
&gt; Avoid only the milk products that give you problems. Try small portions of milk, yogurt, or cheese to see if you can tolerate them.
&gt; Try calcium-fortified non-dairy drinks and foods, which you can identify by food labels.
&gt; Eat more calcium-rich vegetables, including broccoli and greens.</p>
</li>
<li>
<p>Nausea
&gt; Eat bland, soft, easy-to-digest foods rather than heavy meals.
&gt; Eat dry foods such as crackers, breadsticks, or toast throughout the day.
&gt; Eat foods that are easy on your stomach: white toast, plain yogurt, and clear broth.
&gt; Avoid strong food and drink smells.
&gt; Avoid eating in a room that has cooking odors or is overly warm; keep the living space comfortable but well ventilated.
&gt; Sit up or recline with your head raised for 1 hour after eating.
&gt; Rinse your mouth before and after eating.
&gt; Suck on hard candies such as peppermints or lemon drops if your mouth has a bad taste.
&gt; Eat five or six small meals each day instead of three large meals.
&gt; Do not skip meals and snacks; for many people, having an empty stomach makes nausea worse.
&gt; Choose foods that appeal to you. Do not force yourself to eat any food that makes you feel sick. Do not eat your favorite foods, to avoid linking them to being sick.
&gt; Have liquids throughout the day and drink slowly.</p>
</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>&gt; Sip only small amounts of liquids during meals because many people feel full or bloated if they eat and drink at the same time.
&gt; Have foods that are neither too hot nor too cold.
&gt; Eat dry toast or crackers before getting out of bed if you have nausea in the morning.
&gt; Plan the best times for you to eat and drink.
&gt; Relax before each cancer treatment.
&gt; Wear clothes that are loose and comfortable.
&gt; Keep a record of when you feel nausea and why.
&gt; Talk with your doctor about the use of anti-nausea medications.</p>
<ul>
<li>Sore Mouth
&gt; Choose foods that are easy to chew, i.e., soft foods such as milkshakes, scrambled eggs, and custards.
&gt; Cook foods until they are soft and tender.
&gt; Cut food into small pieces and use a blender or food processor to puree foods.
&gt; Drink with a straw to help push the drinks beyond the painful parts of your mouth.
&gt; Use a very small spoon to help you take smaller bites, which may be easier to chew.
&gt; Eat cold or room-temperature foods to avoid hurting your mouth with food that is too hot.
&gt; Suck on ice chips to help numb and soothe your mouth.</li>
</ul>
<p>Avoid certain foods and drinks when your mouth is sore, such as:</p>
<ul>
<li>Citrus foods.</li>
<li>Spicy foods.</li>
<li>Tomatoes and ketchup.</li>
<li>Salty foods.</li>
<li>Raw vegetables.</li>
<li>Sharp, crunchy foods.</li>
<li>Drinks that contain alcohol.</li>
</ul>
<p>&gt; Do not use tobacco products.
&gt; Visit a dentist at least 2 weeks before starting biological therapy, chemotherapy, or radiation therapy to the head or neck.
&gt; Rinse your mouth 3 to 4 times a day. Mix ¼ teaspoon baking soda, ⅛ teaspoon salt, and 1 cup warm water for a mouth rinse.
&gt; Check your mouth each day for sores, white patches, or puffy and red areas.</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Avoid items that can hurt or burn your mouth, such as:</p>
<ul>
<li>
<p>Mouthwash containing alcohol.</p>
</li>
<li>
<p>Toothpicks or other sharp objects.</p>
</li>
<li>
<p>Tobacco products.</p>
</li>
<li>
<p>Alcohol.</p>
</li>
<li>
<p>Sore throat and trouble swallowing</p>
</li>
<li>
<p>Eat five or six small meals each day instead of three large meals.</p>
</li>
<li>
<p>Choose foods that are easy to swallow, e.g., milkshakes, scrambled eggs, and cooked cereal.</p>
</li>
<li>
<p>Choose foods and drinks that are high in protein and calories.</p>
</li>
<li>
<p>Cook foods until they are soft and tender.</p>
</li>
<li>
<p>Cut food into small pieces and use a blender or food processor to puree foods.</p>
</li>
<li>
<p>Moisten and soften foods with gravy, sauces, broth, or yogurt.</p>
</li>
<li>
<p>Sip drinks through a straw to make them easier to swallow.</p>
</li>
<li>
<p>Do not eat or drink things that can burn or scrape your throat, such as:</p>
</li>
<li>
<p>Hot foods and drinks.</p>
</li>
<li>
<p>Spicy foods.</p>
</li>
<li>
<p>Foods and juices that are high in acid.</p>
</li>
<li>
<p>Sharp or crunchy foods.</p>
</li>
<li>
<p>Drinks that contain alcohol.</p>
</li>
<li>
<p>Sit upright and bend your head slightly forward when eating or drinking, and stay upright for at least 30 minutes after eating.</p>
</li>
<li>
<p>Do not use tobacco products.</p>
</li>
<li>
<p>Consider tube feedings if your inability to eat is severely affecting your strength.</p>
</li>
<li>
<p>Taste changes</p>
</li>
<li>
<p>Use plastic utensils, and do not drink directly from metal containers if foods taste metallic.</p>
</li>
<li>
<p>Substitute poultry, fish, eggs, and cheese for red meat.</p>
</li>
<li>
<p>Consult a vegetarian or cookbook for useful nonmeat, high-protein recipes.</p>
</li>
<li>
<p>Add spices and sauces to foods; marinate foods.</p>
</li>
<li>
<p>Eat meat with something sweet, such as cranberry sauce, jelly, or applesauce.</p>
</li>
<li>
<p>Try tart foods and drinks.</p>
</li>
<li>
<p>Try to eat your favorite foods, if you are not nauseated. Try new foods when feeling your best.</p>
</li>
<li>
<p>If tastes are dull but not unpleasant, chew food longer to allow more contact with taste receptors.</p>
</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>&gt; If smells are an issue, keep foods covered, use cups with lids, drink through a straw, and use a kitchen fan when cooking, or cook outdoors.
&gt; Use sugar-free lemon drops, gum, or mints when experiencing a metallic or bitter taste in the mouth. Use special mouthwashes.
&gt; Visit your dentist and maintain good oral hygiene.</p>
<ul>
<li>
<p>Vomiting
&gt; Do not eat or drink until vomiting stops.
&gt; Drink small amounts of clear liquids after vomiting stops.
&gt; Once you can drink clear liquids without vomiting, try full-liquid foods and drinks or those that are easy on your stomach.
&gt; Eat five or six small meals each day instead of three large meals.
&gt; Ask your doctor to prescribe medicine to prevent or control vomiting (antiemetic or antinausea medicines).
&gt; Sit upright and bend forward after vomiting.</p>
</li>
<li>
<p>Weight gain
&gt; Eat lots of fruits and vegetables, which are high in fiber and low in calories.
&gt; Eat foods that are high in fiber, such as whole-grain breads, cereals, and pasta.
&gt; Choose lean meats such as lean beef, pork trimmed of fat, or poultry without skin.
&gt; Choose low-fat milk products.
&gt; Eat less fat; limit amounts of butter, mayonnaise, desserts, fried foods and other high-calorie foods.
&gt; Cook with low-fat methods such as broiling, steaming, grilling, or roasting.
&gt; Eat small portion sizes.
&gt; Eat less salt. Limiting salt will help you not retain water if your weight gain results from water retention.
&gt; Exercise daily.
&gt; Talk with your doctor before going on a diet to lose weight.
&gt; Pay attention to portion sizes; check food labels and the serving sizes listed.
&gt; Include and serve foods that you enjoy most so you feel satisfied.
&gt; Eat only when hungry.
&gt; Consider psychological counseling or medications if you find yourself eating to address feelings of stress, fear or depression and try to find alternatives to eating out of boredom.</p>
</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="oral-nutrition-supplements">Oral nutrition supplements<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#oral-nutrition-supplements" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>
<p>Commercially available oral nutrition supplements (e.g., Boost, Ensure) are often used to improve the adequacy of nutrient intake. These medical food products are not intended to serve as the sole source of nutrition, but to supplement energy, protein, fat, carbohydrate, and/or fiber intake, and also contribute to vitamin and mineral intake. Recommendations for oral nutrition supplements are based on assessment of</p>
</li>
<li>
<p>a patient's nutrition status</p>
</li>
<li>
<p>nutrient needs</p>
</li>
<li>
<p>GI function</p>
</li>
<li>
<p>clinical condition</p>
</li>
<li>
<p>diet</p>
</li>
<li>
<p>food preferences</p>
</li>
<li>
<p>comorbid conditions</p>
</li>
<li>
<p>resources</p>
</li>
<li>
<p>Patients with cancer need adequate protein to maintain and rebuild lean body mass. A systematic review of multi-nutrient, high-protein oral nutrition supplements found significant improvement in total energy and protein intake and reduced incidence of complications. Specialized products are also available for use in clinical conditions requiring diet modifications. Research related to oral nutrition supplements and cancer patients has primarily focused on products containing fish oil/omega-3 fatty acids. A systematic review of 38 studies did not find evidence to support a benefit of fish oil (supplements or enriched oral nutrition drinks) for the treatment of cachexia in advanced cancer. A randomized trial evaluated the perioperative use of an oral nutrition drink enriched with eicosapentaenoic acid (EPA) (fish oil). In patients with resectable gastric cancer, supplementation did not change postoperative weight loss or complication rates</p>
</li>
<li>
<p>Although supplements containing fish oil alone do not seem to be beneficial in cachexia or surgery recovery, studies of immune-enhancing (IE) formulas containing fish oil, as well as arginine and nucleotides, suggest benefit for individuals undergoing GI surgery. A 2012 Cochrane review found significant reduction in postoperative complications and infections when IE oral supplements or enteral feeding were given before GI surgery. A 2015 Bayesian network meta-analysis of randomized controlled trials also demonstrated reduction in postoperative infectious complications when IE formulas were used preoperatively. Studies of both preoperative and postoperative use found that non-infectious complications and hospital length of stay were also reduced</p>
</li>
<li>
<p>There is concern that long-term use of oral nutrition supplements can result in taste fatigue and decreased compliance with recommendations. A systematic review of compliance with oral nutrition supplements suggested that compliance is good, especially with higher-energy-density supplements. Weaknesses of the review were that compliance was not the primary outcome variable of most of the evaluated studies, the analysis involved mean results from groups of subjects rather than individual compliance, and only 11% of the studies involved patients with cancer.</p>
</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>When oral supplements do not achieve nutrition goals, enteral and/or parenteral nutrition can be considered in the context of a patient's nutrition status and the overall medical treatment plan</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pharmaceutical-management-of-cancer-associated-cachexia-and-weight-loss">Pharmaceutical management of cancer-associated cachexia and weight loss<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pharmaceutical-management-of-cancer-associated-cachexia-and-weight-loss" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Many treatments have been suggested for cachexia-anorexia syndrome (CAS), but few of these treatments have resulted in consistent improvement, probably because of the multifactorial mechanisms involved. Treatment must both reverse the metabolic disturbances in carbohydrate, lipid and protein metabolism and treat the associated decrease in caloric intake. Although most studies have examined single agents targeting one part of the multifactorial issues associated with CAS, many investigators have suggested that a multidrug approach might be more beneficial</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="i-appetite-stimulants">i) Appetite stimulants<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-appetite-stimulants" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The first issue widely studied for treatment has been anorexia associated with CAS. The use of agents that improve appetite and resultant caloric intake have been widely studied; these agents include corticosteroids, progesterone analogs, androgens, cannabinoids, and cyproheptadine.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ii-corticosteroids">ii) Corticosteroids<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-corticosteroids" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Perhaps the earliest agents studied for the management of cancer cachexia are dexamethasone and prednisolone. Used in cancer treatment for their anti-inflammatory, antimalignancy, and antiemetic properties, steroids have produced side effects such as increased appetite and weight gain, probably because of their effects in the hypothalamus.</p>
<p>Several large placebo-controlled studies have shown increases in appetite and weight gain associated with steroid use in this setting. However, the palliative effects on CAS have typically been short lived, and prolonged use is associated with significant side effects such as furthering catabolic effects on muscle, myopathy, joint disease, hyperglycemia, and hypertension</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iii-progesterone-analogs">iii) Progesterone analogs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-progesterone-analogs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Like steroids, progesterone antagonists are effective in improving appetite and weight in patients with AIDS-related cachexia and Cachexia-Anorexia Syndrome (CAS). They may also improve muscle catabolism. In a study of tumor-bearing rats, use of megestrol acetate resulted in a reversal of muscle wasting and improved physical performance. However, as with steroids, in clinical trials the improvement was shown to be temporary increases in fat and water mass without concomitant improvements in lean body mass or quality of life</p>
<p>A Cochrane review of 35 trials involving 3,963 patients reported the use of megestrol at doses of 160 to 800 mg/d for treatment of CAS. The only consistent benefits seen were weight gain and improved appetite. No definitive conclusions about other outcomes related to lean body mass, quality of life, or fatigue could be drawn. No improvement in survival was found]</p>
<p>A placebo-controlled study looked at megestrol acetate at a dose of 7.5 mg/kg per day in 26 children with weight loss exceeding 5%. The megestrol group had a mean weight gain of 19.7% compared with weight loss of 1.2% (P = .003) in the placebo group. Megestrol has also been studied in prophylaxis of weight loss, but again there was no demonstrated improvement in quality of life, lean muscle mass, or survival. Concerns have also been</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>raised about a possible increase in thromboembolic phenomena, sex hormone dysregulation, and suppression of the hypothalamic-pituitary axis, resulting in symptomatic adrenal insufficiency</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iv-cannabinoids">iv) Cannabinoids<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iv-cannabinoids" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Interest in the use of cannabinoids in CAS is ongoing because of their effects on appetite and potential benefit in HIV-related cachexia. However, in a study of 469 patients comparing dronabinol alone versus megestrol acetate alone versus dronabinol plus megestrol acetate, dronabinol was inferior to megestrol acetate, and there was no additive effect when the drugs were used together. A similar European trial of 243 patients comparing dronabinol with placebo also found no benefit. Refer to the PDQ summary on Cannabis and Cannabinoids for more information about cannabis and cannabinoids.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="v-cyproheptadine">v) Cyproheptadine<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#v-cyproheptadine" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Cyproheptadine is a serotonin and histamine antagonist developed as an antihistamine. Side effects include increased appetite and weight gain. Studied mostly in children with a wide range of disorders associated with anorexia and weight loss, cyproheptadine has been shown to result in significant improvements in weight in a number of studies. In a study of cyproheptadine use in children with CAS, one group of investigators evaluated 66 children with weight loss exceeding 5%. The children received cyproheptadine at a daily dosage of 0.25 mg/kg. Seventy-six percent of the patients were classified as responders, experiencing either weight gain or no further weight loss. Patients also showed a significant increase in serum leptin levels. Leptin is a protein hormone produced by adipocytes and is associated with body mass, particularly body fat. An increase in serum leptin has been correlated with an increase in body mass index</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="vi-anti-inflammatory-agents">vi) Anti-inflammatory agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#vi-anti-inflammatory-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>CAS is a multifactorial disorder that occurs in more than 50% of patients with advanced cancer. Increases in cytokines associated with cancer—including tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1—have been shown to be important in the etiology of this disorder. Pharmaceutical agents that inhibit the cytokine increases seen with cancer have been studied in patients with CAS. EPA, an omega-3 fatty acid found in fish oil, has been used in a number of trials. However, a meta-analysis has failed to show a consistent improvement in CAS. Similarly, several systemic literature reviews of studies using nonsteroidal anti-inflammatory agents have failed to show conclusive evidence of efficacy</p>
<p>Specific targeted agents have also been studied. These include agents targeting TNF-alpha, such as etanercept, infliximab, and pentoxifylline, which, in small trials, have not had a significant impact</p>
<p>Several studies using thalidomide, a nonspecific antagonist to TNF, have been performed. Thalidomide is of interest as a treatment for CAS because of its immunomodulatory properties. A single-center, double-blind trial randomly assigned 50 pancreatic cancer patients who had lost at least 10% of their body weight to receive thalidomide 200 mg or placebo for 24 weeks. Thalidomide patients had a statistically significant reduction in weight loss compared with placebo patients. A similarly sized trial of thalidomide 100 mg demonstrated no significant treatment effect. Additionally, a Cochrane review on this topic reported insufficient evidence to support the use of thalidomide in patients with advanced cancer.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="other-agents-of-interest">Other agents of interest<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#other-agents-of-interest" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>There has been interest in several other agents for the management of CAS, including mirtazapine, metoclopramide, formoterol, melatonin, and olanzapine. However, no completed clinical trials support their use.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="combination-therapy">Combination therapy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#combination-therapy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Given the multifactorial etiology of, and multiple mechanisms involved in, the development of CAS, it is possible that combining multiple agents with different mechanisms of action might result in greater efficacy. In one study, 332 patients diagnosed with CAS were randomly assigned to one of five treatment arms: medroxyprogesterone alone; oral supplementation with EPA; L-carnitine; thalidomide; or a combination of all four agents. Investigators looked at lean body mass, resting energy expenditure, and fatigue. In this study, the combination arm was found to be superior. Another trial used megestrol alone versus megestrol plus L-carnitine, celecoxib, and antioxidants to treat 104 women with gynecologic malignancies. Again, the combination arm was found to be superior.</p>
<p>Researchers also looked at the combination of formoterol, an anabolic beta-2 adrenergic agonist, and megestrol acetate in 13 patients. Six of seven evaluable patients achieved a major response, with increases in muscle mass. Conversely, another study looking at megestrol plus meloxicam versus meloxicam plus EPA versus megestrol plus meloxicam and EPA showed no advantage to the three-drug regimen. However, such combinations also may result in increased cumulative toxicity. For these reasons, there is no recommended combination at this time. In addition, combining drug therapy with nutrition support and increased physical activity may have even greater efficacy.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="summary-of-pharmaceutical-treatment-strategies">Summary of pharmaceutical treatment strategies<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#summary-of-pharmaceutical-treatment-strategies" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>CAS is a complex, multifactorial complication of cancer and its therapy, resulting in weight loss and decreased lean body mass. As understanding of the mechanisms of CAS improves and new agents that selectively target these proposed pathways become available, more efficacious treatments are also expected to become available. Trials of new agents must be able to compare similar groups of patients. In addition, treating preventatively in high-risk patients, as opposed to treating patients already suffering from CAS, may be associated with better outcomes. Further clinical trials are essential to determine the best possible therapies (Grant BL.et al, 2015)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="nutrition-trends-in-cancer">Nutrition trends in cancer<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nutrition-trends-in-cancer" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="special-diets">Special diets<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#special-diets" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>Maintaining adequate nutrition while undergoing treatment for cancer is imperative because it can reduce treatment-related side effects, prevent delays in treatment and help maintain quality of life.</li>
<li>However, many patients view their diet as a way to enhance treatment effectiveness, minimize treatment-related toxicities, or target the cancer itself, often done by following a specific diet with supposed cancer-fighting benefits or by taking dietary supplements.</li>
</ul>
<p>NB: Patients are likely to search the Internet and other lay sources of information for dietary approaches to manage cancer risk and to improve prognosis.</p>
<p>i) Vegetarian or vegan diet</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>A vegetarian diet is popular, is easy to implement and, if followed carefully, does not result in nutrition deficiencies. There is strong evidence that a vegetarian diet reduces the incidence of many types of cancer, especially cancers of the gastrointestinal (GI) tract. However, it is unknown how following a vegetarian or vegan diet can affect treatment-induced symptoms, cancer therapies, or outcomes for someone undergoing cancer therapy. There are no published clinical trials, pilot studies, or case reports on the effectiveness of a vegetarian diet for the management of cancer therapy and symptoms. There is no evidence suggesting a benefit of adopting a vegetarian or vegan diet upon diagnosis or while undergoing cancer therapy. On the other hand, there is no evidence that an individual who follows a vegetarian or vegan diet before cancer therapy should abandon it upon starting treatment.</p>
<p>One pilot study has suggested that following a plant-based diet can prevent tumor progression in men with localized prostate cancer. A randomized controlled trial based on this pilot study is under way to determine effectiveness. No other current clinical trials are studying the role of a vegetarian or vegan diet in cancer therapy.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ii-macrobiotic-diet">ii) Macrobiotic diet<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-macrobiotic-diet" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A macrobiotic diet varies according to a person's sex, their level of activity, and the climate (and season) in which they live, among other variables. It is a high-carbohydrate, low-fat, plant-based diet stemming from philosophical principles promoting a healthy way of living. The diet consists of 35% to 50% (by weight) whole grains, 25% to 35% vegetables, 5% to 10% soup, 5% to 10% cooked vegetables and sea vegetables, and 5% to 10% fish.</p>
<p>Although there are anecdotal reports on the effectiveness of a macrobiotic diet as an alternative cancer therapy, none have been published in peer-reviewed, scientific journals. No clinical trials, observational studies, or pilot studies have examined the diet as a complementary or alternative therapy for cancer. In fact, two reviews of the diet and its evidence for effectiveness in cancer treatment concluded that there is no scientific evidence for the use of a macrobiotic diet in cancer treatment. Because the current research is severely lacking, recommendations for or against the diet in conjunction with standard cancer treatment cannot be made. No current clinical trials are studying the role of the macrobiotic diet in cancer therapy.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iii-ketogenic-diet">iii) Ketogenic diet<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-ketogenic-diet" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A ketogenic diet has been well established as an effective alternative treatment for some cases of epilepsy and has gained popularity for use in conjunction with standard treatments for glioblastoma. The theory behind the diet as cancer treatment is that reducing glucose availability to a tumor can reduce tumor activity, and that this reduction can be achieved through entering a state of ketosis via the ketogenic diet's restriction of carbohydrates and increased fat intake.</p>
<p>The ketogenic diet can be difficult to follow and relies more on exact proportions of macronutrients (typically a 4 to 1 ratio of fat to carbohydrates and protein) than do other complementary and alternative medicine (CAM) diets. Therefore, most studies have focused on the diet's feasibility, tolerability, and safety, all of which have been shown for glioblastoma patients at various stages of the disease</p>
<p>Because safety and feasibility have been proven, several trials are recruiting patients to study the effectiveness of the ketogenic diet on glioblastoma. Therefore, if a patient diagnosed with glioblastoma wishes to start a</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>ketogenic diet, it would be safe if implemented properly and under the guidance of a registered dietitian. but effectiveness for symptom and disease management remains unknown.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="dietary-supplements">Dietary supplements<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#dietary-supplements" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-vitamin-c">i) Vitamin C<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-vitamin-c" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Refer to the PDQ summary on High-Dose Vitamin C for more information about the use of high-dose vitamin C as a treatment for people with cancer.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="ii-probiotics">ii) Probiotics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-probiotics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>The use of probiotics has become prevalent within and outside of cancer therapy. Strong research has shown that probiotic supplementation during radiation therapy, chemotherapy, or both is well tolerated and can help prevent radiation- and chemotherapy-induced diarrhea, especially in those receiving radiation to the abdomen.. Therefore, if a patient is undergoing radiation to the abdomen or receiving a chemotherapy agent with diarrhea as a common side effect, starting a probiotic supplement upon initiation of therapy could be beneficial.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="iii-melatonin">iii) Melatonin<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-melatonin" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Melatonin is a hormone produced endogenously that has been used as a CAM supplement (along with chemotherapy or radiation therapy) for targeting tumor activity and for reducing treatment-related symptoms, primarily for solid tumors.</p>
<p>Several studies have shown tumor response to, or disease control with, chemotherapy alongside oral melatonin, as opposed to chemotherapy alone; one study has shown tumor response with melatonin in conjunction with radiation therapy. The combination of melatonin with chemotherapy may, in fact, increase survival time compared with chemotherapy alone, for up to 5 years. However, another study did not demonstrate increased survival with melatonin, but did demonstrate improved quality of life</p>
<p>Melatonin taken in conjunction with chemotherapy may help reduce or prevent some treatment-related side effects and toxicities that can delay treatment, reduce doses, and negatively affect quality of life. Melatonin supplementation has been associated with significant reductions in neuropathy and neurotoxicity, myelosuppression, thrombocytopenia, cardiotoxicity, stomatitis, asthenia, and malaise. However, one study found no benefit in taking supplemental melatonin for reducing toxicities or improving quality of life</p>
<p>Overall, several small studies show some evidence supporting melatonin supplementation alongside chemotherapy, radiation therapy, or both for solid tumor treatment, for aiding tumor response and reducing toxicities, while negative side effects for melatonin supplementation have not been found. Therefore, it may be appropriate to provide oral melatonin in conjunction with chemotherapy or radiation therapy to a patient with an advanced solid tumor.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="iv-oral-glutamine">iv) Oral glutamine<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iv-oral-glutamine" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Glutamine is an amino acid that is especially important for GI mucosal cells and their replication. These cells are often damaged by chemotherapy and radiation therapy, causing mucositis and diarrhea, which can lead to treatment delays and dose reductions and severely affect quality of life. Some evidence suggests that oral glutamine can reduce both of those toxicities by aiding in faster healing of the mucosal cells and entire GI tract.</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>For patients receiving chemotherapy who are at high risk of developing mucositis, either because of previous mucositis or having received known mucositis-causing chemotherapy, oral glutamine may reduce the severity and incidence of mucositis</p>
<p>For patients receiving radiation therapy to the abdomen, oral glutamine may reduce the severity of diarrhea and can lead to fewer treatment delays. However, one study found no benefit to oral glutamine for preventing chemotherapy-related diarrhea</p>
<p>In addition to reducing GI toxicities, oral glutamine may also reduce peripheral neuropathy in patients receiving the chemotherapy agent paclitaxel. Larger randomized controlled trials need to be conducted to further determine the effectiveness of oral glutamine in treating peripheral neuropathy.</p>
<p>Oral glutamine is a safe, simple, and relatively low-cost supplement that may reduce severe chemotherapy- and radiation-induced toxicities (Lis CG et al, 2012)</p>
<p>It is not uncommon for patients with cancer to experience loss of appetite throughout the care continuum, leading to weight loss and malnutrition. With prolonged malnutrition, the risk of cancer-induced cachexia is increased. Several factors can lead to malnutrition, including disease, chemotherapy treatment, and psychosocial issues. Throughout treatment, patients are likely to experience any of the following side effects: loss of appetite, constipation and/or diarrhea, dry mouth, lactose intolerance, nausea/vomiting, sore throat, taste changes, and/or cancer-related weight gain. All of these factors can contribute to weight loss and malnutrition.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="identifying-patients-at-risk-of-cancer-related-malnutrition">Identifying patients at risk of cancer-related malnutrition<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#identifying-patients-at-risk-of-cancer-related-malnutrition" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="screening-tools">Screening Tools<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#screening-tools" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Nutrition support personnel should utilize validated screening tools to identify patients requiring nutritional interventions. Several tools are available to assist in identifying patients at risk for poor nutrition:</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="patients-at-particular-risk">Patients at particular risk<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#patients-at-particular-risk" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Some patients are more likely to develop malnutrition secondary to their diagnosis. Patients requiring hematopoietic stem cell transplantation and those with head and neck cancer, esophageal cancer, advanced incurable cancers, and patients in the perioperative setting have an increased risk of poor nutritional intake. These patients often experience treatment-related complications, including mucositis, radiation therapy exposure to the head and neck, chemotherapy-induced nausea/vomiting, tumor obstruction, and surgical interventions that hinder their oral intake.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="other-patients-at-increased-risk-of-developing-malnutrition-include-those-with-the-following-conditions">Other patients at increased risk of developing malnutrition include those with the following conditions:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#other-patients-at-increased-risk-of-developing-malnutrition-include-those-with-the-following-conditions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>GI Malignancies. Patients with GI malignancies and those who undergo extensive bowel resections are at an increased risk for vitamin B12, vitamin D, and calcium deficiencies secondary to impaired absorption.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Hematopoietic Stem Cell Transplants. Chemotherapy and immunosuppressive therapy for hematopoietic stem cell transplantation patients, such as methotrexate, fluorouracil, vinblastine, dacarbazine, cyclosporine, and tacrolimus, can cause photosensitivity and subsequent vitamin D deficiencies due to minimized sun exposure.</li>
<li>Cancer-Supportive Therapies. Medications given to support cancer therapies, such as denosumab and zoledronic acid used in prevention of skeletal-related events and hypercalcemia of malignancy, can induce hypocalcemia.</li>
<li>Electrolyte and Metabolic Abnormalities. Agents such as epidermal growth factor receptor inhibitors, mTOR inhibitors, and tyrosine kinase inhibitors can lead to electrolyte abnormalities (primarily magnesium, potassium, and phosphorus), as well as abnormal cholesterol panels. (Of note, metabolic abnormalities could also arise from treatment-induced hypothyroidism; however, treatment is primarily hormone replacement and is beyond the scope of this article.)</li>
</ul>
<p>These factors should be considered when assessing patients regarding the complications of poor nutrition. Furthermore, these factors can be used to gain administration buy-in to providing resources for nutrition support personnel on care teams.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="goals-of-nutrition-therapy">Goals of nutrition therapy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#goals-of-nutrition-therapy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The goals for medical nutrition therapy are :</p>
<ul>
<li>To address current cancer and treatment-related issues</li>
<li>Minimize treatment-related side effects</li>
<li>Anticipate and manage acute, delayed and late-occurring side effects of cancer and/or cancer treatment</li>
</ul>
<p>&gt; Goals must be individualized for each patient on the basis of:</p>
<ul>
<li>nutrition status</li>
<li>type and stage of disease</li>
<li>comorbid conditions</li>
<li>and overall medical treatment plan</li>
</ul>
<p>NB: Decisions about the best approach for therapy are informed by symptom severity and function of the gastrointestinal (GI) tract. Treatment could include multiple strategies based on these factors.</p>
<p>&gt; Nutrition goals during and after cancer therapy are integrated with goals related to nutrition status and the presence of malnutrition.
&gt; A healthy diet with an emphasis on plant-based foods, regular physical activity and achievement of a healthy weight has been recommended for all patients after cancer treatment on the basis of extensive reviews of the evidence (Marian M, et al, 2014)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="conclusion">Conclusion<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#conclusion" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Malnutrition may occur in a significant percentage of patients with cancer, and it is a major cause of morbidity and mortality in those with advanced disease. The condition is prevalent in patients with GI malignancies, head</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>and neck cancers, and in transplant patients, and is associated with poorer overall survival (in some malignancies), increased chemotherapy-related toxicity, and poorer quality of life.</p>
<p>Due to the paucity of evidence demonstrating benefit in patients who are well nourished or mildly malnourished, nutrition support should be avoided in these patients. Because oral nutritional interventions may improve quality of life, patients with poor oral intake of an expected duration of greater than 7 days, and who are severely malnourished, should be considered for EN or PN therapy; the latter should be tried last. Strong evidence exists to support the use of nutrition therapy in patients undergoing major abdominal surgery, hematopoietic cell transplant patients with severe mucositis or GI manifestations of graft-versus-host disease, and in patients with head and neck cancers.</p>
<p>Nutrition support personnel should be involved in cancer care teams to aid in early identification of patients who would benefit from therapy. Nutrition must be actively managed throughout the continuum of care of cancer patients, as nutritional needs may change over time. Looking ahead, large clinical trials are needed to identify nutritional goals throughout the various cancer care settings</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="hospice-care">Hospice care<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hospice-care" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Hospice is given because one matters to the last moment of his/her life, and therefore all should be done, not only to help one die peacefully, but also to live until one dies.</p>
<ul>
<li>Dame Cicely Saunders is the founder of the first modern hospice</li>
<li>Hospice care is a special kind of care that focuses on the quality of life for people and their caregivers who are experiencing an advanced, life-limiting illness.</li>
<li>Hospice care provides compassionate care for people in the last phases of incurable disease so that they may live as fully and comfortably as possible.</li>
<li>The hospice philosophy accepts death as the final stage of life, it affirms life, but does not try to hasten or postpone death.</li>
<li>Hospice care treats the person and symptoms of the disease, rather than treating the disease itself.</li>
<li>A team of professionals work together to manage symptoms so that a person’s last days may be spent with dignity and quality, surrounded by their loved ones.</li>
<li>Hospice care is also family-centered, it includes the patient and the family in making decisions.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="when-should-hospice-care-start">When should hospice care start?<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#when-should-hospice-care-start" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Hospice care is used when a disease, such as advanced cancer, gets to the point when treatment can no longer cure or control it.</li>
<li>In general, hospice care should be used when a person is expected to live about 6 months or less if the illness runs its usual course.</li>
<li>People with advanced cancer should have a discussion with their family members and doctor to decide together when hospice care should begin.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>NB:</p>
<ul>
<li>Studies show hospice care often is not started soon enough. Sometimes the doctor, patient, or family member will resist hospice because they think it means “giving up” or that there’s no hope. It's important to know that you can leave hospice and go into active cancer treatment any time you want. But the hope that hospice brings is a quality life, making the best of each day during the last stages of advanced illness.</li>
<li>Some doctors/health care team don’t bring up hospice, so the patient or family member might decide to start the conversation. If your treatment isn’t working anymore and you have run out of treatment options, you might want to ask your doctor or a member of your cancer care team about hospice.</li>
</ul>
<p>Palliative care and symptom control</p>
<ul>
<li>Palliative care may also be called supportive care, symptom management, or comfort care. It can be given separately from hospice care E.g, while still in active cancer treatment, but it's often a part of hospice care if cancer is no longer being treated because it has worsened. Palliative care does not treat the cancer itself. Instead, it's used to prevent or treat symptoms and side effects as early as possible.</li>
<li>As part of hospice care, palliative care looks at how the cancer experience is affecting the whole person and help to relieve symptoms, pain, and stress. It gives patients options and allows them and their caregivers to take part in planning their care. It’s about assuring that all their care needs are addressed. The specialized professionals who are part of the palliative care team can help look for and manage mental, physical, emotional, social and spiritual issues that may come up.</li>
<li>The main goal of including palliative care into hospice services is to help patients be comfortable while allowing them to enjoy the last stage of life. This means that discomfort, pain, nausea and other side effects are managed to make sure that you feel as good as possible, and are alert enough to enjoy the people around you and make important decisions.</li>
</ul>
<p>Home care and inpatient hospice care</p>
<p>i) Spiritual care</p>
<p>Since people differ in their spiritual needs and religious beliefs, spiritual care is set up to meet patient’s specific needs. It might include helping patient look at what death means to him/her, helping him/her say good-bye, or helping with a certain religious ceremony or ritual.</p>
<p>ii) Family meetings</p>
<p>Regularly scheduled meetings, often led by the hospice nurse or social worker, keep family members informed about patient’s condition and what to expect. These meetings also give everyone a chance to share feelings, talk about what’s happening and what’s needed, and learn about death and the process of dying. Family members can get great support and stress relief through these meetings. Daily updates may also be given informally as the nurse or nursing assistant talks with the patient and his/her caregivers during routine visits.</p>
<p>iii) Coordination of care</p>
<p>122</p>
<p>The hospice team coordinates and supervises all care 7 days a week, 24 hours a day. This team is responsible for making sure that all involved services share information. This may include the inpatient facility, the doctor, and other community professionals, such as pharmacists, clergy and funeral directors. Patient and his/her caregivers are encouraged to contact the hospice team if one is having a problem, any time of the day or night. There's always someone on call to help the patient with whatever may arise. Hospice care assures the patient and his/her family that the patient are not alone and can get help at any time.</p>
<p>iv) Respite care</p>
<p>For patients being cared for at home, some hospice services offer respite care to allow friends and family some time away from caregiving. Respite care can be given in up to 5-day periods of time, during which the person with cancer is cared for either in the hospice facility or in beds that are set aside in nursing homes or hospitals. Families can plan a mini-vacation, go to special events, or simply get much-needed rest at home while the patient is cared for in an inpatient setting.</p>
<p>v) Bereavement care</p>
<p>Bereavement is the period of mourning after a loss. The hospice care team works with surviving loved ones to help them through the grieving process. A trained volunteer, clergy member, or professional counselor provides support to survivors through visits, phone calls, and/or other contact, as well as through support groups. The hospice team can refer family members and caregiving friends to other medical or professional care if needed. Bereavement services are often provided for about a year after the patient's death.</p>
<p>NB:</p>
<p>Although most hospice care is centered in the home, there might be times when the patient need to be in a hospital, extended-care facility, or an inpatient hospice center. The home hospice team can arrange for inpatient care and will stay involved in patient's care and with the family. Patient can go back to in-home care when he/she and family are ready.</p>
<p>Is hospice care the same as palliative care?</p>
<p>Hospice care and palliative care both aim to provide better quality of life and relief from symptoms and side effects for people with a serious illness. Both have special care teams that address a person's physical, emotional, mental, social and spiritual needs. But although hospice care often includes palliative care, they are not the same thing.</p>
<p>How are they different?</p>
<p>vi) When care is given:</p>
<ul>
<li>Hospice care is offered and provided for patients during their last phase of an incurable illness or near the end of life, such as in some people with advanced or metastatic cancer.</li>
<li>Palliative care can be offered and provided at any stage of a serious illness.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>vii) What other care can be given:</p>
<ul>
<li>Hospice care is provided when there is no active or curative treatment being given for the serious illness. "Treatment" during hospice care involves managing symptoms and side effects.</li>
<li>Palliative care can be provided while the patient is receiving active treatment. In other words, it can be given at the same time as chemotherapy, radiation or immunotherapy for cancer.</li>
</ul>
<p>viii) What the care team does:</p>
<ul>
<li>A hospice care team coordinates the majority of care for a patient, and communicates with the patient's medical care team.</li>
<li>A palliative care team is separate from the patient's medical care team that's giving and managing treatment for the illness, but communicates with the medical care team</li>
</ul>
<p>Example of nursing care plan</p>
<p>Nursing priorities</p>
<ul>
<li>Support adaptation and independence</li>
<li>Promote comfort</li>
<li>Maintain optimal physical functioning</li>
<li>Prevent complications</li>
<li>Provide information about disease process/condition, prognosis and treatment needs</li>
</ul>
<p>Discharge goals</p>
<ul>
<li>Patient is dealing with current situation realistically</li>
<li>Pain alleviated/controlled</li>
<li>Homeostasis achieved</li>
<li>Complications prevented/minimized</li>
<li>Disease process/condition, prognosis and therapeutic choices and regimen understood.</li>
<li>Plan in place to meet needs after discharge.</li>
</ul>
<p>Nursing Diagnosis</p>
<ul>
<li>Risk for impaired skin integrity</li>
<li>Fear/anxiety</li>
<li>Risk for infection</li>
<li>Risk for altered family process</li>
<li>Risk for fluid volume deficit</li>
<li>Risk for constipation/diarrhea</li>
<li>Altered nutrition: less than body requirements</li>
<li>Acute pain</li>
</ul>
<p>Desired outcomes</p>
<ul>
<li>Identify and express feelings appropriately.</li>
</ul>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ul>
<li>Continue normal life activities, looking toward/planning for the future, one day at a time.</li>
<li>Verbalize understanding of the dying process and feelings of being supported in grief work</li>
<li>Verbalize understanding of body changes, acceptance of self in situation.</li>
<li>Begin to develop coping mechanisms to deal effectively with problems.</li>
<li>Demonstrate adaptation to changes/events that have occurred as evidenced by setting of realistic goals and active participation in work/play/personal relationships as appropriate.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="assignment">ASSIGNMENT<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#assignment" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A) Using a diagram describe the Grief and Loss curve
B) Describe the contents of Community care volunteer kit / Health care kit
C) Describe factors that may influence breaking of bad news
D) Differentiate between hospice care and palliative care
E) Read further on pain scales
F) Describe the most common oncology emergencies</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="reference-for-further-reading">Reference for further reading<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#reference-for-further-reading" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>1). African Palliative Care Association
2). Palliative Care Australia
3) National palliative care training curriculum for HIV &amp; AIDS, cancer and other life threatening illnesses, Trainees manual (Kenya, 2013)
4) Hinkle. J &amp; Cheerer, K. (2014). Brunner and Suddarth’s text book of Medical- Surgical Nursing 13th ed. Philadelphia: J.B Lippincott Company</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>126</p></div></div></div></div></div></div></div><div data-testid="stAppIframeResizerAnchor" data-iframe-height="true" class="st-emotion-cache-1dumvfu eht7o1d9"></div></section></div></div></div><div data-testid="portal" id="portal" class="st-emotion-cache-1q6lfs0 e19n7mk11"></div></div><div class=""></div></div>
  

</body></html>